000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1172|3075|lyfalmen|||1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1172||1172|3075||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|27126|37503|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche Registration GmbH|Epóetín||27126||27126|37503||2 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6736|10733|lyfalmen|V0457|8724|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6736||6736|10733||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|20684|29355|lyfalmen|V0475|9416|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20684||20684|29355||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|26716|36985|lyfalmen|V0540|20588|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||26716||26716|36985||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|1|FER|0|0|0|100|DKK|4258|7323|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4258||4258|7323||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4022|7801|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4022||4022|7801||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|1|FER|0|0|0|100|DKK|13021|19384|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||13021||13021|19384||1 000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3007|5601|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||3007||3007|5601||2 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2535|4951|lyfsjukr|||1|5|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||2535||2535|4951||1 000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|2614|5060|lyfalmen|V0942|4569|1|6|0||Icepharma hf|Merck AB|Prógesterón||2614||2614|5060||2 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|4230|7284|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4230||4230|7284||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2487|4885|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2487||2487|4885||1 000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|7236|11422|lyfalmen|V0942|11422|1|15|0||Icepharma hf|Merck AB|Prógesterón||7236||7236|11422||2 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|10133|15409|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||10133||10133|15409||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|32766|44637|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||32766||32766|44637||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3146|5792|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3146||3146|5792||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|81913|106798|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||81913||81913|106798||2 000985|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7648|11989|lyfalmen|V0095|6955|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||7648||7648|11989||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13933|20639|lyfalmen|V0115|8206|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||13933||13933|20639||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1676|3769|lyfalmen|V0050|2136|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1676||1676|3769||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5297|8753|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5297||5297|8753||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2478|4873|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2478||2478|4873||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19128|27790|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||19128||19128|27790||1 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|13102|19496|lyfalmen|V0637|18498|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||13102||13102|19496||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|26202|36335|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||26202||26202|36335||1 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2109|4365|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2109||2109|4365||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|4305|7387|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4305||4305|7387||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1603|2885|lyfalmen|V0291|2425|2|60|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1034||1034|2885||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3042|5649|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3042||3042|5649||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2725|4546|lyfalmen|V0292|3114|2|60|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||2241||2241|4546||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1541|3583|lyfalmen|V0004|3006|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1541||1541|3583||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3138|5781|lyfalmen|V0005|2838|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3138||3138|5781||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22338|31447|lyfsjukr|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||22338||22338|31447||2 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2714|5198|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2714||2714|5198||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12137|18167|lyfalmen|V0492|8791|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||12137||12137|18167||1 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|GPA|0|0|1|100|IKR|||lyfalmen|V0362|2692|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||2692||1 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|926|2737|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||926||926|2737||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|25211|35081|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||25211||25211|35081||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11475|14085|lyfalmen|V0089|2647|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9171||9171|14085||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|7332|11554|lyfalmen|V0515|3586|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||7332||7332|11554||1 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11182|16853|lyfalmen|V0253|5591|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||11182||11182|16853||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|21515|30406|lyfalmen|V0516|5316|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||21515||21515|30406||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|7515|11806|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||7515||7515|11806||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|11096|16734|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||11096||11096|16734||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7199|13828|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7199||7199|13828||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5354|8831|lyfalmen|V0971|8831|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5354||5354|8831||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5020|8371|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5020||5020|8371||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2718|5203|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2718||2718|5203||1 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|0|1|SGB|0|0|0|100|XEU|31253|42723|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||31253||31253|42723||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|1932|4121|lyfalmen|||2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1932||1932|4121||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|26279|31891|lyfalmen|||2|500|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||22689||22689|31891||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|950|2551|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||791||791|2551||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2746|3166|lyfalmen|V0322|2916|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||1238||1238|3166||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|16599|24309|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||16599||16599|24309||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6940|11014|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6940||6940|11014||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3997|6963|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||3997||3997|6963||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|5227|8656|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5227||5227|8656||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|7301|11511|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||7301||7301|11511||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|18472|26887|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||18472||18472|26887||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|5693|5522|lyfalmen|V0381|4563|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||2950||2950|5522||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6748|12973|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6748||6748|12973||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2847|5381|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2847||2847|5381||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001|31.12.2018|R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3744|6615|lyfalmen|||1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3744||3744|6615||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1812|3956|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||1812||1812|3956||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2551|2812|lyfalmen|V0494|2240|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||981||981|2812||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2670|3971|lyfalmen|V0318|3527|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||1823||1823|3971||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2676|5145|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2676||2676|5145||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4755|4577|lyfalmen|V0320|2838|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2263||2263|4577||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1763|3332|lyfalmen|V0317|2838|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||1359||1359|3332||1 004676|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.03.2018||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3144||2 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2263||2 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|32789|44666|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||32789||32789|44666||3 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|7567|11877|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7567||7567|11877||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|737|2476|lyfalmen|||2|24|0|3,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||737||737|2476||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4749|7998|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4749||4749|7998||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|316|1897|lyfalmen|||2|8|0|2,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||316||316|1897||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|810|2577|lyfalmen|||2|14|0|3,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||810||810|2577||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|1386|3370|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||1386||1386|3370||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2259|4571|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2259||2259|4571||1 005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|7708|6864|lyfalmen|V0148|3136|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3925||3925|6864||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2904|4610|lyfalmen|V0353|2805|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2287||2287|4610||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2238|4542|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2238||2238|4542||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2513|3996|lyfalmen|V0337|3799|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1841||1841|3996||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|16061|23568|lyfalmen|V0356|23490|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||16061||16061|23568||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|45069|58914|lyfalmen|V0451|49960|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||44054||44054|58914||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1569|3622|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1569||1569|3622||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5087|8464|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5087||5087|8464||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5158|8561|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5158||5158|8561||1 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1639|3718|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1639||1639|3718||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|5156|8559|lyfalmen|V0020|8559|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5156||5156|8559||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3767|6647|lyfalmen|V0020|4280|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3767||3767|6647||2 005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4073|7068|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Cetrorelix||4073||4073|7068||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4772|8030|lyfalmen|V0324|3250|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4772||4772|8030||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|15776|27192|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||15776||15776|27192||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7660|12005|lyfalmen|V0325|2923|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7660||7660|12005||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2413|4783|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2413||2413|4783||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13466|19077|lyfalmen|V0326|6003|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12798||12798|19077||1 005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RHA|0|0|1|100|IKR|1816|2288|lyfalmen|V0169|2288|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||600||600|2288||2 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5063|8431|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5063||5063|8431||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|87942|114423|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||87942||87942|114423||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4848|8135|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4848||4848|8135||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|67186|88171|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||67186||67186|88171||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3125|6099|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3125|6099||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12212|18271|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12212||12212|18271||1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|1|GEB|0|1|0|100|XEU|443744|502323|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||398780||398780|502323||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12837|19131|lyfalmen|V0099|6865|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||12837||12837|19131||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10362|15724|lyfalmen|V0117|5210|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||10362||10362|15724||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15162|22331|lyfalmen|V0118|8447|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15162||15162|22331||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2123|4384|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Kaptópríl||2123||2123|4384||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|18557|27004|lyfalmen|V0195|9930|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||18557||18557|27004||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|83890|109298|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||83890||83890|109298||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|217364|276692|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||217364||217364|276692||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2526|4939|lyfalmen|V0374|3880|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2526||2526|4939||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6514|10428|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||6514||6514|10428||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|98791|128145|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||98791||98791|128145||3 007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|20233|28785|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||20233||20233|28785||1 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5308|8768|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5308||5308|8768||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|0|1|SHG|0|1|0|100|XEU|217501|276863|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||217501|276863||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4312|7397|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||4312||4312|7397||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|14454|21356|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||14454||14454|21356||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1552|3043|lyfalmen|V0290|2288|2|60|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1149||1149|3043||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|3508|6290|lyfalmen|||1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||3508||3508|6290||1 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|1232|3158|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1232||1232|3158||1 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|301|1876|lyfalmen|V0502|1031|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||301||301|1876||2 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|786|2544|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||786||786|2544||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|921|2730|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||921||921|2730||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|2532|4947|lyfalmen|||2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2532||2532|4947||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|3734|6601|lyfalmen|||2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3734||3734|6601||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|5166|8572|lyfalmen|||2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5166||5166|8572||1 008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|0|1|GEB|0|0|0|100|XEU|122892|159196|lyfsjukr|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||122892||122892|159196||1 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|6960|11996|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||6960||6960|11996||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|10431|19960|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||10431||10431|19960||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1641|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2563||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2533|4948|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2533||2533|4948||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|90650|117848|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||90650||90650|117848||2 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|94040|122136|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||94040||94040|122136||2 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6208|10007|lyfalmen|V0145|2579|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||6208|10007||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|12309|18404|lyfalmen|V0145|5159|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||12309|18404||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4383|6279|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||3500||3500|6279||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6887|10941|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6887||6887|10941||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|3098|4752|lyfalmen|V0063|4752|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||2390||2390|4752||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6887|10941|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6887||6887|10941||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|PEU|0|0|1|100|DKK|10514|15933|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||10514||10514|15933||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6887|10941|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6887||6887|10941||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|45714|61013|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||45714||45714|61013||1 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1000|2838|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1000||1000|2838||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1103|2980|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1103||1103|2980||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1276|3218|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1276||1276|3218||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1598|3661|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1598||1598|3661||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|6157|9936|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6157||6157|9936||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6516|10431|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6516||6516|10431||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|6157|9936|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6157||6157|9936||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|163617|209846|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||163617||163617|209846||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|49542|65855|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||49542||49542|65855||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8669|12125|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||7747||7747|12125||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9394|13353|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8639||8639|13353||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7468|11741|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7468||7468|11741||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9394|13353|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8639||8639|13353||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7572|11884|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7572||7572|11884||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8669|11384|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||7209||7209|11384||1 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|1885|4056|lyfalmen|V0329|2801|1|30|0|15,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||1885||1885|4056||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|131663|170104|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||131663||131663|170104||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|5922|9613|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5922||5922|9613||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|11253|16951|lyfalmen|V0331|3985|1|96|0|96,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||11253||11253|16951||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|15866|23300|lyfalmen|||1|96|0|144,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||15866||15866|23300||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|15399|22657|lyfalmen|V0605|2838|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||15399||15399|22657||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9894|15080|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||9894||9894|15080||1 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8076|12578|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||8076||8076|12578||1 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1097|2972|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1097||1097|2972||2 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|JCI|0|1|0|100|SEK|272590|345378|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||272590||272590|345378||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|JCI|0|1|0|100|SEK|272590|345378|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||272590||272590|345378||3 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|645465|809130|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||645465||645465|809130||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|37012|50007|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||37012||37012|50007||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|MEA|0|0|0|100|DKK|2426|3132|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Meda AB|Kloxacillín||1213||1213|3132||2 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2231|2687|lyfalmen|V0058|2687|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||890||890|2687||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|17734|25871|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||17734||17734|25871||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|12225|18288|lyfalmen|V0716|4903|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||12225||12225|18288||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2980|3114|lyfalmen|V0059|3114|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1200||1200|3114||2 010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1641|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1641||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|27242|37650|lyfalmen|V0683|2825|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||27242||27242|37650||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|G|0|OPC|0|0|0|100|DKK|22011|31034|lyfalmen|V0684|2825|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||22011||22011|31034||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3965|6919|lyfalmen|V0825|2834|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3965||3965|6919||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4120|7133|lyfalmen|V0826|2834|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4120||4120|7133||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14041|20788|lyfalmen|V0327|5642|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14041||14041|20788||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1052|2910|lyfalmen|V0827|1942|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1052||1052|2910||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2156|2558|lyfalmen|V0069|2512|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||796||796|2558||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5282|8732|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5282||5282|8732||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5055|8115|lyfalmen|V0691|5376|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4834||4834|8115||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|6473|7519|lyfalmen|V0624|5162|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4401||4401|7519||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1699|3339|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1699||1699|3339||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PLS|0|0|0|100|DKK|4141|7162|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4141||4141|7162||1 011690|J05AP0101|Copegus|töflur|200|mg|168|stk|1|plglas||J05AP01|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|55831|73809|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||55831||55831|73809||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2753|5393|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2753||2753|5393||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005|31.12.2018|R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|954|2647|lyfalmen|||2|28|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||861||861|2647||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3210|4719|lyfalmen|V0323|4400|2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||2366||2366|4719||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|3555|6355|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3555||3555|6355||2 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|1967|4169|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1967||1967|4169||2 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|24781|34537|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||24781||24781|34537||1 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|3262|5952|lyfalmen|V0909|3021|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3262||3262|5952||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5973|9683|lyfalmen|V0924|3240|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||5973||5973|9683||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|8129|9612|lyfalmen|V0622|5916|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5921||5921|9612||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|837|2614|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||837||837|2614||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|3553|6352|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||3553||3553|6352||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|5486|9013|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||5486||5486|9013||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2101|2480|lyfalmen|V0250|2136|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||740||740|2480||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2756|2591|lyfalmen|V0251|2170|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||820||820|2591||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5815|9466|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5815||5815|9466||1 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|8376|12991|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8376||8376|12991||1 013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|5326|8793|lyfsjukr|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||5326||5326|8793||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2645|5103|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxazósín||2645||2645|5103||1 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|277436|306736|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||241520||241520|306736||1 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1119|3002|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1119||1119|3002||2 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|671|2328|lyfalmen|V0562|2011|2|100|0|33,3300|Alvogen|ratiopharm Oy|Íbúprófen||629||629|2328||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2151|4423|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2151||2151|4423||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|329|1915|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||329||329|1915||2 013872|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9059|13931|lyfalmen|V0215|9663|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9059||9059|13931||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5414|8914|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5414||5414|8914||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2134|4399|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2134||2134|4399||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4068|7061|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4068||4068|7061||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|163144|209258|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||163144||163144|209258||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|296936|375658|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||296936||296936|375658||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2111|4368|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2111||2111|4368||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6088|9841|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6088||6088|9841||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|G|0|UCB|0|0|0|100|DKK|15954|23421|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||15954||15954|23421||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|49783|66160|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||49783||49783|66160||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1407|3087|lyfalmen|V0479|2719|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1181||1181|3087||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1790|3926|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1790||1790|3926||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|15848|23275|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||15848||15848|23275||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|323|1772|lyfalmen|V0563|1772|2|30|0|15,0000|Alvogen|ratiopharm Oy|Íbúprófen||225||225|1772||2 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2231|4385|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2231||2231|4385||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|72751|95210|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||72751|95210||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|814|2194|lyfalmen|V0564|2194|2|100|0|50,0000|Alvogen|ratiopharm Oy|Íbúprófen||532||532|2194||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|825|2597|lyfalmen|V0596|2201|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||825||825|2597||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|23283|32643|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||23283||23283|32643||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|60335|79506|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||60335||60335|79506||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|40432|54333|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||40432||40432|54333||1 014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|637373|799066|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||637373||637373|799066||3 015072|V04CX0005|Hexvix|stofn|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.08.2016||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|66313|87067|lyfsjukr|||0|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||66313|87067||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2318|4469|lyfalmen|V0673|4469|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2185||2185|4469||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7039|11150|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7039||7039|11150||1 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|959|2782|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||959||959|2782||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1599|2710|lyfalmen|V0234|1629|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||907||907|2710||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2282|2710|lyfalmen|V0233|2117|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||907||907|2710||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8269|12843|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8269||8269|12843||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|1|PAM|0|0|0|100|DKK|279690|354209|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||279690||279690|354209||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|1|PAM|0|0|0|100|DKK|79422|103647|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||79422|103647||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4494|7648|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4494||4494|7648||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|11881|17815|lyfalmen|V0828|13745|1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11881||11881|17815||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4528|7694|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4528||4528|7694||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|12517|18690|lyfalmen|V0900|14739|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12517||12517|18690||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4528|7694|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4528||4528|7694||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10935|16513|lyfalmen|V0829|12728|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10935||10935|16513||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|19356|28104|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||19356||19356|28104||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|38713|52158|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||38713||38713|52158||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3476|5991|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||3476||3476|5991||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5343|9209|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5343||5343|9209||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2890|4981|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2890||2890|4981||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2933|5055|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2933||2933|5055||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5129|8840|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||5129||5129|8840||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|100|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1287|3233|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1287||1287|3233||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2820|4861|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2820||2820|4861||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|60|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|1467|3481|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1467||1467|3481||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|956|2778|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||956||956|2778||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1014|2858|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1014||1014|2858||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|2407|4775|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||2407||2407|4775||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|6002|9723|lyfalmen|V0686|2129|1|56|0|14,0000|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||6002||6002|9723||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|9097|13983|lyfalmen|V0687|3030|1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||9097||9097|13983||1 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|4519|7682|lyfalmen|||2|1000|0|1000,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||4519||4519|7682||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|1589|3649|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||1589||1589|3649||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|12833|19125|lyfalmen|V0689|3555|1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||12833||12833|19125||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|84717|110344|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||84717||84717|110344||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3314|6023|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3314||3314|6023||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|2335|4676|lyfalmen|V0685|1626|1|56|0|4,6667|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||2335||2335|4676||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|1158|3056|lyfalmen|||2|200|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1158||1158|3056||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|14536|21469|lyfalmen|V0690|6089|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||14536||14536|21469||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7499||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OPC|0|0|0|100|DKK|27771|38319|lyfalmen|V0682|2825|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||27771||27771|38319||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1606|2339|lyfalmen|||2|12|0|7,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||637||637|2339||1 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|6612|10563|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6612||6612|10563||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2701|5180|lyfalmen|V0240|5180|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2701||2701|5180||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|4984|8322|lyfalmen|V0433|8322|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4984||4984|8322||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|45299|60488|lyfalmen|V0721|11124|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||45299||45299|60488||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|66737|87603|lyfalmen|V0722|19355|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||66737||66737|87603||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|24811|34575|lyfalmen|V0720|8082|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||24811||24811|34575||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|1|GEB|0|1|0|100|XEU|65640|77719|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||58922||58922|77719||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1574|3628|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1574|3628||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GEI|0|0|0|100|DKK|34881|46870|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||34532||34532|46870||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|2721|5207|lyfalmen|V0943|2701|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||2721||2721|5207||2 017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1350|3320|lyfalmen|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1350||1350|3320||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|0|0|1|SKY|0|1|0|100|DKK|233147|296322|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||233147||233147|296322||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|GRP|0|0|0|100|XEU|6041|9777|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||6041||6041|9777||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|GRP|0|0|0|100|SEK|6292|10122|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||6292||6292|10122||1 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|94373|122557|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||94373||94373|122557||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|4950|8275|lyfalmen|V0944|3458|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||4950||4950|8275||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|8998|13847|lyfalmen|V0945|5316|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||8998||8998|13847||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|7691|12048|lyfsjukr|||1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7691||7691|12048||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1040|2893|lyfalmen|||2|20|0|3,3333|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1040||1040|2893||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2393|4756|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2393||2393|4756||2 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1203|3028|lyfalmen|V0168|2485|2|20|0|6,6667|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1138||1138|3028||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5919|11400|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||5919||5919|11400||1 017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1500|2150|lyfalmen|V0556|1892|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2150||2 017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2 017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2300|2838|lyfalmen|V0556|2838|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1000||1000|2838||2 017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1271|2081|lyfalmen|V0551|2081|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2081||2 017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|3500|3389|lyfalmen|V0552|2778|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1400||1400|3389||2 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|7841|12254|lyfalmen|V0107|2508|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||7841||7841|12254||1 018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1544|2563|lyfalmen|V0946|2563|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||800||800|2563||2 018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2300|3389|lyfalmen|V0947|3389|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1400||1400|3389||2 018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2975|3939|lyfalmen|V0948|3939|0|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1800||1800|3939||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|875|2198|lyfalmen|V0243|1922|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||535||535|2198||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6434|10318|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6434||6434|10318||1 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|16358|23977|lyfalmen|V0441|20123|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16358||16358|23977||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|735|2474|lyfalmen|||1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||735||735|2474||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5182|8594|lyfalmen|V0438|7144|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5182||5182|8594||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|964|2789|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||964||964|2789||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|13468|19999|lyfalmen|V0440|16763|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||13468||13468|19999||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|28274|38955|lyfalmen|V0111|6665|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||28274||28274|38955||1 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|45377|60587|lyfsjukr|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||45377||45377|60587||2 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|7921|12364|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||7921||7921|12364||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|271|1835|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||271||271|1835||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TGH|0|0|0|100|NOK|77023|100613|lyfsjukr|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Glatíramer acetat||77023||77023|100613||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|49602|65931|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Fosamprenavír||49602||49602|65931||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|907|1783|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||907||907|1783||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|4734|7978|lyfalmen|V0221|7784|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4734||4734|7978||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5484|9010|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||5484||5484|9010||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3426|6178|lyfalmen|V0220|5734|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||3426||3426|6178||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|158424|203388|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||158424||158424|203388||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16670|24407|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||16670||16670|24407||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1887|4059|lyfalmen|V0219|4029|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||1887||1887|4059||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19938|28905|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||19938||19938|28905||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17927|26137|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||17927||17927|26137||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24126|33709|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||24126||24126|33709||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|79212|103382|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||79212||79212|103382||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|5819|9471|lyfalmen|V0223|8315|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||5819||5819|9471||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9059|13931|lyfalmen|V0215|9663|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9059||9059|13931||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|39606|53288|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||39606||39606|53288||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|19803|28719|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||19803||19803|28719||2 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|4326|8378|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||4326||4326|8378||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|325|1909|lyfalmen|V0633|1909|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||325||325|1909||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|28812|54833|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||28812||28812|54833||1 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6044|9781|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6044||6044|9781||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|44678|59703|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||44678||44678|59703||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6044|9781|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6044||6044|9781||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|829|2427|lyfalmen|V0496|2427|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Ramipríl||701||701|2427||2 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|766|2375|lyfalmen|V0648|2375|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ramipríl||663||663|2375||2 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1160|2838|lyfalmen|V0649|2838|2|100|0|400,0000|Alvogen|ratiopharm GmbH|Ramipríl||1000||1000|2838||2 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|164702|211196|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||164702||164702|211196||2 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|846|2324|lyfalmen|V0159|2135|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||626||626|2324||2 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|0|1|NED|0|1|0|100|XEU|150314|193301|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||150314||150314|193301||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|11406|17161|lyfalmen|V0812|5525|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11406||11406|17161||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|11406|17161|lyfalmen|V0813|5525|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11406||11406|17161||2 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|11406|17161|lyfalmen|V0814|5492|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11406||11406|17161||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|11406|17161|lyfalmen|V0815|5525|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11406||11406|17161||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|11406|17161|lyfalmen|V0816|5525|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11406||11406|17161||2 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|288|1858|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||288|1858||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|RGO|0|0|0|100|DKK|54144|71676|lyfsjukr|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Lamívúdín og abacavír||54144||54144|71676||1 019966|N06AB0405|Citalopram PCD|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|1600|2838|lyfalmen|V0317|2838|2|100|0|50,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1000||1000|2838||2 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1050|2702|lyfalmen|V0160|2443|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||901||901|2702||2 019969|N06AB0405|Citalopram PCD|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|2600|3527|lyfalmen|V0318|3527|2|100|0|100,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1500||1500|3527||2 020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|0|G|0|PDA|0|0|0|100|IKR|4500|2838|lyfalmen|V0320|2838|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||1000||1000|2838||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|2475|4869|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Diltíazem||2475||2475|4869||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3458|6222|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||3458||3458|6222||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|27943|38537|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||27943||27943|38537||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|1930|4118|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||1930||1930|4118||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|86005|111973|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||86005||86005|111973||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|44875|59952|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||44875||44875|59952||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|3092|4266|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2037||2037|4266||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5872|4860|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2469||2469|4860||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|20863|29582|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||20863||20863|29582||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|5811|3805|lyfalmen|V0599|3805|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||1702||1702|3805||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1964|3385|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1964||1964|3385||1 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCC|0|0|0|100|DKK|52569|69684|lyfalmen|||1|180|0||Vistor hf|UCB Pharma S.A.|sodium oxybate||||52569|69684||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2297|3959|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2297||2297|3959||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1516|3549|lyfalmen|V0174|2563|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1516||1516|3549||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2424|4798|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2424||2424|4798||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|2015|4235|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2015||2015|4235||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|505|2157|lyfalmen|V0188|2157|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||505||505|2157||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|HEG|0|0|0|100|XEU|1966|4168|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||||1966|4168||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|1248|2591|lyfalmen|V0189|2591|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||820||820|2591||1 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12345|18454|lyfalmen|V0490|2610|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||12345||12345|18454||1 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1 021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|29142|40053|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||29142||29142|40053||3 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1393|3379|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1393||1393|3379||1 021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|53395|70728|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||53395||53395|70728||3 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3796|6687|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3796||3796|6687||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11783|17680|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||11783||11783|17680||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10987|16584|lyfalmen|V0214|4508|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||10987||10987|16584||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6263|10082|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6263||6263|10082||1 021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|13609|20193|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13609||13609|20193||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13932|20638|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||13932||13932|20638||1 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|18146|26438|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||18146||18146|26438||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|16023|23516|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||16023||16023|23516||1 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21446|30319|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||21446||21446|30319||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8011|12488|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||8011||8011|12488||1 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4043|7027|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4043||4043|7027||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17169|25093|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||17169||17169|25093||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|3072|5690|lyfalmen|V0692|2328|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3072||3072|5690||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4986|8325|lyfalmen|V0693|3163|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4986||4986|8325||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|12351|18462|lyfalmen|V0694|5693|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||12351||12351|18462||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SCI|0|0|0|100|DKK|67757|88893|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Ireland Limited|Anagrelidum||67757||67757|88893||3 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|72967|95483|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration GmbH|Erlótiníb||72967||72967|95483||2 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|2380|4738|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2380||2380|4738||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|93951|122023|lyfsjukr|||1|1200|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||93951||93951|122023||2 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|3936|6879|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||3936||3936|6879||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|254900|323377|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration GmbH|Erlótiníb||254900||254900|323377||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|264956|335884|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration GmbH|Erlótiníb||264956||264956|335884||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|14260|21089|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||14260||14260|21089||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2001|3449|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2001||2001|3449||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3351|3004|lyfalmen|V0056|2497|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1120||1120|3004||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5941|3897|lyfalmen|V0057|2497|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1769||1769|3897||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1895|3266|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1895||1895|3266||2 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1227|2115|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1227||1227|2115||2 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1744|3758|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1668||1668|3758|31.12.2018|1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5942||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|21834|30810|lyfalmen|||1|8|0|40,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||21834||21834|30810||2 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3916||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|XEU|1617|3688|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1617||1617|3688||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|XEU|2980|4655|lyfalmen|V0125|2864|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2320||2320|4655||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|0|1|0|1|GEI|0|0|0|100|DKK|70588|92474|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||70588||70588|92474||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SCI|0|0|0|100|DKK|22696|31900|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||22696||22696|31900||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SCI|0|0|0|100|DKK|35435|48012|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||35435||35435|48012||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|3000|3527|lyfalmen|V0125|2864|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1500||1500|3527||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|17248|25202|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||17248||17248|25202||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|5231|5729|lyfalmen|V0125|5729|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||3100||3100|5729||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|13213|16189|lyfalmen|V0256|16189|2|100|0|44,4400|Alvogen|ratiopharm GmbH|Gabapentín||10700||10700|16189||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|DKK|6917|10231|lyfalmen|V0254|10231|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Gabapentín||6371||6371|10231||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|18127|26412|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||18127||18127|26412||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2068|2833|lyfalmen|V0250|2136|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||996||996|2833||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2668|3204|lyfalmen|V0251|2170|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1266||1266|3204||2 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SND|0|0|0|100|XEU|15222|22414|lyfalmen|V0029|6047|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||15222||15222|22414||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1813|3957|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1813||1813|3957||2 023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|111310|144791|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||111310||111310|144791||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2701|lyfalmen|V0066|2575|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2701||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2907|lyfalmen|V0449|2907|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2907||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|536|2200|lyfalmen|V0448|2200|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||536||536|2200||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4049|7035|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||4049||4049|7035||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2327|4665|lyfalmen|V0673|4469|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||2327||2327|4665||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|65598|86163|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Europe MA EEIG|Síldenafíl||65598||65598|86163||1 023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|5316|lyfalmen|V0007|5316|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2800||2800|5316||2 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2460|4848|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2460||2460|4848||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1874|4041|lyfalmen|V0222|3487|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||1874||1874|4041||1 024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|55055|72828|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||55055||55055|72828||3 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1235|2889|lyfalmen|V0048|2357|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||1037||1037|2889||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2036|3861|lyfalmen|V0049|2976|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1743||1743|3861||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3587|6061|lyfalmen|V0054|3664|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3341||3341|6061||1 024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3264|4490|lyfalmen|V0323|4490|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2200||2200|4490||2 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21446|30319|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||21446||21446|30319||1 024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1926|2976|lyfalmen|V0322|2976|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|2976||2 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6751|10754|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6751||6751|10754||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6751|10754|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6751||6751|10754||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11375|17119|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11375||11375|17119||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11394|17145|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11394||11394|17145||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4868|8162|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4868||4868|8162||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|OPH|0|0|0|100|DKK|47911|63792|lyfalmen|||1|100|0|1,2500|Artasan ehf|Novartis Europharm Ltd|Zoledronsýra||47911||47911|63792||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11511|17306|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11511||11511|17306||1 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1386|3370|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1386||1386|3370||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4868|8162|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4868||4868|8162||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6751|10754|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6751||6751|10754||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6751|10754|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6751||6751|10754||1 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1386|3370|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1386||1386|3370||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1848|4006|lyfalmen|||2|100|0|66,6660|Alvogen|ratiopharm GmbH|Metóprólól||1848||1848|4006||2 025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994|30.11.2018|R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|515|2171|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||515||515|2171||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17169|25093|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||17169||17169|25093||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1212|2150|lyfalmen|V0051|2150|2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||500||500|2150||2 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|65659|86240|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||65659||65659|86240||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8508|16312|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||8508||8508|16312||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|13809|20469|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||13809||13809|20469||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|ATN|0|0|0|100|DKK|4659|7875|lyfalmen|V0205|1267|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Íbandrónsýra||4659||4659|7875||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|ATN|0|0|0|100|DKK|12485|18646|lyfalmen|V0205|3802|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Íbandrónsýra||12485||12485|18646||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|39928|53695|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||39928||39928|53695||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|5981|9694|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||5981||5981|9694||2 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21446|30319|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||21446||21446|30319||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|895|2618|lyfalmen|V0597|2618|2|28|0|3,7300|Alvogen|ratiopharm GmbH|Oxýcódon||840||840|2618||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|2997|5043|lyfalmen|V0598|5043|2|98|0|13,0700|Alvogen|ratiopharm GmbH|Oxýcódon||2602||2602|5043||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|45926|61281|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||45926|61281||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|30831|42189|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||30831||30831|42189||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3457|5958|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3457||3457|5958||1 025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|81842|86656|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||65988||65988|86656||2 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1947|3827|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1947||1947|3827||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|8248|14216|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||8248||8248|14216||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17169|25093|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||17169||17169|25093||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|37869|51091|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||37869||37869|51091||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|0|0|1|PFM|0|0|0|100|DKK|189347|241847|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||189347||189347|241847||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1613|3682|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1613|3682||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6467|10363|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6467|10363||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3187|5849|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3187|5849||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|12624|18838|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||12624|18838||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|18917|27499|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||18917|27499||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|25211|35081|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||25211|35081||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1165|3065|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Nítrófúrantóín||1165||1165|3065||2 026692|L01XE2701|IMBRUVICA|hylki|140|mg|120|stk|1|glas|hart|L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|936267|1170807|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||936267|1170807||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|4027|7005|lyfalmen|V0099|7005|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||4027||4027|7005||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|905|2708|lyfalmen|V0160|2443|3|30|0|10,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||905||905|2708||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|626|2324|lyfalmen|V0159|2135|3|20|0|6,6667|D.A.C. ehf|D.A.C. ehf|Amoxicillín||626||626|2324||2 027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7824|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7824||2 027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|18256|26590|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18256||18256|26590||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|4274|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||2043||2043|4274||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|657|2366|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||657||657|2366||2 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1927|4114|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||1927||1927|4114||1 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|12112|9174|lyfalmen|||2|100|0|66,6600|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||5603||5603|9174||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|11320|9174|lyfalmen|V0342|9174|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||5603||5603|9174||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2176|4457|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2176||2176|4457||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|5594|9162|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||5594||5594|9162||1 027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|IKR|3502|5316|lyfalmen|V0945|5316|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||2800||2800|5316||2 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|536|2200|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||536||536|2200||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|617|2311|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||617||617|2311||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OPC|0|0|0|100|DKK|18207|26522|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||18207||18207|26522||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|20986|29737|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||20986|29737||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OPC|0|0|0|100|DKK|20648|29310|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||20648||20648|29310||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|28665|39450|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28665||28665|39450||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|42356|56766|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||42356|56766||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3813|6710|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||3813||3813|6710||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|20165|28699|lyfalmen|V0387|28699|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||20165||20165|28699||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2907||2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17853|26035|lyfalmen|V0386|26035|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||17853||17853|26035||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|44935|60028|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||44935||44935|60028||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2340|4683|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir mótefnavakar||2340||2340|4683||1 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|37602|50753|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||37602|50753||1 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1445|3451|lyfalmen|V0202|3451|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1445||1445|3451||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1620|3692|lyfalmen|V0428|2940|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1620||1620|3692||2 028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|632|2054|lyfalmen|V0266|2054|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||430||430|2054||2 028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|2582|3045|lyfalmen|V0267|3045|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||1150||1150|3045||2 028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|0|G|0|KAN|0|0|0|100|IKR|14853|21906|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21906||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|1489|3511|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1489||1489|3511||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|6056|4734|lyfalmen|V0245|3860|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2377||2377|4734||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|11188|10380|lyfalmen|V0232|7503|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||6479||6479|10380||1 028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|709|2431|lyfalmen|V0266|2054|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||704||704|2431||2 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7061|13567|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7061||7061|13567||2 028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2892|4117|lyfalmen|V0267|3045|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||1929||1929|4117||2 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|SDF|0|0|1|100|IKR|1084|2838|lyfalmen|V0625|2050|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Flútíkasón||1000||1000|2838||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5848|9511|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5848||5848|9511||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|14575|21523|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||14575||14575|21523||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2572|5002|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2572||2572|5002||1 029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|33261|45263|lyfalmen|V0802|45263|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||33261||33261|45263||2 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|33300|45312|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||33300||33300|45312||2 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|33300|45312|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||33300||33300|45312||2 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013|30.11.2018|R|0|0|0|1|G|0|UAK|0|0|0|100|XEU|1224|3147|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1224||1224|3147||1 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|10986|16583|lyfalmen|V0801|14959|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||10986||10986|16583||2 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|UAK|0|0|0|100|GBP|271|1835|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||271||271|1835||1 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|32957|44878|lyfalmen|V0801|44878|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||32957||32957|44878||2 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|11087|16722|lyfalmen|V0802|15088|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||11087||11087|16722||2 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|33261|45263|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||33261||33261|45263||2 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|33300|45312|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||33300||33300|45312||2 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|0|1|EIG|0|1|0|100|SEK|49662|66007|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||49662||49662|66007||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|3807|6702|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3807||3807|6702||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10412|15793|lyfalmen|V0094|15793|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||10412|15793||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10101|15365|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||10101|15365||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|5254|8694|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5254||5254|8694||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010|31.12.2018|R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|83375|108647|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||83375||83375|108647||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010|31.12.2018|R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|166750|213743|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||166750||166750|213743||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2485|lyfalmen|V0168|2485|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||743||743|2485||2 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|7292|11499|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7292||7292|11499||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|PGB|0|0|0|100|IKR|12900|19218|lyfalmen|V0277|4903|1|100|0|33,3333|Icepharma hf|BGP Products ApS|Klózapín||12900||12900|19218||2 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|0|0|PGB|0|0|0|100|IKR|4000|6968|lyfalmen|V0276|3114|1|100|0|8,3333|Icepharma hf|BGP Products ApS|Klózapín||4000||4000|6968||2 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|14651|25252|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||14651||14651|25252||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1070|2804|lyfalmen|V0051|2150|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||975||975|2804||2 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2593|5031|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2593||2593|5031||2 031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2246|4553|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2246||2246|4553||2 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5165|8571|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5165||5165|8571||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19392|28153|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19392||19392|28153||1 032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GEN|0|0|0|100|SEK|3940|2394|lyfalmen|V0686|2129|2|56|0|14,0000|Icepharma hf|Generics UK Ltd|Pregabalín||677||677|2394||2 032257|C01CA1703|Hypotron|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|BCP|0|0|0|100|IKR|9248|14191|lyfalmen|V0969|13460|2|50|0|8,3333|CampusPharma AB|Brancaster Pharma Ltd.|midodrine||9248||9248|14191||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OPC|0|0|0|100|DKK|18772|27300|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||18772||18772|27300||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|13009|22422|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||13009||13009|22422||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|965|2790|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||965||965|2790||2 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|2563|lyfalmen|V0069|2563|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||800||800|2563||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|19820|28742|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||19820||19820|28742||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|37949|51192|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||37949|51192||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1092|1882|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1092||1092|1882||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2742|5236|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2742||2742|5236||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8175|15680|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8175|15680||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9344|14323|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||9344||9344|14323||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5488|9016|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||5488||5488|9016||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|16197|23756|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||16197||16197|23756||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1257|3192|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1257||1257|3192||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1330|2591|lyfalmen|V0189|2591|2|100|0|50,0000|Alvogen|ratiopharm Oy|Díklófenak||820||820|2591||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|591|2248|lyfalmen|V0188|2157|2|30|0|15,0000|Alvogen|ratiopharm Oy|Díklófenak||571||571|2248||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|15049|13127|lyfalmen|V0185|13127|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||8475||8475|13127||2 033833|J02AC0107|Fluconazol Krka|hylki|50|mg|98|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|10456|8344|lyfalmen|||2|98|0|24,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||5000||5000|8344||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|71519|93651|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||71519||71519|93651||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2207|4338|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2207|4338||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|XEU|1692|2876|lyfalmen|V0098|2876|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||1027||1027|2876||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|16392|24024|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||16392||16392|24024||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|60070|79171|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||60070||60070|79171||1 034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3711|4577|lyfalmen|V0323|4490|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2263||2263|4577||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1265|3203|lyfalmen|||1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1265||1265|3203||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2283|4604|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2283||2283|4604||1 034988|L03AB0702|Rebif|stl|44|mcg/,5ml|1,5|ml|4|rörlyk|132 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|94199|122337|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||94199||94199|122337||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6828|10860|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6828||6828|10860||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1999|4213|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1999||1999|4213||1 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|2223|4522|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2223|4522||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|13940|20649|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13940||13940|20649||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|980|2362|lyfalmen|V0050|2136|2|100|0|15,8300|Alvogen|ratiopharm GmbH|Metóprólól||654||654|2362||2 035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|571|2248|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||571||571|2248||1 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2119|2558|lyfalmen|V0244|2558|2|56|0|9,3300|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||796||796|2558||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1190|2648|lyfalmen|V0048|2357|2|100|0|31,6600|Alvogen|ratiopharm GmbH|Metóprólól||862||862|2648||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2001|2976|lyfalmen|V0049|2976|2|100|0|63,3300|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|2976||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7063|11183|lyfalmen|V0080|5774|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7063||7063|11183||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4372|3664|lyfalmen|V0054|3664|2|100|0|126,6600|Alvogen|ratiopharm GmbH|Metóprólól||1600||1600|3664||2 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|4991|3176|lyfalmen|V0233|3176|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1245||1245|3176||1 035802|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10412|15793|lyfalmen|V0094|15793|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||10412|15793||1 035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GEB|0|0|0|100|XEU|25420|35345|lyfalmen|V0680|10684|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||25420||25420|35345||1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6278|10103|lyfalmen|V0081|5774|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||6278||6278|10103||1 036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|7414|11667|lyfalmen|||1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7414|11667||2 036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1474|3491|lyfalmen|V0426|3491|1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1474|3491||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|661|2372|lyfalmen|V0929|2219|1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||661||661|2372||2 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|17632|25731|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17632||17632|25731||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1162|3061|lyfalmen|||1|60|0|3,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1162||1162|3061||2 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1274|2196|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1274||1274|2196||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036577|L01XE0104|Imatinib Mylan|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|150330|193321|lyfsjukr|||2|30|0||Icepharma hf|Mylan AB|Imatiníb||150330||150330|193321||2 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|2294|4619|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2294||2294|4619||2 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|695|2419|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||695||695|2419||2 036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|9483|3798|lyfalmen|||2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1697||1697|3798|31.12.2018|2 036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|2013|lyfalmen|V0006|1270|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2013||2 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|6746|6985|lyfalmen|V0532|6502|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4013||4013|6985||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|11480|9731|lyfalmen|V0533|9320|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6008||6008|9731||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|17187|18110|lyfalmen|V0534|15504|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||12095||12095|18110||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2209|4502|lyfalmen|V0434|4502|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2209||2209|4502||2 037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3533|3664|lyfalmen|V0054|3664|2|100|0|126,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1600||1600|3664||2 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2603||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3856||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6246|10059|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||6246|10059||1 038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|3108|4014|lyfalmen|||1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1854||1854|4014||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1525|2653|lyfalmen|V0110|2563|2|100|0|133,3333|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||865||865|2653||1 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988|31.12.2018|R|0|0|0|0|0|0|SON|0|0|1|100|DKK|903|2705|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||903||903|2705||2 038540|G04BE0808|Tadalafil Sandoz|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|4299|5769|lyfalmen|V0924|3240|2|4|0|4,0000|Artasan ehf|Sandoz A/S|Tadalafíl||3129||3129|5769||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|12793|19070|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||12793|19070||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|25864|35907|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||25864||25864|35907||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|15656|15642|lyfalmen|||2|50|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||10302||10302|15642||1 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1447|3454|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1447||1447|3454||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|5275|8722|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5275||5275|8722||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGB|0|0|0|100|XEU|17477|25517|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||17477||17477|25517||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2708|5189|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||2708||2708|5189||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|345|1937|lyfalmen|V0541|1858|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||345||345|1937||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|496|2048|lyfalmen|V0542|1867|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||426||426|2048||2 039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|945|2763|lyfalmen|V0821|2150|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||945||945|2763||1 039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1657|3743|lyfalmen|V0822|2838|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1657||1657|3743||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1873|2669|lyfalmen|V0110|2512|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||877||877|2669||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|5986|3941|lyfalmen|V0182|3941|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1801||1801|3941||1 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|1529|2293|lyfalmen|V0033|2293|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||604||604|2293||1 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014|31.12.2018|R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8541|13218|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||8541||8541|13218||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|HES|0|0|0|100|XEU|||lyfalmen|||0|15|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||2370||1 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014|31.10.2018|R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|72052|94326|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||72052|94326||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2339|4352|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2100||2100|4352||2 040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||||1 040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|221723|282114|lyfsjukr|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||221723||221723|282114||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|7940|12391|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7940||7940|12391||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|8105|12618|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8105||8105|12618||2 041693|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.07.2016||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|51276|97451|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||51276||51276|97451||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3173|5469|vetorma|||0|100|0||Vistor hf|Intervet International BV|||3173||3173|5469||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|913|2719|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||913||913|2719||2 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|11097|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11097||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7926|12371|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7926||7926|12371||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|6000|9583|lyfalmen|||2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5900||5900|9583||2 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2135|4401|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2135||2135|4401||1 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3556|6356|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3556||3556|6356||1 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1932|4121|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1932||1932|4121||1 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2555|4979|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2555||2555|4979||1 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1866|4030|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1866||1866|4030||1 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2113|4370|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2113||2113|4370||1 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2034|4262|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2034||2034|4262||1 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2915|5474|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2915||2915|5474||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2036|4264|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2036||2036|4264||1 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|3143|5788|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||3143||3143|5788||2 042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MLT|0|0|1|100|XEU|1253|3187|lyfalmen|V0560|3187|2|100|0||BGP Products AsP|Mylan Ireland Limited|Lídókaín||1253||1253|3187||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|441|2069|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||441||441|2069||2 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|14029|6264|lyfalmen|V0516|5316|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||3489||3489|6264||2 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|3398|6139|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3398||3398|6139||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|467|2105|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||467||467|2105||1 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009|31.12.2018|L|1|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|12377|18498|lyfalmen|V0637|18498|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12377||12377|18498||3 044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|1|0|1|ZAA|0|0|0|100|DKK|13319|19794|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||13319||13319|19794||2 044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8866|6968|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||4000||4000|6968||2 044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|4761|8015|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4761||4761|8015||1 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|295647|374055|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||295647||295647|374055||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|418832|527262|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||418832||418832|527262||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|4746|7994|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4746||4746|7994||2 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010|30.11.2018|R|0|0|0|0|G|0|BII|0|0|0|100|DKK|36437|49280|lyfalmen|||1|100|0|120,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||36437||36437|49280||1 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6661|10630|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6661||6661|10630||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1207|2398|lyfalmen|V0109|2230|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||680||680|2398||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|998|2237|lyfalmen|V0108|2085|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||563||563|2237||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1834|3986|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1834|3986||2 045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2632|5085|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2632|5085||2 045634|N02AJ0603|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AJ06|01.01.2011||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|354|1949|lyfalmen|||2|10|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Kódein og Paracetamól||354||354|1949||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|GRP|0|0|0|100|SEK|1687|3784|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||1687||1687|3784||1 046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|2075|3802|lyfalmen|V0429|3802|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||1700||1700|3802||2 046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|15729|11785|lyfalmen|V0419|11785|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||7500||7500|11785||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1263|3200|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1263|3200||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|820|2591|lyfalmen|V0648|2375|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||820||820|2591||1 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|586|2030|lyfalmen|V0021|2030|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||413||413|2030||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|712|2314|lyfalmen|V0022|2314|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||619||619|2314||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|912|2553|lyfalmen|V0023|2553|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||793||793|2553||1 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSA|0|0|1|100|IKR|1264|2563|lyfalmen|V0625|2563|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||800||800|2563||2 046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|0|G|0|POF|0|0|0|100|IKR|4372|3802|lyfalmen|V0205|3802|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3802||2 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|783|2540|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||783||783|2540||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19889|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19889||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63342|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63342||5 047998|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011|31.12.2018|R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|13265|6347|lyfalmen|||2|30|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||3549||3549|6347||2 048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|3957|6908|lyfsjukr|||1|250|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||3957||3957|6908||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7682|12035|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||7682||7682|12035||1 048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|6419|10297|lyfsjukr|||1|100|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||6419||6419|10297||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2345|3250|lyfalmen|V0324|3250|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1299||1299|3250||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1006|2847|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1006||1006|2847||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2650|3513|lyfalmen|V0325|2923|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1490||1490|3513||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3299|6003|lyfalmen|V0326|6003|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3299||3299|6003||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3637|5642|lyfalmen|V0327|5642|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3037||3037|5642||1 048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|4932|6571|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||3712||3712|6571||2 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1011|2854|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||1011||1011|2854||2 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10849|16395|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||10849||10849|16395||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1592|3653|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1592||1592|3653||1 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|0|1|GEB|0|1|0|100|XEU|765691|958658|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||765691||765691|958658||1 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|364|1963|lyfalmen|V0230|1963|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||364||364|1963||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|0|1|GAA|0|0|0|100|SEK|3468|6235|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3468||3468|6235||2 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|35925|48632|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||35925||35925|48632||3 048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4081|3500|lyfalmen|V0148|3136|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1481||1481|3500||2 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1779|3911|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1779||1779|3911||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3998|3878|lyfalmen|V0599|2283|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1755||1755|3878||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4706|7939|lyfalmen|V0376|3682|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||4706|7939||1 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|347545|438601|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||347545||347545|438601||1 049169|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.10.2006||R|0|1|0|0|0|0|ATN|0|0|0|100|DKK|13823|20488|lyfalmen|V0957|12498|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Íbandrónsýra||13823||13823|20488||2 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|917|2724|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||917||917|2724||1 049536|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7063|11183|lyfalmen|V0080|5774|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7063||7063|11183||1 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1154|2277|lyfalmen|V0109|2230|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||592||592|2277||2 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|829|2603|lyfalmen|V0496|2427|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||829||829|2603||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|DKK|||lyflausa|||0|30|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1620|3189|lyfalmen|V0649|2838|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1255||1255|3189||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1805||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1805||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1902||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|72291|94628|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||72291||72291|94628||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|150211|193173|lyfsjukr|||1|200|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||150211||150211|193173||3 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|7511|11800|lyfsjukr|||1|10|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||7511||7511|11800||3 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|18777|27307|lyfsjukr|||1|25|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||18777||18777|27307||3 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|37553|50691|lyfsjukr|||1|50|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||37553||37553|50691||3 049942|B03BB0108|Folsyra Evolan|töflur|5|mg|100|stk|1|þpakki||B03BB01|01.10.2018||R|1|0|0|0|G|0|BYA|0|0|1|100|IKR|2000|4215|lyfalmen|||2|100|0|1250,0000|LYFIS ehf|Biosyn Arzneimittel GmbH|Fólínsýra||2000||2000|4215||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|74967|98013|lyfsjukr|||1|100|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||74967||74967|98013||3 049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|0|1|0|1|MBV|0|1|0|100|DKK|1855727|2314357|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1855727||1855727|2314357||1 050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|6692|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6692||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3839||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|3311|6019|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||3311||3311|6019||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|62325|82023|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||62325|82023||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GEN|0|0|0|100|SEK|981|2163|lyfalmen|||2|56|0|4,6667|Icepharma hf|Generics UK Ltd|Pregabalín||509||509|2163|30.11.2018|2 050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3000|5591|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||3000||3000|5591||2 050604|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.01.2018|31.10.2018|R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1923|2310|lyfalmen|||2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||616||616|2310||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|11133|16785|lyfalmen|V0688|5075|1|56|0|42,0000|Icepharma hf|Pfizer Europe MA EEIG|Pregabalín||11133||11133|16785||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4615|5894|lyfalmen|V0002|5894|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3220||3220|5894||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4360|2288|lyfalmen|V0006|2116|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||600||600|2288||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|6304|2976|lyfalmen|V0001|2838|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1100||1100|2976||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|968|2617|lyfalmen|V0363|2617|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||839||839|2617||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2979|4674|lyfalmen|V0365|4674|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2334||2334|4674||2 051447|A07AA0203|Nystimex|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.04.2018||R|0|0|0|0|0|0|RPH|0|0|1|100|SEK|5039|8398|lyfalmen|||2|100|0||Vistor hf|RPH Pharmaceuticals AB|Nýstatín||5039||5039|8398||1 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|19508|28313|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||19508||19508|28313||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|710|2439|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||710||710|2439||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|164|1688|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||164||164|1688||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|387|1995|lyfalmen|V0305|1107|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||387||387|1995||2 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|246|1801|lyfalmen|V0439|1801|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||246||246|1801||2 052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|565|2240|lyfalmen|V0047|1598|2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||565||565|2240||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|546|2213|lyfalmen|V0305|2213|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||546||546|2213||2 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|514993|646860|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||514993||514993|646860||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3005|5598|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||3005||3005|5598||1 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|7238|11424|lyfalmen|||1|9|0|180,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||7238||7238|11424||1 052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4715|4032|lyfalmen|V0335|2838|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1867||1867|4032||2 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|31029|42440|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||31029||31029|42440||1 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25226|35100|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||25226||25226|35100||1 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25958|36026|lyfsjukr|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||25958||25958|36026||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22761|31982|lyfsjukr|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||22761||22761|31982||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|4946|3898|lyfalmen|V0682|2825|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3898||2 052790|N06BA0904|Atomoxetine Sandoz|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|10231|5525|lyfalmen|V0815|5525|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2952||2952|5525||1 052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|13317|19791|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||13317||13317|19791||1 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|4845|8131|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4845||4845|8131||1 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|32106|43802|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||32106||32106|43802||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5375|8860|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5375||5375|8860||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1576|3623|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1570||1570|3623||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|5129|8522|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||5129||5129|8522||1 053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|7435|8206|lyfalmen|V0115|8206|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4900||4900|8206||2 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDH|0|0|0|100|XEU|26026|36112|lyfalmen|V0453|33527|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||26026||26026|36112||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|9650|14744|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||9650||9650|14744||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OPC|0|0|0|100|DKK|1379|3360|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1379||1379|3360||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|3218|5891|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Haemophilus influenzae B||3218||3218|5891||1 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|4|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2131|4395|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2131||2131|4395||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2921|5482|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2921||2921|5482||1 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|SEK|1058|2918|lyfalmen|V0907|2008|1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1058||1058|2918||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|1000|2838|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1000||1000|2838||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1362|3337|lyfalmen|V0061|3337|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1362||1362|3337||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|5014|9683|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5014||5014|9683||2 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|0|1|G|0|TAB|0|0|0|100|XEU|18256|26590|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||18256||18256|26590||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|0|1|G|0|TAB|0|0|0|100|XEU|6436|5309|lyfalmen|V0187|4567|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||2795||2795|5309||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|1839|3993|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1839|3993||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|8293|12876|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8293||8293|12876||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1689|3708|lyfalmen|V0467|1740|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1632||1632|3708||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13500|18667|lyfalmen|V0965|18667|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||12500||12500|18667||2 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2334|4674|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2334||2334|4674||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2548|3355|lyfalmen|V0112|2770|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1375||1375|3355||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3578|3455|lyfalmen|V0113|2770|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1448||1448|3455||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5197|3455|lyfalmen|V0114|2770|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1448||1448|3455||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BNB|0|0|0|100|XEU|28912|39762|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||28912||28912|39762||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|24321|41920|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24321||24321|41920||2 056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|3030|5632|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3030||3030|5632||1 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1305|3258|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1305||1305|3258||2 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|2388|4749|lyfalmen|||1|15|0||Icepharma hf|Meda AB|Pímekrólímus||2388||2388|4749||2 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|0|1|BNB|0|1|0|100|XEU|193917|247531|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||193917||193917|247531||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7648|11989|lyfalmen|V0095|6955|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||7648||7648|11989||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3065|5681|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3065||3065|5681||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3395|6135|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3395||3395|6135||1 057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2859|2838|lyfalmen|V0334|2838|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2838||2 057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3700|2838|lyfalmen|V0335|2838|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2838||2 057401|N06DA0406|Galantamine Alvogen|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|16252|19219|lyfalmen|V0350|19219|2|84|0|84,0000|Alvogen|Alvogen|Galantamín||12901||12901|19219||2 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4399|7517|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4399||4399|7517||1 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2391|4753|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2391||2391|4753||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|280608|355350|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||280608||280608|355350||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|9440|3037|lyfalmen|V0607|2984|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||1144||1144|3037||2 057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|97996|127140|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||97996|127140||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|PEU|0|0|1|100|DKK|18142|26433|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||18142|26433||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|379|1984|lyfalmen|||1|5|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Bútýlskópólamín||379||379|1984||1 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|371564|468474|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||371564||371564|468474||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|146122|251856|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||146122|251856||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|221974|382594|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||221974|382594||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1164|3064|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||1164||1164|3064||2 058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|31442|42962|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||31442||31442|42962||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4505|7663|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4505||4505|7663||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1079|2947|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1079||1079|2947||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1553|3600|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1553||1553|3600||1 059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|0|KWA|0|0|0|100|XEU|11714|17585|lyfalmen|V0970|17585|1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||11714||11714|17585||2 059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|16000|19768|lyfalmen|V0350|19219|2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||13300||13300|19768||2 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|2374|2701|lyfalmen|V0006|1185|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||900||900|2701||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|9933|15134|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||9933||9933|15134||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|84850|110513|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||84850||84850|110513||1 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|57331|75706|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||57331||57331|75706||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|22419|31550|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||22419||22419|31550||1 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|4923|8238|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4923|8238||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8057|12552|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8057||8057|12552||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|40287|54149|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||40287||40287|54149||1 059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|3119|5755|lyfsjukr|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3119||3119|5755||2 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1870|4029|lyfalmen|V0219|4029|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||1865||1865|4029||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|3317|5734|lyfalmen|V0220|5734|2|5|0|15,0000|Alvogen|ratiopharm GmbH|Fentanýl||3104||3104|5734||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|4782|7784|lyfalmen|V0221|7784|2|5|0|22,5000|Alvogen|ratiopharm GmbH|Fentanýl||4593||4593|7784||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|5082|8315|lyfalmen|V0223|8315|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||4979||4979|8315||2 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|20236|28789|lyfalmen|V0713|28789|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||20236||20236|28789||1 060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|0|EQL|0|0|1|100|IKR|3879|6801|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||3879||3879|6801||2 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGB|0|1|0|100|XEU|121235|157135|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||121235||121235|157135||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|95296|60062|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||44962||44962|60062||2 061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1994|2770|lyfalmen|V0112|2770|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2770||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|5489|8530|lyfalmen|V0133|7414|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||5135||5135|8530||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|5136|8531|lyfalmen|V0133|7414|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||5136||5136|8531||1 061775|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki||A06AH03|01.11.2017||R|1|0|0|0|0|0|KWA|0|0|0|100|XEU|11714|17585|lyfalmen|V0970|17585|1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||11714||11714|17585||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3726|6590|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3726||3726|6590||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|14253|21080|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||14253||14253|21080||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|19835|28763|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||19835||19835|28763||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|1|0|1|G|0|GPA|0|0|0|100|XEU|13166|13700|lyfalmen|V0187|13700|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||8891||8891|13700||1 062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|15000|9720|lyfalmen|V0924|9720|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||6000||6000|9720||2 062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|0|1|0|1|GSE|0|1|0|100|XEU|1920697|2395162|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||1920697|2395162||1 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|833|2609|lyfalmen|V0308|2511|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||833||833|2609||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|16185|27896|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||16185||16185|27896||2 062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|70228|88031|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||67075||67075|88031||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|11260|14308|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||9333||9333|14308||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|106965|139387|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||106965||106965|139387||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|5144|8542|lyfalmen|||1|10|0|1,6667|Artasan ehf|Novartis Healthcare A/S|Famcíclóvír||5144||5144|8542||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1648|3480|lyfalmen|V0276|3114|2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1466||1466|3480||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5088|5350|lyfalmen|V0277|4903|2|100|0|33,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||2825||2825|5350||1 063514|C07AB0214|Bloxazoc|forðatfl|50|mg|30|stk|1|þpakki||C07AB02|01.05.2017|31.12.2018|R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|500|2081|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||450||450|2081||2 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3242||2 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1959|3419|lyfalmen|V0123|3419|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Terbínafín||1422||1422|3419||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3744|6615|lyfalmen|V0458|2701|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3744||3744|6615||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRG|0|1|0|100|DKK|133081|171868|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||133081||133081|171868||2 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1832|3984|lyfalmen|V0310|3444|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1832||1832|3984||1 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|844257|1056372|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||844257|1056372||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|390846|492456|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||390846|492456||2 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|3450369|4297645|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3450369|4297645||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|1535013|1915479|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1535013|1915479||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1843|3999|lyfalmen|V0009|3999|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1843||1843|3999||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|5880|6288|lyfalmen|V0029|6047|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3506||3506|6288||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1063|2089|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1063||1063|2089||1 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|6070|10462|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||6070|10462||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1863|4026|lyfalmen|||1|100|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Bútýlskópólamín||1863||1863|4026||1 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|36520|49385|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||36520||36520|49385||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|747|2490|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||747||747|2490||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|429|2052|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||429||429|2052||1 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4490|8689|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||4490||4490|8689||2 065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|534|2197|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||534||534|2197||2 065276|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6278|10103|lyfalmen|V0081|5774|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||6278||6278|10103||1 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14865|21922|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||14865||14865|21922||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9651|14746|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9651||9651|14746||2 065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8600|7104|lyfalmen|V0830|7096|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7104||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|45034|60153|lyfalmen|V0451|49960|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||45034||45034|60153||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|DKK|967|2507|lyfalmen|V0163|2507|2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||759||759|2507||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1471|3487|lyfalmen|V0222|3487|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1471||1471|3487||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|2396|4760|lyfalmen|||2|200|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||2396||2396|4760||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3049|5659|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||3049||3049|5659||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|630|2329|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||630||630|2329||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|2129|4073|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1897||1897|4073||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|3697|5672|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3059||3059|5672||1 066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|9710|14827|lyfalmen|||0|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||9710||9710|14827||3 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4038|7831|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4038||4038|7831||2 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5129|8522|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||5129||5129|8522||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|27566|38060|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||27566||27566|38060||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|846|2626|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||846||846|2626||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|7500|9445|lyfalmen|V0272|9445|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5800||5800|9445||2 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|XEU|1301|3253|lyfalmen|V0006|2116|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1301||1301|3253||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|840|2618|lyfalmen|V0036|2618|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||840||840|2618||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|7600|11923|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||7600||7600|11923||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7915|12356|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7915||7915|12356||1 067215|C01BC0402|Flecainid STADA|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.01.2018||R|1|0|0|1|G|0|ASR|0|0|0|100|IKR|3320|4036|lyfalmen|V0933|4036|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Flekaíníð||1870||1870|4036||2 067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|116631|151409|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtricitabine, tenofovir alafenamide og rilpivirine||||116631|151409||2 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2155|4428|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2155|4428||2 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|96810|125640|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||96810||96810|125640||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEA|0|0|0|100|DKK|4544|5824|lyfalmen|V0933|4036|1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||3169||3169|5824||2 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2717|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3087||2 068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|6061|3822|lyfalmen|V0182|3753|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1715||1715|3822||2 068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|6365|10223|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||6365||6365|10223||1 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2 068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2784|5294|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2784||2784|5294||2 068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2264|4578|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2264||2264|4578||2 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2115|4373|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||2115||2115|4373||2 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3586||2 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3769||2 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3540||2 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3719||2 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12717|18966|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12717||12717|18966||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|40140|53963|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||40140||40140|53963||1 069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10133|lyfalmen|V0195|10133|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10133||2 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|362075|456672|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||362075||362075|456672||1 069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|G|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3249||2 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|60138|79257|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||60138|79257||2 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|19421|28193|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||19421||19421|28193||2 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8846|13638|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||8846||8846|13638||1 070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|6300|10859|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||6300||6300|10859||1 071029|C07AB0214|Bloxazoc|forðatfl|25|mg|30|stk|1|þpakki||C07AB02|01.05.2017|31.12.2018|R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|445|2074|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||445||445|2074||2 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|0|0|1|RIE|0|0|0|100|SEK|50463|67020|lyfsjukr|||1|1|0|8,3300|Vistor hf|RIEMSER Pharma GmbH|Ziconotíð||50463||50463|67020||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|0|0|1|RIE|0|0|0|100|SEK|255217|323771|lyfsjukr|||1|5|0|41,6500|Vistor hf|RIEMSER Pharma GmbH|Ziconotíð||255217||255217|323771||1 071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|4305|2383|lyfalmen|||2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||669||669|2383|31.12.2018|2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GEB|0|0|0|100|XEU|68678|90058|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||68678|90058||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|540|2205|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||540||540|2205||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|412|2029|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||412||412|2029||2 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6309|12140|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6309||6309|12140||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|5880|6047|lyfalmen|V0029|6047|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3331||3331|6047||2 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184798|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184798||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184798|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184798||5 072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|6000|6968|lyfalmen|V0148|6968|2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||4000||4000|6968||2 072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3114|5748|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3114||3114|5748||2 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|479|2121|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||479||479|2121||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|50436|66986|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||50436||50436|66986||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7982|6688|lyfalmen|V0286|6380|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3797||3797|6688||1 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|416|2002|lyfalmen|V0500|1992|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||392||392|2002||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|JCI|0|1|0|100|SEK|314310|397266|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||314310|397266||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|604210|757821|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||604210||604210|757821||1 073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2569|4428|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2569||2569|4428||1 073520|N02AE0101|Bupremyl|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|IKR|1874|3458|lyfalmen|V0944|3458|2|4|0|5,6000|Icepharma hf|Mylan AB|Búprenorfín||1450||1450|3458||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3055|5667|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3055||3055|5667||1 073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|262384|332685|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||262384||262384|332685||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|15049|13618|lyfalmen|V0185|13127|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||8832||8832|13618||1 073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|3802|lyfalmen|V0924|3240|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1700||1700|3802||2 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|861|2647|lyfalmen|V0305|2213|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||861||861|2647||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|463|2099|lyfalmen|V0439|1801|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||463||463|2099||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1259|3195|lyfalmen|V0047|3195|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1259||1259|3195||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|926|2737|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2737||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|3160|5447|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3160||3160|5447||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|868|2657|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||868||868|2657||2 074001|L01XC0202|Blitzima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2018||R|0|1|0|0|0|1|CTH|0|1|0|100|DKK|65600|86165|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||65600||65600|86165||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2861|5400|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2861||2861|5400||1 074364|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|40|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|917|2724|lyfalmen|||2|40|0|20,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||917||917|2724||2 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|699|2424|lyfalmen|||2|25|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||699||699|2424||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|551|2220|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||551||551|2220||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|896|2695|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||896||896|2695||1 074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GEN|0|0|0|100|IKR|5446|3555|lyfalmen|V0689|3555|2|56|0|56,0000|Icepharma hf|Generics UK Ltd|Pregabalín||1521||1521|3555||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|650|2260|lyfalmen|V0923|2083|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||580||580|2260||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|819|2551|lyfalmen|V0510|2551|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||791||791|2551||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|684|2403|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||684||684|2403||2 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|345|1937|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||345||345|1937||2 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|2004|4220|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2004||2004|4220||2 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|4935|8254|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4935||4935|8254||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|14469|21377|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14469||14469|21377||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|5212|8636|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5212||5212|8636||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1723|3833|lyfalmen|V0363|2617|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1723||1723|3833||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|15263|22470|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15263||15263|22470||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|7557|11863|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||7557||7557|11863||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||4518||1 075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3637|3832|lyfalmen|V0445|3832|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1722||1722|3832||2 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1094|2150|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1094||1094|2150||1 075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|11497|16763|lyfalmen|V0440|16763|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||11117||11117|16763||2 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|4928|8245|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4928||4928|8245||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|4928|8245|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4928||4928|8245||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5452|8966|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5452||5452|8966||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|UAK|0|0|0|100|GBP|634|2335|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||634||634|2335||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5747|9372|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||5747||5747|9372||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17609|25699|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||17609|25699||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17665|25776|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||17665||17665|25776||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|17699|25823|lyfalmen|||1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||17699||17699|25823||1 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2425|lyfalmen|V0143|1176|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2425||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3535|lyfalmen|V0143|2351|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3535||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|3527|lyfalmen|V0143|3527|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1500||1500|3527||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2577|lyfalmen|V0144|1382|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2577||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3861|lyfalmen|V0144|2764|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3861||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4146|lyfalmen|V0144|4146|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4146||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076378|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1553|2425|lyfalmen|V0290|2288|2|60|0|6,0000|Alvogen|Alvogen ehf|Risperídón||700||700|2425||2 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1604|2425|lyfalmen|V0291|2425|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||700||700|2425||2 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3258||1 076435|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|4765|4290|lyfalmen|V0144|4146|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||2055||2055|4290||2 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2288|lyfalmen|V0290|2288|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||600||600|2288||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|242355|307774|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||242355||242355|307774||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|161570|207300|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||161570||161570|207300||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|80909|105528|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||80909||80909|105528||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|40693|54663|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||40693||40693|54663||1 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|2604|5046|lyfalmen|V0598|5043|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2604||2604|5046||1 076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|75112|98196|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||75112||75112|98196||2 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076995|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|4503|3554|lyfalmen|V0145|2579|2|4|0|8,0000|Alvogen|ratiopharm GmbH|Tadalafíl||1520||1520|3554||2 077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|1933|4123|lyfalmen|V0005|3041|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||1933||1933|4123||2 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|47999|63903|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||47999||47999|63903||2 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2589|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2589||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2357|lyfalmen|V0671|2357|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||650||650|2357||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4661|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4661||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6004|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6004||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8344|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8344||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10133|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10133||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12638|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12638||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|663|2375|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||663||663|2375||1 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|0|G|0|TVA|0|0|0|100|IKR|8800|5316|lyfalmen|V0275|5316|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5316||2 078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|9090|13973|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9090||9090|13973||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|28203|53677|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||28203||28203|53677||2 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|602|2291|lyfalmen|||1|20|0|2,5000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||602||602|2291||2 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985|30.11.2018|R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|817|2586|lyfalmen|||1|40|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||817||817|2586||2 078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHI|0|0|0|100|DKK|12159|18198|lyfalmen|||1|30|0|50,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|lisdexamfetamine||12159||12159|18198||3 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7977|6072|lyfalmen|V0069|2512|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3349||3349|6072||1 079109|J05AP0701|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AP07|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1268406|1583894|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1268406||1268406|1583894||1 079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2071|3939|lyfalmen|V0901|3939|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3939||2 079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|9882|11517|lyfalmen|V0688|9063|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||7305||7305|11517||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|3121|5758|lyfalmen|V0315|5758|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3121||3121|5758||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSA|0|0|0|100|XEU|9641|4910|lyfalmen|V0184|4910|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||2505||2505|4910||2 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1854|4014|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1854||1854|4014||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|452|2084|lyfalmen|||2|10|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||452||452|2084||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|733|2471|lyfalmen|V0418|2352|2|20|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||733||733|2471||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|744|2486|lyfalmen|V0177|2366|2|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||744||744|2486||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1338|3087|lyfalmen|V0411|3087|2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||1181||1181|3087||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3597|6995|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3597|6995||2 080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|7263|3074|lyfalmen|||2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1171||1171|3074|31.12.2018|2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|3527|lyfalmen|V0422|3527|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1500||1500|3527||2 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11692|20152|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11692||11692|20152||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|8685|6573|lyfalmen|||2|30|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Letrózól||3713||3713|6573||1 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2048|4281|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2048||2048|4281||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4930|8248|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||4930||4930|8248||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2409|4778|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2409||2409|4778||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|13385|19885|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||13385||13385|19885||1 080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|30301|41519|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||30301||30301|41519||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|26388|36570|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||26388||26388|36570||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|AMR|0|0|0|100|XEU|2862|5389|lyfsjukr|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||2853||2853|5389||2 081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|9453|5542|lyfalmen|V0815|5525|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2964||2964|5542||2 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|656749|823164|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||656749||656749|823164||1 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|4826|3586|lyfalmen|V0515|3586|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||1543||1543|3586||2 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4124|7138|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4124||4124|7138||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|6070|9817|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9817||2 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1882|4052|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1882||1882|4052||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|4279|7352|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4279||4279|7352||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|6026|9756|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6026||6026|9756||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011|31.12.2018|R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13502|7983|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||4738||4738|7983||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|24894|34680|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||24894||24894|34680||2 082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|11427|19696|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||11427||11427|19696||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|49740|85732|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||49740||49740|85732||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|559|2231|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||559||559|2231||1 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2374|4730|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2374||2374|4730||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3973|6930|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3973||3973|6930||1 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3031|5634|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3031||3031|5634||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3300|6004|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3300||3300|6004||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4727|6582|lyfalmen|V0080|5892|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3720||3720|6582||1 083019|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.04.2018||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|248261|303677|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||239061||239061|303677||2 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|3326|6040|lyfalmen|||1|100|0|16,6700|Icepharma hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||3326||3326|6040||2 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4479|7627|lyfalmen|V0701|6417|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4479||4479|7627||1 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|6566|3948|lyfalmen|V0686|3802|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1806||1806|3948||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5525|10653|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5525||5525|10653||2 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|795|2468|lyfalmen|||1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||731||731|2468||1 083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|4605|5218|lyfalmen|V0624|5162|2|30|0|36,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2729||2729|5218||1 084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|147238|189475|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||147238||147238|189475||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|2430|4807|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4807||2 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|61339|80776|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||61339||61339|80776||1 084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|6141|9663|lyfalmen|V0215|9663|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||5958||5958|9663||2 084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1129|3016|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1129||1129|3016||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|38478|51861|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||38478||38478|51861||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|11341|17072|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||11341||11341|17072||1 085171|A10BJ0101|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|13050|19424|lyfalmen|||1|60|0|20,0000|Vistor hf|AstraZeneca AB|Exenatide||13050||13050|19424||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|XEU|32683|44532|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||32683||32683|44532||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2329|4668|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2329||2329|4668||2 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|785|2542|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||785||785|2542||1 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|11051|16673|lyfsjukr|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||11051||11051|16673||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4154|7180|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4154||4154|7180||2 085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4051|4008|lyfalmen|V0445|3910|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1850||1850|4008||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|18411|26803|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||18411||18411|26803||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|15488|21636|lyfalmen|V0652|21492|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||14657||14657|21636||1 085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7955|12411|lyfsjukr|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7955||7955|12411||2 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|81060|105719|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||81060||81060|105719||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|GPA|0|0|0|100|SEK|21311|26076|lyfalmen|V0579|26076|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||17883||17883|26076||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|28839|39670|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||28839||28839|39670||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|0|1|GRP|0|0|0|100|XEU|7600|11923|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||7600||7600|11923||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2399|4764|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||2399||2399|4764||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|7080|11207|lyfalmen|||1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||7080||7080|11207||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|340|1930|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||340||340|1930||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1753|3875|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1753||1753|3875||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|5253|8692|lyfalmen|V0365|4674|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5253||5253|8692||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BNB|0|0|0|100|XEU|51014|67717|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||51014||51014|67717||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|18923|27508|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai GmbH|Perampanel||18923||18923|27508||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|6905|10966|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6905||6905|10966||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|7494|11777|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7494||7494|11777||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10301|15640|lyfalmen|V0012|5668|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10301||10301|15640||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|26207|36341|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||26207|36341||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|47447|63205|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||47447|63205||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|0|1|BSP|0|1|0|100|DKK|45789|61108|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||45789||45789|61108||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|14991|22096|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||14991|22096||2 086649|L01XX5001|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|747110|935548|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||747110||747110|935548||1 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|44441|59403|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||44441||44441|59403||2 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 087094|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|30|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|680|2288|lyfalmen|V0931|2288|2|30|0|15,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||600||600|2288||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|315|1896|lyfalmen|V0060|1847|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||315||315|1896||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|108666|141503|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare BV|Maravíroc||108666||108666|141503||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|213|1755|lyfalmen|V0312|574|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||213||213|1755||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|188|1721|lyfalmen|V0312|1721|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||188||188|1721||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|1582|3639|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1582||1582|3639||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|13957|20672|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||13957||13957|20672||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|13957|20672|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||13957||13957|20672||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4085||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1696|3796|lyfalmen|V0952|3110|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1696||1696|3796||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|30899|53258|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||30899||30899|53258||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3985|7731|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3985||3985|7731||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|21501|37059|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||21501||21501|37059||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2784|5294|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2784||2784|5294||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|DKK|949|2768|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||949||949|2768||1 088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2878|5423|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2878||2878|5423||2 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|9197|3898|lyfalmen|V0684|2825|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3898||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|8185|12728|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||8185||8185|12728||1 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4149|7173|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4149||4149|7173|31.12.2018|1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|7274|11474|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7274||7274|11474||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13451|19976|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13451||13451|19976||1 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|421906|531085|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||421906||421906|531085||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1314|3271|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1314||1314|3271||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|20788|29487|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||20788||20788|29487||1 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|118147|153294|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||118147||118147|153294||1 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6186||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|108666|141503|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Maravíroc||108666||108666|141503||1 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|19047|27678|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||19047||19047|27678||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|45713|61012|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||45713||45713|61012||1 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012|31.12.2018|L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||1944||2 089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|1419|2357|lyfalmen|V0048|2357|2|100|0|31,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||650||650|2357||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|22016|31040|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22016||22016|31040||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|88064|114578|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||88064||88064|114578||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2198|4487|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2198||2198|4487||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|4396|7513|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||4396||4396|7513||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|665|2377|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||665||665|2377||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5163|8568|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5163||5163|8568||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|115713|150267|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||115713||115713|150267||3 090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|1743|3861|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1743||1743|3861||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|723|2457|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||723||723|2457||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|0|1|AAS|0|0|0|100|XEU|13383|19882|lyfsjukr|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||13383||13383|19882||1 091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1084|2701|lyfalmen|V0333|2701|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||900||900|2701||2 091219|N05AH0414|Quetiapin Hexal|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|7977|9707|lyfalmen|V0273|7793|2|100|0|50,0000|Artasan ehf|Hexal A/S|Quetíapín||5990||5990|9707||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2321|4657|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2321||2321|4657||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4016|6990|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4016||4016|6990||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|11788|17687|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||11788||11788|17687||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|3153|5802|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3153||3153|5802||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|5824|9478|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5824||5824|9478||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|TRI|0|0|1|100|SEK|3268|5960|lyfalmen|||1|30|0||Vistor hf|Trimb Healthcare AB|Dexametasón||3268||3268|5960||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|922|2059|lyfalmen|V0021|2030|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||434||434|2059||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1594|2359|lyfalmen|V0022|2314|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||652||652|2359||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1036|2888|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||1036||1036|2888||1 092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6118|11778|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||6118||6118|11778||2 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2 092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2803||2 092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2065|4215|lyfalmen|V0011|2723|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4215||2 092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3453|4765|lyfalmen|V0011|4765|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2400||2400|4765||2 092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|1510|2838|lyfalmen|V0005|2838|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2838||2 092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2400|4215|lyfalmen|V0012|3174|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4215||2 092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4794|5584|lyfalmen|V0012|5555|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2995||2995|5584||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SND|0|0|0|100|XEU|4317|7404|lyfalmen|V0009|3999|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||4317||4317|7404||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2014|4234|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2014||2014|4234||1 092694|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar|H02AB04|01.01.2019||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|603|2292|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||603||603|2292||1 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|722|2456|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||722||722|2456||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|1369|3346|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1369||1369|3346||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2977|3092|lyfalmen|V0203|3089|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1184||1184|3092||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|883|2677|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||883||883|2677||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2028|4253|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2028||2028|4253||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3942|6888|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3942||3942|6888||2 093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|268965|340870|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||268965||268965|340870||1 093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|392451|494452|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||392451||392451|494452||1 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4110|7119|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4110||4110|7119|30.11.2018|1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5245|8681|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5245||5245|8681||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|0|1|0|1|ERZ|0|0|0|100|XEU|21889|30879|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||21889||21889|30879||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1762|3887|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1762||1762|3887||1 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|DKK|4857|8147|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4857||4857|8147||2 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|DKK|3596|6411|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3596||3596|6411||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2165|4442|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2165||2165|4442||2 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|29995|41132|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||29995||29995|41132||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19578|28409|lyfalmen|V0588|19101|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||19578||19578|28409||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|382884|482553|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||382884||382884|482553||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|382884|482553|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||382884||382884|482553||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAC|0|0|0|100|DKK|5147|8546|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5147||5147|8546||2 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1578|3101|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1578||1578|3101||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|939|2754|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||939||939|2754||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014|31.12.2018|L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15058|15504|lyfalmen|V0534|15504|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||10202||10202|15504||2 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VIC|0|0|0|100|DKK|67306|88323|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||67306||67306|88323||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|HAL|0|0|0|100|DKK|41914|56207|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||41914|56207||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|5735|9885|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||5735||5735|9885||2 094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|0|1|TAG|0|0|0|100|DKK|35752|48413|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||35752||35752|48413||1 095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|46163|58792|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||43958||43958|58792||1 095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|0|0|AIS|0|1|0|100|DKK|89892|116890|lyfalmen|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||89892||89892|116890||1 095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|336565|424945|lyfalmen|V0919|424945|1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||336565|424945||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|7747|12125|lyfalmen|||1|50|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Dísúlfíram||7747||7747|12125||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|13922|20624|lyfalmen|V0963|15914|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||13922||13922|20624||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|14130|20910|lyfalmen|V0964|15914|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14130||14130|20910||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|16450|24104|lyfalmen|V0965|18667|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16450||16450|24104||1 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1956|4154|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1956|4154||2 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|3091|5716|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3091|5716||2 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|871|2270|lyfalmen|V0225|2194|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||587||587|2270||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|6417|lyfalmen|V0701|6417|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||3600||3600|6417||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|108992|141908|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||108992||108992|141908||1 096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|621874|779790|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||621874||621874|779790||2 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|13131|19535|lyfalmen|V0347|17185|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||13131||13131|19535||1 096473|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|470|2013|lyfalmen|V0930|2013|2|20|0|10,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||400||400|2013||2 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|665544|834103|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||665544||665544|834103||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|616906|773611|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||616906||616906|773611||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|649375|813993|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||649375||649375|813993||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|711994|891874|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||711994||711994|891874||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|11944|17902|lyfalmen|V0349|17902|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||11944||11944|17902||1 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNP|0|0|0|100|XEU|10980|16575|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||10980||10980|16575||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|64903|111867|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||64903||64903|111867||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7165|13764|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7165|13764||2 097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|9815|14971|lyfalmen|V0334|2781|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||9815||9815|14971||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|18261|26596|lyfalmen|V0335|2781|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||18261|26596||1 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|30872|42241|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||30872||30872|42241||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5471|10550|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5471||5471|10550||2 097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|17880|26072|lyfalmen|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||17880||17880|26072||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2288|2610|lyfalmen|V0023|2553|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||834||834|2610||1 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2676|5145|lyfsjukr|||2|2000|0|5,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2676|5145||2 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|973|2801|lyfalmen|V0329|2801|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||973||973|2801||1 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|522|2180|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||522||522|2180||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|522|2180|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||522||522|2180||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|953|2288|lyfalmen|V0243|2288|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||600||600|2288||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1609|2425|lyfalmen|V0244|2284|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||700||700|2425||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|4409|3939|lyfalmen|V0245|3939|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1800||1800|3939||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|9120|7656|lyfalmen|V0232|7656|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||4500||4500|7656||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|3162|4563|lyfalmen|V0381|4563|2|10|0|2,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2253||2253|4563||2 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|14250|21076|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||14250||14250|21076||1 099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2991|2563|lyfalmen|V0107|2508|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||800||800|2563||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|60916|80241|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||60916||60916|80241||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2166|2330|lyfalmen|V0284|2230|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||631||631|2330||2 099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|9773|12048|lyfalmen|V0272|9445|2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||7691||7691|12048||1 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4047|3700|lyfalmen|V0285|3527|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1626||1626|3700||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|7243|6812|lyfalmen|V0286|6380|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||3887||3887|6812||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3514|2903|lyfalmen|V0685|2903|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1047||1047|2903||1 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1538|2160|lyfalmen|V0247|2160|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||507||507|2160||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2821|3605|lyfalmen|V0248|3605|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1557||1557|3605||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5088|4092|lyfalmen|V0249|4092|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1911||1911|4092||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|154509|198518|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||154509||154509|198518||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|297815|376751|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||297815||297815|376751||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|595608|747122|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||595608||595608|747122||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011|31.12.2018|R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|627|2325|lyfalmen|||2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||627||627|2325||1 099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|storn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|0|1|ACC|0|1|0|100|XEU|131388|169762|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Pemetrexed||131388||131388|169762||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|4932|7950|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||4932||4932|7950||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|10274|15603|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||10274|15603||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1752|3613|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1563||1563|3613|31.12.2018|1 100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|322|1740|lyfalmen|||2|30|0|15,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||202||202|1740|31.12.2018|2 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|1954|3656|lyfalmen|V0685|1626|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1594||1594|3656||2 100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2150|lyfalmen|V0821|2150|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2150||2 100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2838|lyfalmen|V0822|2838|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2838||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|3827|6729|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||3827||3827|6729||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|9679|12414|lyfalmen|V0254|10231|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||7957||7957|12414||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|14160|20952|lyfalmen|V0256|16189|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||14160||14160|20952||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|56894|91713|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||56894||56894|91713||1 101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5189||5189|10015||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|1123|2701|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||900||900|2701||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2464|3985|lyfalmen|V0331|3985|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1833||1833|3985||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|10996|21032|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||10996||10996|21032||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5450|8963|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5450||5450|8963||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|16168|23716|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||16168||16168|23716||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|948|2767|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||948||948|2767||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1429|3429|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1429||1429|3429||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5121|8511|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5121||5121|8511||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|370|1971|lyfalmen|V0230|1963|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||370||370|1971||1 102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2 102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015|31.12.2018|R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2620|3396|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1405||1405|3396||1 102355|J01CR0202|Augmentin|sts|1200|mg/hgl|10|hgl|1|pakki|1000+200 mg|J01CR02|01.07.2018||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|5069|8439|lyfsjukr|||1|10|0|3,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill||5069||5069|8439||1 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|0|G|0|WEH|0|0|0|100|XEU|8252|3209|lyfalmen|V0684|2825|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1269||1269|3209||2 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2850|5385|lyfalmen|V0041|3231|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2850||2850|5385||1 102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|14130|20123|lyfalmen|V0441|20123|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||13558||13558|20123||2 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1847|lyfalmen|V0060|1847|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||280||280|1847||2 103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2336|4677|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2336||2336|4677||2 103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|0|1|0|0|PMA|0|0|0|100|DKK|6606|8757|lyfalmen|V0657|8757|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||5300||5300|8757||1 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|92144|119738|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||92144||92144|119738||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2030|3125|lyfalmen|V0088|2362|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3125||2 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2590|3711|lyfalmen|V0089|2647|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3711||2 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1845|3898|lyfalmen|V0069|2512|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3898||2 103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2859|3939|lyfalmen|V0334|2838|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3939||2 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4715|4032|lyfalmen|V0335|2838|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1867||1867|4032||2 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1599|3487|lyfalmen|V0222|3487|2|5|0|3,6000|Alvogen|ratiopharm GmbH|Fentanýl||1471||1471|3487||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|263003|333455|lyfsjukr|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||263003||263003|333455||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|108795|141663|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||108795||108795|141663||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3514|6837|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3514||3514|6837||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2289||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8247|12813|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8247||8247|12813||2 104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3689|6539|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||3689||3689|6539||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2507|4913|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2507||2507|4913||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6009|9733|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6009||6009|9733||1 104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 104593|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.08.2017||L|0|0|0|0|G|0|BOI|0|0|1|100|NOK|||lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð|||||2841||1 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|9390|14386|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||9390||9390|14386||1 104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|4500|5316|lyfalmen|V0275|5316|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2800||2800|5316||2 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6929|10999|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6929||6929|10999||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3591|6405|lyfalmen|V0017|5328|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3591||3591|6405||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|5313|8775|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5313||5313|8775||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|4023|6999|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4023||4023|6999||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|97544|126568|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||97544|126568||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|10964|15638|lyfalmen|V0012|5668|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||10299||10299|15638||2 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1141|3032|lyfalmen|V0545|2142|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1141||1141|3032||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|XEU|3377|3021|lyfalmen|V0107|2508|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||1133||1133|3021||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1967|4169|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||1967||1967|4169||2 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2325|4662|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2325||2325|4662||2 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRG|0|0|0|100|DKK|1629|3704|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1629||1629|3704||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRG|0|0|0|100|DKK|3120|3701|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1627||1627|3701||2 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|404183|509043|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||404183||404183|509043||1 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|15555|22872|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||15555||15555|22872||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|8602|13302|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||8602||8602|13302||1 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3211|2955|lyfalmen|V0107|2508|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||1085||1085|2955||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|1|CHI|0|0|0|100|DKK|143012|184219|lyfsjukr|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||143012||143012|184219||1 107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2870|4947|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2870||2870|4947||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1390|3375|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1390||1390|3375||1 107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4128|7144|lyfalmen|V0438|7144|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||4128||4128|7144||2 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PCC|0|0|0|100|XEU|18999|24489|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Critical Care Limited|Sevóflúran||16730||16730|24489||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|819|2589|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||819||819|2589||1 107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|11390|5493|lyfalmen|V0814|5492|2|28|0|8,7500|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||2929||2929|5493||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20582|3898|lyfalmen|V0683|2825|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3898||2 107785|L01XE4201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|277350|351298|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||277350||277350|351298||1 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1969|4172|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||1969||1969|4172||2 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2 108347|J05AP0701|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AP07|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1268406|1583894|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1268406||1268406|1583894||1 108413|C10AX1401|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|64979|85380|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||64979||64979|85380||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8651|13369|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||8651||8651|13369||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|65935|86589|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||65935||65935|86589||3 109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|987|1985|lyfalmen|V0827|1942|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||380||380|1985||2 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999|31.10.2018|R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19428|28203|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||19428||19428|28203||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999|31.10.2018|R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15554|22870|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15554||15554|22870||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|1459|3396|lyfalmen|V0584|3393|2|28|0|7,4700|Alvogen|ratiopharm GmbH|Oxýcódon||1405||1405|3396||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|5103|7314|lyfalmen|V0585|7314|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4252||4252|7314||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|2668|5134|lyfalmen|V0586|5134|2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||2668||2668|5134||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|8654|12918|lyfalmen|V0587|12918|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||8323||8323|12918||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|14456|19101|lyfalmen|V0588|19101|2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||12815||12815|19101||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|315|1896|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||315||315|1896||2 110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7315|5228|lyfalmen|V0694|5228|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||2736||2736|5228||1 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1648|3730|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1648||1648|3730||1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|3527|lyfalmen|V0291|2425|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1500||1500|3527||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2608|3114|lyfalmen|V0292|3114|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1200||1200|3114||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3684|6533|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3684||3684|6533||2 110341|A10BJ0601|Ozempic|stl|0,25|mg/ml|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|0|NON|0|0|0|100|DKK|18354|26724|lyfalmen|||1|1,5|0||Vistor hf|Novo-Nordisk|Semaglutide||18354||18354|26724||1 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|8344|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8344||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1360|3334|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1360||1360|3334||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|23546|32975|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||23546||23546|32975||1 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3792|6681|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3792||3792|6681||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MBV|0|0|0|100|DKK|81479|106249|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||81479||81479|106249||1 110820|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|81998|106905|lyfsjukr|||2|60|0||Icepharma hf|Mylan AB|Imatiníb||81998||81998|106905||2 110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|10641|16108|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare Limited|Temozolomid||10641||10641|16108||1 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|0|GED|0|0|0|100|XEU|14245|17979|lyfalmen|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||12000||12000|17979||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2616|4665|lyfalmen|V0373|4665|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2327||2327|4665||2 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CRC|0|0|0|100|IKR|||lyflausa|||0|2|0||Recordati AB|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|620|2315|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||620||620|2315||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|179742|229901|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||179742||179742|229901||1 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3701|lyfalmen|||2|100|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3701||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|14883|16602|lyfalmen|||2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||11000||11000|16602||2 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|V0655|4394|2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5041||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6849|10889|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6849||6849|10889||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6169|9953|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6169||6169|9953||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|2052|4286|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||2052||2052|4286||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|2564|4991|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2564||2564|4991||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5197|7032|lyfalmen|V0681|7032|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4047||4047|7032||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|4404|7524|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4404||4404|7524||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|442243|556379|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||442243||442243|556379||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|536|2200|lyfalmen|V0930|2013|1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||536||536|2200||2 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|779|2534|lyfalmen|V0931|2288|1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||779||779|2534||2 113982|B05AA0510|RescueFlow|irl|||250|ml|6|pokar|60/75 g/l|B05AA05|01.03.2017||R|0|0|0|0|0|1|ARM|0|0|0|100|DKK|43294|57952|lyfsjukr|||1|1500|0||Williams & Halls efh|Pharmanovia A/S|Dextran||43294||43294|57952||2 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|644|2348|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||644||644|2348||1 114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5000|3802|lyfalmen|V0145|2579|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1700||1700|3802||2 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|18597|27059|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||18597|27059||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|31297|42779|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||31297|42779||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3650|6486|lyfalmen|V0824|2842|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3650||3650|6486||1 114461|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|18120|7738|lyfalmen|V0145|7738|2|12|0|24,0000|Alvogen|ratiopharm GmbH|Tadalafíl||4560||4560|7738||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|9761|14897|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||9761||9761|14897||2 114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|DKK|7868|11277|lyfalmen|V0973|11277|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||7131||7131|11277||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|10133|lyfalmen|V0420|10133|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||6300||6300|10133||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5371|9257|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5371||5371|9257||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2183|2898|lyfalmen|V0278|2898|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1043||1043|2898||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2879|5425|lyfalmen|V0279|3767|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2879||2879|5425||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|7469|4469|lyfalmen|V0280|4469|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2185||2185|4469||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10321|3309|lyfalmen|V0282|3309|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1342||1342|3309||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|8724|lyfalmen|V0457|8724|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8724||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12503|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12503||2 115015|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|pakki|+ 9 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|85393|111199|lyfalmen|||1|2,16|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||85393||85393|111199||1 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9416|lyfalmen|V0475|9416|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9416||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20588|lyfalmen|V0540|20588|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20588||2 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|84381|109919|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||84381||84381|109919||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|7843|12257|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||7843||7843|12257||2 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1019|2800|lyfalmen|V0158|2494|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||972||972|2800||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1862|3114|lyfalmen|V0276|3114|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1200||1200|3114||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10093|15354|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10093||10093|15354||1 115348|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.07.2016|31.10.2018|R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|137|1651|lyfalmen|||1|25|0|12,5000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||137||137|1651||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9220|14152|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9220||9220|14152||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|45830|61160|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||45830||45830|61160||1 115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|0|STE|0|0|0|100|DKK|3027|5628|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3027||3027|5628||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2984|5569|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2984||2984|5569||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|3103|5733|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3103||3103|5733||1 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|1623|3696|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1623||1623|3696||1 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|671|2273|lyfalmen|V0562|2011|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||589||589|2273||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|334|1922|lyfalmen|V0563|1772|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||334||334|1922||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|804|2548|lyfalmen|V0564|2194|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||789||789|2548||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|13979|20703|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||13979||13979|20703||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3959|6367|lyfalmen|V0081|5892|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3564||3564|6367||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|5448|8961|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5448||5448|8961||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|5838|9497|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5838||5838|9497||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PEU|0|0|0|100|DKK|14986|22089|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||14986||14986|22089||1 116907|N02AE0104|Buprenorphine ratiopharm|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|IKR|1632|3458|lyfalmen|V0944|3458|2|4|0|5,6000|Alvogen|ratiopharm GmbH|Búprenorfín||1450||1450|3458||2 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|8658|16596|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||8658||8658|16596||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1387|3371|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1387||1387|3371||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3897|6826|lyfalmen|V0435|6416|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3897||3897|6826||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|10312|14978|lyfalmen|V0275|5316|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||9820||9820|14978||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|18996|25356|lyfalmen|V0273|7793|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||17360||17360|25356||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1307|3261|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1307||1307|3261||2 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|27264|37678|lyfalmen|V0272|9445|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||27264||27264|37678||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|39906|53667|lyfalmen|V0261|13850|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||39906|53667||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|50589|67179|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||50589||50589|67179||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005|31.12.2018|R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|6393|11019|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||6393||6393|11019||2 117787|N06BA0904|Atomoxetine Sandoz|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|10231|5525|lyfalmen|V0816|5525|2|28|0|21,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2952||2952|5525||1 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|5133|9909|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5133||5133|9909||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|10253|19622|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||10253||10253|19622||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1602|3667|lyfalmen|V0278|2898|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1602||1602|3667||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2628|3767|lyfalmen|V0279|3767|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1675||1675|3767||1 118074|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|600|2219|lyfalmen|V0929|2219|2|20|0|8,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||550||550|2219||2 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|8975|3696|lyfalmen|V0282|3309|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1623||1623|3696||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1549|3594|lyfalmen|V0283|3101|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1549||1549|3594||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14554|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14554||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7469|5551|lyfalmen|V0280|4469|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2971||2971|5551||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4758|9197|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4758||4758|9197||2 118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|19367|28119|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||19367||19367|28119||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2567|4995|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2567||2567|4995||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|432|2057|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||432||432|2057||2 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|1149|3043|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1149||1149|3043||2 119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2800|2914|lyfalmen|V0824|2842|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1055||1055|2914||2 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3614|6436|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3614||3614|6436||2 119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5500|5316|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2800||2800|5316||2 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|1297|3247|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3247||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|299027|378258|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||299027||299027|378258||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|277613|351625|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||277613||277613|351625||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|HES|0|0|0|100|XEU|1603|3668|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Cýklópentólat||1603||1603|3668||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|0|1|NED|0|1|0|100|XEU|38031|51296|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||38031||38031|51296||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|8619|lyfalmen|V0118|8619|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5200||5200|8619||2 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|400241|504140|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||400241||400241|504140||2 121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8619|lyfalmen|V0118|8619|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||5200||5200|8619||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|3910|6844|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3910||3910|6844||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|6706|10692|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Rókúrón, brómíð||6706||6706|10692||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MEA|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|414|2032|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||414||414|2032||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|403|2017|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||403||403|2017|31.10.2018|1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|NAA|0|0|0|100|DKK|1508|3538|lyfalmen|||1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1508||1508|3538||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|343|1934|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||343||343|1934||1 121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|248|1803|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||248||248|1803||1 121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3287|5986|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3287||3287|5986||2 122133|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|3416|3602|lyfalmen|V0145|2579|2|4|0|8,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||1555||1555|3602||2 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2 122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|2825|lyfalmen|V0010|2212|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2825||2 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8171|14084|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||8171||8171|14084||1 122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|262384|332685|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||262384||262384|332685||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|499|2149|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||499||499|2149||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|759|2507|lyfalmen|||2|10|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||759||759|2507||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|1254|3188|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1254||1254|3188||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|29161|50262|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||29161||29161|50262||2 123435|N05AX1205|Aripiprazol Krka|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|5668|4903|lyfalmen|V0716|4903|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||2500||2500|4903||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|AZA|0|0|0|100|SEK|17535|25597|lyfalmen|||1|90|0|90,0000|Vistor hf|AstraZeneca AB|Roflumílast||17535||17535|25597||1 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014|31.12.2018|R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|24327|41930|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||24327||24327|41930||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|585|2267|lyfalmen|||2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||585||585|2267||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|XEU|20971|29718|lyfalmen|V0579|26076|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||20971||20971|29718||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1613|3170|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1613|3170||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SND|0|0|0|100|XEU|27794|38348|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||27794||27794|38348||1 124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|28804|39626|lyfalmen|||0|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||28804||28804|39626||3 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|7932|12380|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||7932||7932|12380||2 124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8604|13305|lyfalmen|||1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||8604||8604|13305||1 124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4493||1 125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|809|2575|lyfalmen|V0066|2575|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||809||809|2575||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|11207|16887|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||11207||11207|16887||2 125197|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.08.2017||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5829|2812|lyfalmen|V0490|2663|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||981||981|2812||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|4399|3527|lyfalmen|V0285|3527|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1500||1500|3527||2 125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|1535013|1915479|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1535013||1535013|1915479||2 125661|G04BE0805|Tadalafil Actavis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|11463|5931|lyfalmen|V0145|5159|2|8|0|16,0000|Actavis Group hf|Actavis Group PTC ehf|Tadalafíl||3247||3247|5931||1 125688|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|2028|4253|lyfalmen|||1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||||2028|4253||1 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|32785|44661|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||32785||32785|44661||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|65570|86127|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||65570||65570|86127||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|131140|169454|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||131140||131140|169454||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|0|1|FIN|0|1|0|100|DKK|119874|155442|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||119874||119874|155442||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|30331|41557|lyfalmen|V0976|41123|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30331|41557||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|3321|6033|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3321|6033||1 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|6688|10667|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||6688||6688|10667||2 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2954|4882|lyfalmen|V0011|4862|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2485||2485|4882||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||1 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|944|2761|lyfalmen|V0313|2761|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||944||944|2761||2 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|6302|10136|lyfalmen|V0279|3767|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6302||6302|10136||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|12771|24400|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||12771||12771|24400||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1163|3063|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1163||1163|3063||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3273|5967|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3273||3273|5967||1 128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|0|1|0|0|PEU|0|1|0|100|DKK|215216|274021|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||215216||215216|274021||2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|24682|34412|lyfalmen|V0282|3309|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||24682||24682|34412||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|407|2022|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||407||407|2022||1 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|17552|10793|lyfalmen|V0680|10684|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||6779||6779|10793||2 129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3261||2 129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3157|5807|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3157||3157|5807||1 129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|9453|5542|lyfalmen|V0812|5525|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2964||2964|5542||2 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15128|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15128||2 130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|0|1|0|1|MRP|0|0|0|100|SEK|287974|364512|lyfsjukr|||1|1|0||Icepharma hf|Merck Europe B.V.|Cladribine||287974||287974|364512||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1776|3906|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1776||1776|3906||2 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|0|1|PFM|0|0|0|100|SEK|284250|359880|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||284250||284250|359880||1 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|18269|34830|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||18269||18269|34830||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1388|3372|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1388||1388|3372||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|PEU|0|0|1|100|DKK|10048|15292|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||10048|15292||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|40502|65289|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||40502|65289||1 131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|6264|12055|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||6264||6264|12055||2 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2544|4964|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2544|4964||2 131155|H05BX0104|Cinacalcet Mylan|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|IKR|34212|19355|lyfalmen|V0722|19355|2|28|0|42,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||13000||13000|19355||2 131334|N03AB0209|Fenantoin Meda|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|894|2692|lyfalmen|||2|100|0|33,3333|Icepharma hf|Meda AB|Fenýtóín||894||894|2692||2 131383|N03AA0207|Fenemal Meda|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1473|3489|lyfalmen|||2|100|0|15,0000|Icepharma hf|Meda AB|Fenemal||1473||1473|3489||2 131417|N03AA0207|Fenemal Meda|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1669|3759|lyfalmen|||2|100|0|50,0000|Icepharma hf|Meda AB|Fenemal||1669||1669|3759||2 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3164|4268|lyfalmen|V0348|4268|2|28|0|14,0000|Alvogen|Alvogen|Galantamín||2039||2039|4268||2 132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|XEU|1063|2208|lyfalmen|V0003|2208|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||542||542|2208||2 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|0|1|TPA|0|1|0|100|DKK|417200|525233|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||417200||417200|525233||1 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|8923|13744|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||8923||8923|13744||1 132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|2421|2647|lyfalmen|V0089|2647|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||861||861|2647||2 132662|R05DA0403|Kodein Meda|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|MEA|0|0|1|100|DKK|1185|3093|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Kódein||1185||1185|3093||2 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4930|8248|lyfalmen|V0681|7032|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4930||4930|8248||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5841|11252|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||5841|11252||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|4188|3799|lyfalmen|V0335|2838|2|100|0|150,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1698||1698|3799||1 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|XEU|455|2088|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Proxýmetakaín||455||455|2088||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|SLP|0|0|0|100|SEK|20636|29295|lyfsjukr|||1|0,5|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||20636||20636|29295||1 133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|1323|2288|lyfalmen|V0037|2288|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||600||600|2288||2 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|SLP|0|0|0|100|SEK|27439|37899|lyfsjukr|||1|1|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||27439||27439|37899||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|SLP|0|0|0|100|SEK|37311|50385|lyfsjukr|||1|2|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||||37311|50385||1 133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|0|1|GAA|0|0|0|100|SEK|3793|6683|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3793||3793|6683||2 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|BVB|0|1|0|100|DKK|207835|264841|lyfsjukr|||1|2|0||Lyfjaver ehf|Shire Services BVBA|C1 hemill||||207835|264841||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0||Icepharma hf|Meda AB|Makrógól 3350|||||||2 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|20|0|10,0000|Icepharma hf|Meda AB|Makrógól 3350|||||||2 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|7524|11818|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||7524||7524|11818||1 133856|N06BA0904|Atomoxetine Sandoz|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|10231|5492|lyfalmen|V0814|5492|2|28|0|8,7500|Artasan ehf|Sandoz A/S|Atomoxetín||2928||2928|5492||1 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2298|4625|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2298||2298|4625|31.12.2018|3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BFP|0|0|0|100|XEU|1227|3151|lyfalmen|V0333|2894|2|30|0|11,2500|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1227||1227|3151||1 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2697|5174|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2697||2697|5174||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7050|11166|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7050||7050|11166||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|0|0|1|GRP|0|0|0|100|GBP|3680|6527|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Epírúbicín||3680||3680|6527||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|52967|70187|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||52967||52967|70187||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|106323|138589|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||106323||106323|138589||2 134920|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|13745|lyfalmen|V0828|13745|2|100|0|11,1100|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13745||2 135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4201|lyfalmen|V0678|4065|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1990||1990|4201||2 135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3500|6211|lyfalmen|V0679|5974|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||3450||3450|6211||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|362075|456672|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer AG|Riociguatum||362075||362075|456672||1 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|9336|14312|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9336||9336|14312||1 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1127|3013|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1127||1127|3013||1 135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|DKK|2909|3284|lyfalmen|V0909|3021|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||1324||1324|3284||2 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|35721|48374|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||35721||35721|48374||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|MEA|0|0|0|100|DKK|5537|9083|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||5537||5537|9083||2 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|61339|80776|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||61339||61339|80776||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|2851|5386|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2851||2851|5386||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|IKR|804|2569|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2569||2 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól|||||||1 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|39000|13850|lyfalmen|V0261|13850|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9000||9000|13850||2 137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|0|1|0|1|MRP|0|0|0|100|SEK|1727843|2155305|lyfsjukr|||1|6|0||Icepharma hf|Merck Europe B.V.|Cladribine||1727843||1727843|2155305||2 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|DKK|5539|9086|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5539||5539|9086||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|DKK|4838|8121|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4838||4838|8121||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|DKK|5468|8988|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5468||5468|8988||1 137881|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|10854|13044|lyfalmen|||2|90|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||8415||8415|13044||1 137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|6500|7793|lyfalmen|V0273|7793|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4600||4600|7793||2 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|9279|4010|lyfalmen|V0689|3555|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1851||1851|4010||2 138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2467|4858|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2467||2467|4858||2 138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|2377275|2963017|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2377275|2963017||2 138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2500|2770|lyfalmen|V0114|2770|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2770||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1439|3443|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1439||1439|3443||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15135|22294|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||15135||15135|22294||1 138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3231|5909|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3231||3231|5909||2 138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|4573|5415|lyfalmen|V0691|5376|2|30|0|18,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2872||2872|5415||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|2457|4665|lyfalmen|V0373|4665|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2327||2327|4665||1 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CBV|0|1|0|100|XEU|108789|141656|lyfsjukr|||1|56|0|28,0000|Celgene AB|Celgene Europe B.V.|Apremilast||108789||108789|141656||2 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981|31.12.2018|L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||5031||1 139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|27510|37989|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|37989||2 140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|514|2169|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||514||514|2169||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1009|2851|lyfalmen|V0266|2054|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||1009||1009|2851||1 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|14238|19101|lyfalmen|V0588|19101|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||12815||12815|19101||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|9686|14794|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9686||9686|14794||1 140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4788|8052|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||4788||4788|8052||2 140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|1|0|0|0|ARO|0|0|0|100|DKK|6302|10136|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||6302||6302|10136||2 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|71423|135674|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||71423||71423|135674||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|47207|62902|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||47207||47207|62902||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1068|2932|lyfalmen|V0413|2714|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1068||1068|2932||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|3175|5832|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3175|5832||1 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3454|6216|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3454||3454|6216||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MRP|0|0|0|100|SEK|13200|19630|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||13200|19630||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|38440|51813|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||38440||38440|51813||3 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009|31.12.2018|R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3503|6283|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3503|6283||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|UAK|0|0|1|100|XEU|1054|2913|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||1054||1054|2913||1 141783|R02AX0101|Strefen|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 141805|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|3|dropaí||A07DA02|01.06.2018||R|0|0|1|0|0|0|ARO|0|0|0|100|DKK|17795|25955|lyfalmen|||2|30|0|3,0000|Pharmanovia A/S|Pharmanovia A/S|opium||17795||17795|25955||2 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3425||1 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TVA|0|0|0|100|XEU|5325|8791|lyfalmen|V0492|8791|2|98|0|39,2000|Alvogen|Teva B.V.|Montelúkast||5325||5325|8791||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5847|9510|lyfalmen|V0267|3045|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5847||5847|9510||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1497|3522|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1497||1497|3522||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|0|0|1|LIN|0|0|0|100|XEU|20521|29149|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||20521|29149||5 142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2386|4113|vetorma|||0|0,9|0||Vistor hf|Merial|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2386||2386|4113||1 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|3758|4446|lyfalmen|V0384|3343|2|10|0|5,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2168||2168|4446||1 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|762|2511|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||762||762|2511||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|2799|5315|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Metenamín||2799||2799|5315||2 142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|484445|608866|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||484445||484445|608866||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2673|lyfalmen|V0946|2563|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||880||880|2673||2 142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2043|2976|lyfalmen|V0049|2976|2|100|0|66,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1100||1100|2976||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16784||1 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1474|3491|lyfalmen|V0426|3491|1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1474||1474|3491||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1993|4205|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1993||1993|4205||1 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|11006|5850|lyfalmen|V0687|5411|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3188||3188|5850||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|NOK|4757|8009|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4757||4757|8009||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|516|1905|lyfalmen|V0542|1905|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||322||322|1905||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|XEU|968|2794|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Trópíkamíð||968||968|2794||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1202|3116|lyfalmen|V0173|2288|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1202||1202|3116||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5773|9408|lyfalmen|V0387|8200|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5773||5773|9408||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MBV|0|0|0|100|DKK|5809|9457|lyfalmen|V0386|7439|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5809||5809|9457||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|GRP|0|0|0|100|DKK|2579|5012|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Litíum||2579||2579|5012||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1517|3550|lyfalmen|V0174|2563|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1517||1517|3550||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1836|3989|lyfalmen|V0938|3989|1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1836||1836|3989||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|61252|80666|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||61252||61252|80666||1 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3044|5652|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3044||3044|5652||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|40841|54850|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||40841||40841|54850||1 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|8323|12918|lyfalmen|V0587|12918|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||8323||8323|12918||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|20420|29021|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||20420||20420|29021||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|0|0|1|JAN|0|1|0|100|DKK|69017|90487|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||69017||69017|90487||1 145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4549|7723|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4549|7723||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2732|5354|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2732||2732|5354||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3938|7642|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3938||3938|7642||1 145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|449|2080|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||||449|2080||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5265|10159|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5265||5265|10159||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|6405|12322|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||6405||6405|12322||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8473|13124|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8473||8473|13124||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|4897|8202|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||4897||4897|8202||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|25362|35272|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||25362||25362|35272||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|1|RGP|0|1|0|100|DKK|25345|35251|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||25345||25345|35251||1 146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015|31.12.2018|R|0|0|0|0|0|1|PLS|0|0|0|100|XEU|7471|11745|lyfsjukr|||2|25|0||Icepharma hf|Pfizer Aps|Írinótekan||7471||7471|11745||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|15735|23120|lyfalmen|V0817|6559|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||15735||15735|23120||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|295|1868|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||295||295|1868||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|3917|5376|lyfalmen|V0691|5376|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2844||2844|5376||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3334||1 147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|2096|2805|lyfalmen|V0353|2805|2|30|0|3,7500|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||976||976|2805||1 147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|6431|5591|lyfalmen|V0687|5411|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3000||3000|5591||2 147902|L01XE2901|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|0|1|0|1|EUL|0|0|0|100|SEK|216005|275002|lyfsjukr|||1|30|0||Eisai AB|Eisai Europe Ltd.|Lenvatinib||216005||216005|275002||1 148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|150412|193423|lyfsjukr|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||150412|193423||2 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|99015|128428|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||99015||99015|128428||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1062|2670|lyfalmen|V0577|2670|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||878||878|2670||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1581|3638|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1581||1581|3638||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|5435|8582|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||5173||5173|8582||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|54454|72068|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||54454||54454|72068||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|54454|72068|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||54454||54454|72068||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|350|1944|lyfalmen|V0601|1944|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||350||350|1944||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|1012|2855|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1012||1012|2855||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81735|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81735||5 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998|31.12.2018|R|0|0|0|0|0|1|ALV|0|0|0|100|XEU|25516|35467|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||25516||25516|35467||2 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3200|6242|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3200||3200|6242||2 149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|247913|314687|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||247913||247913|314687||1 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2164|4440|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2164||2164|4440||1 149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|1|WEH|0|0|0|100|IKR|14270|21103|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||14270||14270|21103||2 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||6976||1 150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4613|5591|lyfalmen|V0253|5591|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3000||3000|5591||2 150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|0|0|1|AEB|0|1|0|100|DKK|169727|217445|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||169727||169727|217445||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|39017|52543|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||39017|52543||1 151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4300|3045|lyfalmen|V0607|2984|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1150||1150|3045||2 151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|43198|57831|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||43198||43198|57831||2 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|5635|9218|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5635||5635|9218||1 151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|1287|3233|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1287||1287|3233||1 151250|J05AP5301|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AP53|01.10.2015||R|0|0|0|1|0|1|ABD|0|1|0|100|DKK|1741552|2172356|lyfsjukr|||1|56|0||Vistor hf|AbbVie Deutschland GmbH & Co. KG|Ombitasvir, paritaprevir og ritonavir||1741552||1741552|2172356||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|29645|40689|lyfalmen|V0607|2984|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||29645||29645|40689||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|373|1975|lyfalmen|V0633|1909|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||373||373|1975||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MCE|0|0|0|100|SEK|3814|6712|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||3814|6712||2 151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|5688|3238|lyfalmen|V0682|2825|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1290||1290|3238||2 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|999|2837|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||999||999|2837||1 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1195|2349||2 151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1691|2640|lyfalmen|V0234|1629|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||856||856|2640||1 151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|103501|135079|lyfsjukr|||2|12|0|24,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||103501||103501|135079||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1381|3363|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1381||1381|3363||1 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|787|2536|lyfalmen|V0050|2136|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||780||780|2536||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1682|3777|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1682||1682|3777||1 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2474|4867|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2474||2474|4867||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3971|6928|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3971||3971|6928||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|7260|11455|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||7260||7260|11455||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010|31.12.2018|R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|16389|24020|lyfalmen|||3|100|0|40,0000|LYFIS ehf|LYFIS ehf|Pramipexól||16389||16389|24020||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|5751|4000|lyfalmen|V0182|3941|2|42|0|7,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||1844||1844|4000||1 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|5926|8472|lyfalmen|||2|90|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||5093||5093|8472||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1445|3451|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1445||1445|3451||2 153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RTH|0|0|0|100|DKK|1193|2789|lyfalmen|V0444|2789|2|5|0|25,0000|Alvogen|ratiopharm GmbH|Brinzólamíð||964||964|2789||2 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|29263|40206|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||29263|40206||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0575|1641|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||3975||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|189227|241698|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||189227||189227|241698||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|637|2339|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||637||637|2339||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|28540|39292|lyfalmen|V0452|39292|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||28540||28540|39292||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3270|5963|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3270||3270|5963||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1478|2242|lyfalmen|||2|24|0|8,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||567||567|2242||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1065|2928|lyfalmen|||2|24|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1065||1065|2928||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|IKR|555|2013|lyfalmen|V0908|2013|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||400||400|2013||2 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|19550|15843|lyfalmen|V0183|15843|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||10448||10448|15843||2 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|7832|12242|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||7832||7832|12242||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17912|26116|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||17912||17912|26116||1 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20466|29080|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||20466||20466|29080||1 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25602|35576|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||25602||25602|35576||1 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23358|32737|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||23358||23358|32737||1 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23400|32791|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||23400||23400|32791||1 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28360|39064|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||28360||28360|39064||1 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15271|22481|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||15271||15271|22481||1 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2684|5156|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2684||2684|5156||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22567|31737|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||22567||22567|31737||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3100|2988|lyfalmen|V0334|2781|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1109||1109|2988||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5432|2988|lyfalmen|V0335|2781|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1109||1109|2988||1 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2377|3939|lyfalmen|V0901|3939|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Memantín||1800||1800|3939||2 155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|0|1|0|1|MRP|0|0|0|100|SEK|1151895|1438987|lyfsjukr|||1|4|0||Icepharma hf|Merck Europe B.V.|Cladribine||1151895||1151895|1438987||2 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1538|2160|lyfalmen|V0247|2160|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||507||507|2160||2 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2821|3605|lyfalmen|V0248|3605|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1557||1557|3605||2 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|5088|4092|lyfalmen|V0249|4092|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1911||1911|4092||2 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|15620|22961|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||15620||15620|22961||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1370|3348|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1370||1370|3348||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1347|2563|lyfalmen|V0466|2240|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2563||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|8295|7087|lyfalmen|V0253|5591|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4087||4087|7087||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|590|2274|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||590||590|2274||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1253|3187|lyfalmen|V0590|3187|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1253||1253|3187||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4980|8316|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4980||4980|8316||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|18111|26390|lyfalmen|V0383|26390|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||18111||18111|26390||1 156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4589|2976|lyfalmen|V0552|2976|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1100||1100|2976||2 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4772|8030|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4772||4772|8030||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|5342|8815|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5342||5342|8815||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|347|1940|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||347||347|1940||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|570|2247|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||570||570|2247||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|IKR|6850|13166|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||6850||6850|13166||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13415|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13415||2 157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2 157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|66211|86938|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||66211||66211|86938||2 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|37655|50820|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||37655|50820||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1345|3313|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1345||1345|3313||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|5926|9619|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5926||5926|9619||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|905|2708|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||905||905|2708||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|17671|25784|lyfalmen|V0910|8069|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||17671|25784||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|1|APG|0|0|0|100|XEU|40270|54128|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||40270|54128||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|1|APG|0|0|0|100|XEU|53004|70234|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||53004||53004|70234||1 158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3557|3805|lyfalmen|V0143|3527|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1702||1702|3805||1 158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|293989|371993|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||293989|371993||2 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|784|2516|lyfalmen|V0469|2288|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||766||766|2516||2 158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|12870|6566|lyfalmen|V0817|6559|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||3708||3708|6566||2 158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|2000|2838|lyfalmen|V0967|2838|2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1000||1000|2838||2 158866|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|pakki|+ 3 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|14232|21051|lyfalmen|||1|0,36|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||14232||14232|21051||1 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1866|4030|lyfalmen|V0219|4029|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1866||1866|4030||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|3105|5736|lyfalmen|V0220|5734|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3105||3105|5736||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4593|7784|lyfalmen|V0221|7784|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4593||4593|7784||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4979|8315|lyfalmen|V0223|8315|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4979||4979|8315||1 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|15226|lyfalmen|V0421|15226|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||10000||10000|15226||2 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|0|0|1|IPC|0|1|0|100|SEK|115518|150025|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||115518||115518|150025||2 159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2 159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|1|ESS|0|0|0|100|DKK|42221|56595|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||42221||42221|56595||2 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|402|2015|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||402||402|2015||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1219|3140|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1219||1219|3140||2 159751|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|478|2120|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||478||478|2120||2 159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|27510|37989|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|37989||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|121058|156915|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||121058||121058|156915||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3721|7230|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3721||3721|7230||2 160047|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|100|stk|1|þpakki||M01AH05|01.08.2017|31.12.2018|R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|12000|6968|lyfalmen|||2|100|0|200,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|6968||2 160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAQ|0|1|0|100|XEU|61790|81346|lyfsjukr|||2|4|0|14,2900|Biogen Idec Ltd.|Samsung Bioepis NL B.V.|Etanercept||61790||61790|81346||2 160195|C09CA0307|Valsartan Jubilant|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|IKR|2000|4201|lyfalmen|V0678|4065|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1990||1990|4201||2 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|5069|3872|lyfalmen|V0010|2212|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1751||1751|3872||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|6653|5330|lyfsjukr|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2810||2810|5330||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|726|2461|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||726||726|2461||1 160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|3600|6417|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||3600||3600|6417||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|603|2292|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||603||603|2292||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|814|2582|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||814||814|2582||1 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1299|3250|lyfalmen|V0169|2288|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1299||1299|3250||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2243|4549|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2243||2243|4549||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|536|2200|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||536||536|2200||1 161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1498|2538|lyfalmen|V0143|1176|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||782||782|2538||1 161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|6279|lyfalmen|V0145|5159|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||3500||3500|6279||2 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|50643|67248|lyfalmen|V0452|39292|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||50643||50643|67248||1 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|5749|9375|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||5749|9375||2 161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|26385|36566|lyfalmen|||1|90|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||26385||26385|36566||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|482367|606282|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||482367||482367|606282||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1787|3922|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1787||1787|3922||1 162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|16000|8482|lyfalmen|V0145|7738|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||5100||5100|8482||2 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5010|9675|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||5010||5010|9675||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2195|3297|lyfalmen|V0041|3297|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1333||1333|3297||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|438|1992|lyfalmen|V0500|1992|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||385||385|1992||1 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|657|2366|lyfalmen|||2|100|0|42,5000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||657||657|2366||1 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|566|2241|lyfalmen|V0502|2061|2|60|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||566||566|2241||1 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1231|3156|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1231||1231|3156||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|8574|13263|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||8574||8574|13263||1 163082|N02BA5103|Triplo|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2018||L|0|0|0|0|0|0|OEC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|Orifarm Generics A/S|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|1084|2954|lyfalmen|V0671|2357|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1084||1084|2954||1 163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2 163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3688|6538|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3688||3688|6538||2 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|1224|3147|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1224||1224|3147||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|5583|9146|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5583||5583|9146||1 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|10178|15471|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10178||10178|15471||2 163453|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|8350|8344|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||5000||5000|8344||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2147|4417|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2147||2147|4417||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|463676|583036|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||463676||463676|583036||2 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1748|3868|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1748||1748|3868||1 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|540|2070|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm Oy|Íbúprófen||442||442|2070||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1487|2925|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Íbúprófen||1063||1063|2925||2 163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|800|2150|lyfalmen|V0827|1942|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2150||2 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3503|6283|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3503||3503|6283||1 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|34928|47371|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||34928||34928|47371||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8498|16293|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||8498||8498|16293||1 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|362075|456672|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||362075||362075|456672||1 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|895|2694|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||895||895|2694||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1027|2876|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1027||1027|2876|30.11.2018|2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|DKK|4682|7906|lyfalmen|V0014|7906|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4682||4682|7906||2 164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||1 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1350|3320|lyfalmen|||2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1350||1350|3320||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6130|11800|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6130||6130|11800||2 165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2018||R|0|0|0|0|0|1|EHF|0|0|0|100|XEU|7599|11921|lyfsjukr|||2|25|0||Actavis Group PTC hf|Actavis ehf|Írinótekan||7599||7599|11921||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|147343|189606|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||147343||147343|189606||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2017|31.10.2018|R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|474|2114|lyfalmen|||1|100|0|50,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||474||474|2114||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972|31.10.2018|R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|137|1651|lyfalmen|||1|25|0|12,5000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||137||137|1651||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972|31.10.2018|L|1|0|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|179742|229901|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||179742||179742|229901||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3702|6557|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3702||3702|6557||1 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|5304|10233|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||5304|10233||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010|31.12.2018|R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4082|7915|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4082|7915||1 166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8916|6004|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3300||3300|6004||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1398|3386|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1398||1398|3386||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PLS|0|0|0|100|DKK|13808|20467|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||13808||13808|20467||1 166204|J07BB0205|Influvac|stl|||0,5|ml|10|áfspr||J07BB02|01.11.2017||R|0|0|0|0|0|0|PGB|0|0|0|100|DKK|7705|12067|lyfalmen|||1|5|0||Icepharma hf|BGP Products ApS|Inflúensa, hreinsaðir mótefnavakar||||7705|12067||2 166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2665|2770|lyfalmen|V0113|2770|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2770||2 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1696|3796|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1696||1696|3796||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3210|5880|lyfalmen|V0428|5880|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3210||3210|5880||2 166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|0|1|0|1|ABD|0|1|0|100|DKK|131147|169463|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||131147||131147|169463||1 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010|30.11.2018|L|0|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|0|EVO|0|0|0|100|IKR|8346|11647|lyfalmen|V0968|11053|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||7400||7400|11647||2 167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|38286|51618|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||38286||38286|51618||2 167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2588|3045|lyfalmen|V0826|3036|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3045||2 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1590|3002|lyfalmen|V0005|2838|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1119||1119|3002||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GEI|0|0|0|100|DKK|156498|200992|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||156498||156498|200992||2 168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|10133|lyfalmen|V0420|10133|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||6300||6300|10133||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|395|2006|lyfalmen|V0119|1944|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||395|2006||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4473|7619|lyfalmen|V0007|5316|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4473||4473|7619||1 168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|3035|5639|lyfalmen|V0458|2431|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||3035||3035|5639||1 168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2223|4522|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2223||2223|4522||2 168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2646|5104|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2646||2646|5104||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2701|5180|lyfalmen|V0240|5180|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2701||2701|5180||1 168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4986|8325|lyfalmen|V0433|8322|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||4986||4986|8325||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|0|0|1|PFP|0|0|0|100|SEK|23658|33117|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||23658||23658|33117||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|8146|5075|lyfalmen|V0688|5075|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2625||2625|5075||2 169287|M05BA0606|Ibandronic acid WH|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|0|0|WEH|0|0|0|100|IKR|54874|72599|lyfalmen|||2|84|0|840,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||54874||54874|72599||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|0|0|1|PFP|0|0|0|100|SEK|118289|153471|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||118289||118289|153471||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995|31.10.2018|R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|16540|24228|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||16540||16540|24228||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4450|7587|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||4450||4450|7587||1 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|XEU|1185|3087|lyfalmen|V0411|3087|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1181||1181|3087||2 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|XEU|657|2366|lyfalmen|V0177|2366|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||657||657|2366||2 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|XEU|647|2352|lyfalmen|V0418|2352|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||647||647|2352||2 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2394|4757|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2394||2394|4757||2 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2577|5009|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2577||2577|5009||2 169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|0|CLE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Clear Eyes Pharma Ltd.|Nafazólín|||||||2 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|18931|27519|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||||18931|27519||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|46984|62620|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||||46984|62620||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4672|7893|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4672||4672|7893||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|93484|121433|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||93484||93484|121433||2 170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|841|2128|lyfalmen|V0108|2128|2|100|0|33,3400|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||484||484|2128||1 170486|C10AX1401|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|187136|239097|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||187136||187136|239097||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|HSS|0|0|0|100|DKK|11478|17260|lyfalmen|||1|100|0|50,0000|Artasan ehf|Sandoz GmbH|Rífampicín||11478||11478|17260||1 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1959|4158|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||1959||1959|4158||2 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|10137|15415|lyfsjukr|||2|1600|0|6,6700|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||10137||10137|15415||2 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|24385|34036|lyfsjukr|||2|1600|0|20,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||24385||24385|34036||2 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|36577|49457|lyfsjukr|||2|2400|0|30,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||36577||36577|49457||2 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|31667|43247|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||31667|43247||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2977|3089|lyfalmen|V0203|3089|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1182||1182|3089||1 170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|0|1|CPV|0|1|0|100|XEU|51019|67723|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe B.V.|Azasitidín||51019||51019|67723||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2424|4764|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2424||2424|4764||1 171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|0|1|HUN|0|1|0|100|DKK|43530|58251|lyfsjukr|||1|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||43530||43530|58251||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2968|5547|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2968||2968|5547||2 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2996|5586|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2996||2996|5586||2 171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|0|G|0|PGB|0|0|0|100|DKK|1121|3005|lyfalmen|||1|30|0|20,0000|Icepharma hf|BGP Products ApS|Mebeverín||1121||1121|3005||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2396|4760|lyfalmen|V0247|2160|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2396||2396|4760||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4163|7192|lyfalmen|V0248|3605|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4163||4163|7192||1 172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|100223|131002|lyfalmen|V0920|128030|1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||100223|131002||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|7707|12070|lyfalmen|V0249|4092|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7707||7707|12070||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|14026|20767|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||14026||14026|20767||1 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011|31.12.2018|R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|37989|lyfalmen|||3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||27510||27510|37989||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|17906|26108|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||17906||17906|26108||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8481|13135|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||8481||8481|13135||1 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2413|2310|lyfalmen|V0284|2230|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||616||616|2310||1 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|541830|680237|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||541830||541830|680237||1 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|337|1926|lyfalmen|||1|50|0|50,0000|Icepharma hf|Meda AB|Nítrazepam||337||337|1926||2 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|9437|8936|lyfalmen|V0118|8447|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||5430||5430|8936||1 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3773||1 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|11714|17585|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||11714||11714|17585||1 173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|16461|6910|lyfalmen|V0684|5045|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||3958||3958|6910||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1794|3931|lyfsjukr|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1794||1794|3931||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|513|2168|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||513||513|2168||2 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1273|3214|lyfalmen|||1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1273||1273|3214||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5454|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5454||2 174615|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.01.2017|30.11.2018|R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|276|1606|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Zópíklón||105||105|1606||2 174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|10603|16056|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||10603||10603|16056||1 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3680|6527|lyfalmen|V0368|4519|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3680||3680|6527||1 174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|47535|58088|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||43401||43401|58088||2 174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||1 174875|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.08.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2426|2865|lyfalmen|V0325|2865|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||1019||1019|2865||1 174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHI|0|0|0|100|DKK|14545|21482|lyfalmen|||1|30|0|70,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|lisdexamfetamine||14545||14545|21482||3 174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|262384|332685|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||262384||262384|332685||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|0|0|TVA|0|0|0|100|IKR|1262|3199|lyfalmen|||2|10|0|1,2500|Alvogen|Teva B.V.|Quetíapín||1262||1262|3199||2 175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|21006|29763|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||21006|29763||3 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|7555|7191|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||4162||4162|7191||1 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4738|9159|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||4738||4738|9159||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MBV|0|0|0|100|DKK|14052|20803|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme B.V.|Follitrópín beta||||14052|20803||1 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|2116|2498|lyfalmen|V0033|2293|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||753||753|2498||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|4422|7548|lyfalmen|V0278|2898|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4422||4422|7548||2 176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1313|3269|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón||1313||1313|3269||1 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2354|4260|lyfalmen|V0429|3802|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2033||2033|4260||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|2442|4823|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2442||2442|4823||1 176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1832|3984|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||1832||1832|3984||2 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5838|11246|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5838||5838|11246||2 176955|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas|+spaði|D01AE16|01.12.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|2130|4394|lyfalmen|V0655|4394|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||||2130|4394||2 177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|0|1|AEB|0|0|0|100|DKK|381249|480520|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||381249||381249|480520||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6929|10999|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||6929||6929|10999||2 177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|492794|619250|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||492794||492794|619250||1 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|673|2388|lyfalmen|||2|300|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||673||673|2388|31.12.2018|1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4067|7886|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4067||4067|7886||2 177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|336566|424946|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||336566|424946||2 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|7530|9813|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||6067||6067|9813|31.10.2018|1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|30331|41557|lyfalmen|V0975|40610|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||30331||30331|41557||2 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|787036|985205|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||787036||787036|985205||1 178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|84027|109472|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||84027|109472||3 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|5658|3021|lyfalmen|V0320|2838|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Cítalópram||1133||1133|3021||1 179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|129510|167427|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||129510||129510|167427||1 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|125518|162462|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||125518||125518|162462||1 179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|8562|13247|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8562|13247||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|15836|23259|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||15836||15836|23259||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|103688|135311|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||103688||103688|135311||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4390|7504|lyfalmen|V0953|7504|1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4390||4390|7504||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|2191|3733|lyfalmen|V0148|3484|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1650||1650|3733||2 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|706|2434|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||706||706|2434||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|8660|13382|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||8660||8660|13382||1 181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|5420|8922|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||5420||5420|8922||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6105||2 182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2150|lyfalmen|V0556|1892|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2150||2 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|10681|16163|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||10681||10681|16163||1 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|13721|20348|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||13721||13721|20348||2 182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017|30.11.2018|R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|14364|6886|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3941||3941|6886||1 182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|14607|27883|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||14607||14607|27883||1 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|18330|34946|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||18330|34946||2 182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016||R|0|1|0|0|0|1|ARD|0|0|0|100|XEU|10131|5265|lyfsjukr|||2|5|0|1,0000|Artasan ehf|Accord Healthcare Limited|Zoledronsýra||2763||2763|5265||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3038|5643|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3038||3038|5643||1 183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|0|1|PIP|0|0|0|100|DKK|157465|202195|lyfsjukr|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||157465||157465|202195||1 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4775|9230|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||4775||4775|9230||1 183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3836|6417|lyfalmen|V0612|6417|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3600||3600|6417||2 183485|L01XE4201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|138675|178825|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||138675||138675|178825||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013|31.10.2018|R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1531|2527|lyfalmen|||2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||774||774|2527||1 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|5127|8519|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5127|8519||1 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|6167|11871|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6167||6167|11871||2 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1053|2911|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Flúdrókortisón||1053||1053|2911||2 184046|L01XE2701|IMBRUVICA|hylki|140|mg|90|stk|1|glas|hart|L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|702200|879693|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||702200|879693||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|689|2410|lyfalmen|||2|100|0|1,6667|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||689||689|2410||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1743|2881|lyfalmen|||2|100|0|3,3333|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1031||1031|2881||1 184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|313892|396746|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||313892||313892|396746||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|DKK|2809|5328|lyfalmen|V0017|5328|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||2809||2809|5328||2 184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|38981|52497|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||38981|52497||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|45030|60148|lyfalmen|V0185|13127|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||45030||45030|60148||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1428|3170|lyfalmen|||2|16|0|5,3333|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1241||1241|3170||1 184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|0|PHM|0|0|0|100|XEU|11360|21723|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||11360||11360|21723||2 184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|0|0|KRK|0|0|0|100|IKR|3362|6089|lyfalmen|V0690|6089|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6089||2 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2 185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2150|lyfalmen|V0545|2142|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||500||500|2150||2 186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|252082|319872|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||252082|319872||3 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|15806|13248|lyfalmen|V0419|12627|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||8563||8563|13248||1 186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|14434|16730|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||11093||11093|16730||2 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|842|2621|lyfalmen|V0597|2618|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||842||842|2621||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|10028|3045|lyfalmen|V0607|3045|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||1150||1150|3045||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|5518|9057|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5518||5518|9057||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4847|lyfalmen|V0462|4847|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4847||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5183|8933|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5183||5183|8933||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|3691|6542|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3691||3691|6542||2 187638|L01XC0202|Blitzima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2018||R|0|1|0|0|0|1|CTH|0|1|0|100|DKK|164001|210324|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||164001||164001|210324||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3009||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|PEU|0|0|0|100|DKK|68359|89655|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||68359||68359|89655||1 188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1397|3385|lyfalmen|V0621|2001|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1397||1397|3385||2 188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|15148|22312|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||15148||15148|22312||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2600|5041|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2600||2600|5041||1 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|4943|8266|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||4943||4943|8266||1 188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|1400|2701|lyfalmen|V0458|2701|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||900||900|2701||2 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|IKR|2931|3595|lyfalmen|V0422|3527|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3595||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|8550|12570|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||8070||8070|12570||2 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|36881|49841|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||36881||36881|49841||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6341|10190|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6341||6341|10190||1 189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|4709|7943|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4709||4709|7943||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2505|4910|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2505||2505|4910||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|910|2714|lyfalmen|V0413|2714|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||910||910|2714||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|440|2068|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||440||440|2068||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|408|2024|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||408||408|2024||1 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1512|3543|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1512||1512|3543||2 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|6839|10875|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer AB|Nífedipín||||6839|10875||2 190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|21024|29785|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||21024||21024|29785||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3824||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3421|6171|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3421||3421|6171||1 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|6212|5487|lyfalmen|V0117|5210|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||2924||2924|5487||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3223|5898|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3223||3223|5898||1 191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|2201|2362|lyfalmen|V0088|2362|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||654||654|2362||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3362|6089|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3362||3362|6089||1 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|462|2098|lyfalmen|V0936|1984|1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||462||462|2098||1 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|16592|10524|lyfalmen|V0689|6348|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6584||6584|10524||1 192030|QD06AA0202|Cyclospray vet.|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|0|ERO|0|0|0|100|XEU|1015|1995|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1015||1015|1995||1 192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||2 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|3398|6139|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3398||3398|6139||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|2707|3836|lyfalmen|V0429|3802|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||1725||1725|3836||1 192558|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|GOP|0|0|1|100|SEK|536|2200|lyfalmen|||1|100|0|50,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||536||536|2200||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2052|4286|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||2052||2052|4286||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6065|9810|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6065||6065|9810||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|0|1|IRE|0|1|0|100|XEU|156444|200925|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||156444||156444|200925||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2416|2640|lyfalmen|V0233|2117|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||856||856|2640||1 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|788|2547|lyfalmen|V0447|2329|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||788||788|2547||1 193323|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.05.2018||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1800|2541|lyfalmen|V0069|2512|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||784||784|2541||2 193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|IKR|21696|11124|lyfalmen|V0721|11124|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||7020||7020|11124||2 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|18923|27508|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai GmbH|Perampanel||18923||18923|27508||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2724||1 193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|0|0|0|1|ZEN|0|0|0|100|SEK|312441|394942|lyfsjukr|||1|1|0||Vistor hf|AstraZeneca AB|Benralizumab||312441||312441|394942||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|35974|57990|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||35974||35974|57990||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|2334|2196|lyfalmen|V0556|1892|2|4|0|3,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||533||533|2196||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4854|9380|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4854||4854|9380||2 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|5446|5668|lyfalmen|V0012|5668|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3056||3056|5668||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1401|3390|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1401||1401|3390||2 195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 195449|A02BC0403|Rabeprazol Krka|sþ-hylki|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0||LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13284||2 195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|23000|28490|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28490||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|49115|65315|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||49115||49115|65315||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|124495|161189|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||124495||124495|161189||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|876|2668|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||876||876|2668||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|556|2227|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||556||556|2227||1 195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|G|0|WEH|0|0|0|100|IKR|3842|3926|lyfalmen|V0205|3802|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1790||1790|3926||2 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1790|3926|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||1790||1790|3926||2 196106|C10AA0107|Simvastatin LYFIS|filmhtfl|40|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2047|2563|lyfalmen|V0110|2563|2|100|0|133,3333|LYFIS ehf|LYFIS ehf|Simvastatín||800||800|2563||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1681|3776|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||1681||1681|3776||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||2105||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|6314|10153|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||6314||6314|10153||2 196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|547|2215|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||547||547|2215||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|19508|28313|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||19508|28313||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|564|1944|lyfalmen|V0119|1944|2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||350||350|1944||2 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|0|0|1|PPA|0|1|0|100|XEU|56230|74314|lyfsjukr|||2|1|0|26,6700|Alvogen HS|Pfizer Europe MA EEIG|Infliximab||56230||56230|74314||2 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1483|3503|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1483||1483|3503||2 197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|231563|294352|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||231563||231563|294352||1 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|2990|3939|lyfalmen|V0116|3269|2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1800||1800|3939||2 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1883|2563|lyfalmen|V0069|2563|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||800||800|2563||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|6316|10155|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6316||6316|10155||1 198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3564|6367|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3564||3564|6367||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|31868|43501|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||31868||31868|43501||1 199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|7414|11667|lyfalmen|||1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7414|11667||2 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|557|2229|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||557||557|2229||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|82888|108031|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||82888|108031||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4109|7118|lyfalmen|V0126|7118|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4109||4109|7118||1 199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5253|8692|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||5253||5253|8692||1 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|2272377|2832553|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2272377||2272377|2832553||1 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|34622|65855|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||34622||34622|65855||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1244|3159|lyfalmen|||2|20|0|7,5000|Alvogen|ratiopharm GmbH|Amoxicillín||1233||1233|3159||2 370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|1|0|1|0|1|ALO|0|1|0|100|XEU|226429|287967|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||226429||226429|287967||2 371058|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.06.2016||L|0|0|0|0|0|0|MEA|0|0|0|100|SEK|||lyfalmen|V0592|5835|0|50|0|25,0000|Icepharma hf|Meda AB|Makrógól 3350|||||5835||2 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9378||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|751236|940680|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib hydrochloride||751236||751236|940680||2 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|3288|5988|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3288||3288|5988||1 372121|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.11.2018||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3067|5683|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3067||3067|5683||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|1|WIL|0|1|0|100|XEU|9905|15095|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||9905||9905|15095||2 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2734||2 373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3200|5178|lyfalmen|V0934|5178|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||2700||2700|5178||2 373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|73343|95958|lyfsjukr|||0|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||73343|95958||3 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|5275|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5275||2 373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|4827|6511|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||3668||3668|6511||2 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|11208|16889|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||11208||11208|16889||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|84940|110626|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||84940||84940|110626||2 373252|N05AX1205|Aripiprazol Krka|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.04.2017|31.12.2018|R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|3507|5866|lyfalmen|||2|28|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||3200||3200|5866||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50/100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3420|6169|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3420||3420|6169||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50/250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4108|7116|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4108||4108|7116||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50/500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|5254|8694|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5254||5254|8694||1 373581|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|pakki|+ 6 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|42696|57196|lyfalmen|||1|1,08|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||42696||42696|57196||1 373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|3734|6601|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3734||3734|6601||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|5587|4829|lyfalmen|V0420|3378|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||2446||2446|4829||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|392|1896|lyfalmen|V0541|1896|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||315||315|1896||1 373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|0|IPH|0|0|0|100|XEU|369053|465351|lyfalmen|||1|30|0|15,0000|Intercept|Intercept Pharma Ltd.|Obeticholic acid||369053||369053|465351||2 374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|7483|11762|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7483||7483|11762||3 374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|320799|395537|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||312920||312920|395537||1 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|196759|251066|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||196759||196759|251066||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|431|2055|lyfalmen|V0500|1992|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||431||431|2055||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5148|8548|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5148||5148|8548||1 374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3383|6118|lyfalmen|V0926|3904|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3383||3383|6118||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|9540|14593|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||9540||9540|14593||1 374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|492794|619250|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||492794||492794|619250||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|4015|6988|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4015||4015|6988||1 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|6172|9957|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6172||6172|9957||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|7285|11489|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7285||7285|11489||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|8532|13205|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8532||8532|13205||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|9650|14744|lyfalmen|V0383|13195|2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||9650||9650|14744||1 374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|5331|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2720||2720|5331||2 375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|3450369|4297645|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3450369||3450369|4297645||2 375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2800|5316|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5316||2 375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|0|1|ACC|0|0|0|100|XEU|10065|15315|lyfsjukr|||2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||10065|15315||1 375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4000|2838|lyfalmen|V0605|2838|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1000||1000|2838||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|23665|33126|lyfalmen|V0459|33126|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||23665||23665|33126||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|5541|9089|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||5541||5541|9089||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|15997|23480|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||15997||15997|23480||1 376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|82180|107136|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||82180||82180|107136||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014|31.12.2018|R|1|1|0|1|0|1|RRG|0|0|0|100|DKK|753665|943701|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration GmbH|Vismodegibum||753665||753665|943701||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11238|19370|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11238||11238|19370||2 377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|189553|242103|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||189553||189553|242103||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|9239|7251|lyfalmen|V0182|3941|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4206||4206|7251||1 377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018||R|1|0|0|0|G|0|TVA|0|0|0|100|DKK|2025|3021|lyfalmen|V0909|3021|2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||1133||1133|3021||2 377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|25902|35955|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||25902||25902|35955||1 378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|501809|630462|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||501809||501809|630462||2 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1741|3858|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1741||1741|3858||1 378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GEN|0|0|0|100|SEK|5691|3031|lyfalmen|V0687|3030|2|56|0|28,0000|Icepharma hf|Generics UK Ltd|Pregabalín||1140||1140|3031||2 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|14444|21343|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||14444||14444|21343||1 378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1553|3600|lyfalmen|V0937|3600|1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1553||1553|3600||1 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1224|3147|lyfalmen|V0677|2717|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1224||1224|3147||1 379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|9400|7241|lyfalmen|V0830|7241|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4199||4199|7241||2 379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|168055|215366|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||168055|215366||3 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|135752|175190|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||||135752|175190||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|103534|135120|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||103534||103534|135120||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|116094|150741|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||116094||116094|150741||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|149928|192821|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||149928||149928|192821||1 379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|5149|6502|lyfalmen|V0532|6502|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3662||3662|6502||2 379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|1968|4171|lyfalmen|||2|12,5|0|2,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1968||1968|4171||1 379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|2807|5326|lyfalmen|||2|12,5|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2807||2807|5326||1 379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2616|3021|lyfalmen|V0322|2976|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1133||1133|3021||1 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|18405|26795|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||18405||18405|26795||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1431|3432|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1431||1431|3432||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|26021|36106|lyfalmen|V0653|36106|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||26021|36106||1 380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|529|2190|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||||529|2190||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|17988|10133|lyfalmen|V0195|10133|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10133||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4393|4988|lyfalmen|V0902|4988|2|30|0|30,0000|Alvogen|ratiopharm GmbH|Memantín||2562||2562|4988||2 380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|538|2202|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||538||538|2202||1 381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2799|4824|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2799||2799|4824||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MBV|0|0|0|100|DKK|39590|53268|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Follitrópín beta||||39590|53268||1 381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|292017|369540|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||292017||292017|369540||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|7060|9320|lyfalmen|V0533|9320|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5709||5709|9320||2 382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|0|1|0|0|OHA|0|0|0|100|XEU|150838|193953|lyfalmen|||1|5|0||Orphan Europe Nordic AB|Orphan Europe SARL|mercaptamine ||150838||150838|193953||3 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|126041|163112|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||126041|163112||3 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4443|7577|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4443||4443|7577||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5206|8627|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||5206||5206|8627||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1133|1924|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1116||1116|1924||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1258|3193|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1258||1258|3193||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|34904|47341|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||34904||34904|47341||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2373|2013|lyfalmen|V0006|1185|2|56|0|56,0000|Alvogen|ratiopharm GmbH|Ómeprazól||400||400|2013||2 384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6363|10220|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6363||6363|10220||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 384858|L01XE0105|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|0|1|0|1|RTH|0|1|0|100|XEU|149483|171021|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatiníb||132400||132400|171021||2 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|6683|10660|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||6683||6683|10660||1 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|372825|470042|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||372825||372825|470042||1 386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|13329|6665|lyfalmen|V0111|6665|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6665||2 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7629|11963|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||7629||7629|11963||1 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|0|1|WEH|0|1|0|100|XEU|131389|169764|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||131389||131389|169764||2 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|819|2511|lyfalmen|V0308|2511|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||762||762|2511||2 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5089|9825|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5089||5089|9825||2 387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10696|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10696||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TSA|0|0|0|100|XEU|5937|9634|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||5937||5937|9634||2 388068|A07DA0601|Truberzi|filmhtfl|100|mg|56|stk|1|þpakki||A07DA06|01.08.2017||R|1|0|0|1|0|0|AIP|0|0|0|100|XEU|15669|23029|lyfalmen|||2|56|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Eluksadólín||||15669|23029||1 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|0|0|1|PEU|0|0|0|100|DKK|132605|171276|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Temsirolímus||132605||132605|171276||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2524|4936|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2524||2524|4936||2 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2754|5253|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||2754||2754|5253||2 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.01.2017||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|10479|15885|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||10479||10479|15885||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|4959|8288|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur||4959||4959|8288||2 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|59635|20598|lyfalmen|V0722|19355|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||13903||13903|20598||2 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|8643|13358|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||8643||8643|13358||2 389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|0|0|1|WEH|0|0|0|100|IKR|6370|10230|lyfsjukr|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||6370||6370|10230||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|2257|4568|lyfalmen|V0410|4568|1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||2257||2257|4568||2 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|708|2436|lyfalmen|V0128|2436|1|84|0|84,0000|Icepharma hf|Meda AB|Estradíól||708||708|2436||2 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|489|2135|lyfalmen|||1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||489||489|2135||2 389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|391986|493873|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||391986|493873||2 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|716|2447|lyfalmen|||1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||716||716|2447||1 389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|16000|23484|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||16000||16000|23484||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010|31.12.2018|R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2849|3939|lyfalmen|||3|100|0|10,0000|LYFIS ehf|LYFIS ehf|Pramipexól||1800||1800|3939||2 389453|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|14|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|450|2081|lyfalmen|||2|14|0|5,6000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||450||450|2081||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MRP|0|0|0|100|SEK|37986|51239|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||37986|51239||2 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|15201|22385|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||15201||15201|22385||1 390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2717|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2717||2 390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|1|TEE|0|1|0|100|NOK|66709|87568|lyfsjukr|||1|10|0||Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Reslizumab||66709||66709|87568||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|72511|94906|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||72511||72511|94906||1 390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18154|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18154||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|5736|9357|lyfalmen|V0429|3802|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||5736||5736|9357||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2444|4826|lyfalmen|V0037|2288|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2444||2444|4826||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MRP|0|0|0|100|SEK|19780|28687|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||19780|28687||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|9843|15010|lyfalmen|V0196|4765|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||9843||9843|15010||1 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|236294|300236|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||236294||236294|300236||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013|31.10.2018|R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|215662|98866|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||75642||75642|98866||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1849|4007|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||1849||1849|4007||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|494|2142|lyfalmen|V0545|2142|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||494||494|2142||1 392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|0|1|0|1|ASR|0|0|0|100|IKR|45000|51889|lyfsjukr|||2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||38500||38500|51889||2 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|12821|19109|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12821||12821|19109||2 392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|0|1|0|1|BNB|0|1|0|100|XEU|24754|34503|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||24754||24754|34503||2 393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2250|2425|lyfalmen|V0109|2275|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||700||700|2425||2 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3438||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|63209|83141|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||63209||63209|83141||3 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2018|4056|lyfalmen|V0669|4056|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1885||1885|4056||2 394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|1843|3419|lyfalmen|V0123|3419|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1422||1422|3419||2 394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|49683|66033|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||49683||49683|66033||2 395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|73028|95560|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||73028||73028|95560||1 395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|35433|48010|lyfalmen|||1|15|0|75,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||35433||35433|48010||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|131455|168831|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||130639||130639|168831||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|5655|9246|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5655||5655|9246||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|3710|5974|lyfalmen|V0679|5974|2|98|0|196,0000|Alvogen|ratiopharm GmbH|Valsartan||3278||3278|5974||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|16004|23490|lyfalmen|V0356|23490|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||16004||16004|23490||3 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4377|7486|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4377||4377|7486||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3581|6391|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3581||3581|6391||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|18831|35897|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||18831||18831|35897||2 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|2013|lyfalmen|V0006|1185|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2013||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4974|9607|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||4974||4974|9607||1 397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|4186|3802|lyfalmen|V0686|3802|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3802||2 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2225|2672|lyfalmen|V0250|2136|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||879||879|2672||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|0|1|MKA|0|1|0|100|SEK|22874|32125|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||22874||22874|32125||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|27736|38275|lyfsjukr|||1|120|0||Icepharma hf|Roche Registration GmbH|Capecitabín||27736||27736|38275||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5792||1 398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|667|2125|lyfalmen|V0923|2125|2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||482||482|2125||2 398759|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|16285|14216|lyfalmen|||2|90|0|162,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||9266||9266|14216|31.10.2018|1 399034|C09CA0307|Valsartan Jubilant|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|0|0|0|JUB|0|0|0|100|IKR|3500|6211|lyfalmen|V0679|5974|2|98|0|196,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||3450||3450|6211||2 399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|0|1|0|1|GSD|0|1|0|100|DKK|166026|212842|lyfsjukr|||1|1|0|27,7700|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||166026||166026|212842||1 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MBV|0|0|0|100|DKK|27907|38491|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme B.V.|Follitrópín beta||||27907|38491||1 399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|72991|95513|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||72991||72991|95513||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|532|2194|lyfalmen|V0225|2194|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||532||532|2194||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2388|2898|lyfalmen|V0244|2558|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1043||1043|2898||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|7978|12443|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7978||7978|12443||1 399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|492794|619250|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||492794||492794|619250||1 399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2440|2866|lyfalmen|V0824|2842|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1020||1020|2866||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|1090|2962|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1090||1090|2962||1 400134|J05AR2201|Symtuza|filmhtfl|30|mg|30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|108057|140745|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||108057||108057|140745||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2390|4752|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2390||2390|4752||1 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|49749|66117|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||49749||49749|66117||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|198|1734|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||198||198|1734||1 400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|514|2169|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||514||514|2169||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|340|1930|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||340||340|1930||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|171|1697|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||171||171|1697||1 400508|N02AE0104|Buprenorphine ratiopharm|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|IKR||2701|lyfalmen|V0943|2701|2|4|0|2,8000|Alvogen|ratiopharm GmbH|Búprenorfín||900||900|2701||2 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|4767|8023|lyfalmen|V0612|5989|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||4767||4767|8023||1 400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|0|1|0|1|BNB|0|1|0|100|XEU|167138|214225|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||167138||167138|214225||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2068|2677|lyfalmen|V0037|2288|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||883||883|2677||2 401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|702|2288|lyfalmen|V0173|2288|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||600||600|2288||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|8176|12715|lyfalmen|V0459|11042|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||8176||8176|12715||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|729|2465|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||729||729|2465||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1070|2935|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1070||1070|2935||1 402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|457|1964|lyfalmen|V0038|1964|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||365||365|1964||2 402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1197|3110|lyfalmen|V0952|3110|2|100|0||Vistor hf|Galenica AB|Mómetasón||1197||1197|3110||1 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|804992|1007537|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||804992||804992|1007537||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1757|3453|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1757||1757|3453||1 402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|0|1|0|0|JCI|0|1|0|100|SEK|287395|363791|lyfalmen|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||287395||287395|363791||1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12449|18597|lyfalmen|V0349|17902|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12449||12449|18597||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|4587|3516|lyfalmen|V0552|2976|2|30|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||1492||1492|3516||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5786|11148|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5786||5786|11148||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|32689|44539|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||32689|44539||1 403915|A07EB0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||A07EB01|01.09.2018||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|938|2753|lyfalmen|||0|13,5|0||Vistor hf|Sanofi-aventis Norge AS|cromoglicic acid ||||938|2753||1 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|16394|24027|lyfalmen|||1|6|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||16394||16394|24027||2 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2600||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|58378|77031|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||58378||58378|77031||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1064|2926|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1064||1064|2926||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404997|A10BJ0301|Lyxumia|stl|||3|ml|2|áfpen|10 mcg/sk og 20 mcg/sk|A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|9229|14165|lyfalmen|||1|6|0|21,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||9229||9229|14165||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1398|3386|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3386||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2797|4821|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2797||2797|4821||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2468||1 405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|0|IPH|0|0|0|100|XEU|369053|465351|lyfalmen|||1|30|0|30,0000|Intercept|Intercept Pharma Ltd.|Obeticholic acid||369053||369053|465351||2 405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|2436|3045|lyfalmen|V0467|3045|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1150||1150|3045||2 405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|29236|40172|lyfsjukr|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||29236|40172||2 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|3227|5904|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3227||3227|5904||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|16228|23798|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16228||16228|23798||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|435|2061|lyfalmen|V0502|2061|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||435||435|2061||1 406106|C10AX1401|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|187136|239097|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||187136||187136|239097||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17534|25596|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17534||17534|25596||1 406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|0|1|0|0|AZA|0|1|0|100|SEK|627974|787376|lyfalmen|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||627974||627974|787376||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|52880|70077|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||52880||52880|70077||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|60947|80280|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||60947||60947|80280||1 406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1553|3600|lyfalmen|V0937|3600|1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1553||1553|3600||1 407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|0|G|0|GRP|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4266||1 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|16340|31171|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||16340|31171||2 407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2517|4338|vetorma|||0|2,7|0||Vistor hf|Merial|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2517||2517|4338||1 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|148|1666|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||148||148|1666||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|305|1882|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||305||305|1882||1 408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|30301|41519|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||30301||30301|41519||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|15047|22173|lyfalmen|V0974|20688|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||15047||15047|22173||2 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1731|3444|lyfalmen|V0310|3444|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1440||1440|3444||2 408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2 408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|4226|7279|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4226||4226|7279||2 408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|9453|5542|lyfalmen|V0813|5525|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2964||2964|5542||2 408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2688|3664|lyfalmen|V0515|3586|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||1600||1600|3664||2 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2907|5011|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2907||2907|5011||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|3405|6149|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3405||3405|6149||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8272|12848|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||8272||8272|12848||1 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|56343|74457|lyfalmen|V0728|74457|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||56343||56343|74457||1 409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|15287|22503|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||15287||15287|22503||1 409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|52984|70208|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||52984||52984|70208||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6706|10692|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6706||6706|10692||1 409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|6396|4888|lyfalmen|V0234|4888|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2489||2489|4888||1 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|15308|22532|lyfalmen|V0651|22532|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15308||15308|22532||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3440|5414|lyfalmen|V0196|4765|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2871||2871|5414||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2999|5590|lyfalmen|V0620|5259|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||2999||2999|5590||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3276|5349|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||2824||2824|5349||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|RCP|0|0|0|100|SEK|1483|3503|lyfalmen|||1|20|0|6,2000|Icepharma hf|Recip AB|Klórókín||1483||1483|3503||1 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|519|2176|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||519||519|2176||2 411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|909|2713|lyfalmen|V0510|2603|2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||909||909|2713||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1346|3315|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1346||1346|3315||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RTH|0|0|1|100|XEU|387|1964|lyfalmen|V0230|1963|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||365||365|1964||2 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1427|2486|lyfalmen|V0692|2328|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||744||744|2486||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5735|9356|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5735||5735|9356||2 411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|12728|lyfalmen|V0829|12728|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8185||8185|12728||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4752|5162|lyfalmen|V0624|5162|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2688||2688|5162||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|21042|29808|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Lamívúdín||21042||21042|29808||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyfalmen|V0554|1880|2|1|0|0,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól|||||2256||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|5486|9013|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5486||5486|9013||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|16689|23469|lyfalmen|V0183|15843|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||15989||15989|23469||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|2734|5225|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2734||2734|5225||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|CES|1|0|0|100|DKK|3924|7615|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||3924||3924|7615||2 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4369|8459|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4369||4369|8459||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|91274|118638|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||91274||91274|118638||2 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|45736|61041|lyfalmen|V0711|15729|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||45736||45736|61041||1 412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|45238|60411|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||45238||45238|60411||1 412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|4100|7036|lyfalmen|V0581|7036|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4050||4050|7036||2 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2605|5047|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2605||2605|5047||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2688|5162|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||2688||2688|5162||2 413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|29773|40851|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||29773||29773|40851||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|1320|3279|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1320||1320|3279||2 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TGH|0|0|0|100|NOK|112673|146486|lyfsjukr|||1|12|0|24,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Glatíramer acetat||112673||112673|146486||1 414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|36914|49883|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||36914||36914|49883||2 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1129|3016|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||1129||1129|3016||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1083|2953|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1083||1083|2953||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1826|3975|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1826||1826|3975||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|179742|229901|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||179742||179742|229901||1 415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|118973|154322|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||118973||118973|154322||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|7214|6805|lyfalmen|V0253|5591|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3882||3882|6805||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8392|9080|lyfalmen|V0088|2362|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5535||5535|9080||1 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3837|6743|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||3837||3837|6743||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2561|4987|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2561||2561|4987||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|893|2691|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||893||893|2691||2 417633|A10BJ0601|Ozempic|stl|0,5|mg/ml|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|0|NON|0|0|0|100|DKK|18354|26724|lyfalmen|||1|1,5|0||Vistor hf|Novo-Nordisk|Semaglutide||18354||18354|26724||1 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|34441|46755|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Abacavír||34441||34441|46755||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|PHH|0|1|0|100|DKK|87850|114307|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||87850||87850|114307||1 417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|BCP|0|0|0|100|IKR|18496|26920|lyfalmen|V0969|26920|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ltd.|midodrine||18496||18496|26920||2 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|28487|39225|lyfalmen|V0460|39225|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||28487|39225||1 418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|4905|3264|lyfalmen|V0682|2825|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||1309||1309|3264||1 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|119047|154414|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||119047||119047|154414||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|5372|8856|lyfalmen|V0014|7906|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5372||5372|8856||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2440|4820|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2440||2440|4820||1 419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2418|4790|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Ceftríaxón||||2418|4790||2 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|8165|12700|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||8165||8165|12700||1 419385|J01FA0901|Klacid|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.03.2017||R|1|0|0|0|0|0|DUT|0|0|1|100|DKK|3884|6672|lyfalmen|V0116|3269|1|14|0|14,0000|Icepharma hf|BGP Products AB|Klaritrómýcín||3785||3785|6672||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MBV|0|0|0|100|DKK|43999|58844|lyfsjukr|||1|180|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Indínavír||43999||43999|58844||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5390|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5390||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|35344|47897|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mercaptamín||35344||35344|47897||3 419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|12151|18187|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan Europe (S)|Mercaptamín||12151||12151|18187||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982|31.10.2018|R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|530|2191|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||530||530|2191||1 419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1633|3710|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1633||1633|3710||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|10660|16134|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||10660||10660|16134||1 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|141039|181766|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||141039||141039|181766||2 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4359|2150|lyfalmen|V0006|2116|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2150||2 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/ml/sprautu|B01AB04|01.05.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|3309|6016|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3309||3309|6016||1 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/ml/sprautu|B01AB04|01.05.2018||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|4720|7959|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||4720||4720|7959||1 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RTH|0|0|1|100|DKK|2274|2719|lyfalmen|V0479|2719|2|60|0|6,0000|Alvogen|ratiopharm GmbH|Amoxicillín||913||913|2719||2 420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2 421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4600|lyfalmen|V0214|4600|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4600||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1142|3034|lyfalmen|V0036|2618|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1142||1142|3034||1 421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2000|2743|lyfalmen|V0114|2715|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2743||2 421729|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|14623|13284|lyfalmen|V0959|13284|2|100|0|120,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||8589||8589|13284||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|29916|56927|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||29916||29916|56927||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|XEU|1982|3155|lyfalmen|V0458|2701|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1230||1230|3155||2 421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 422022|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.11.2017||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1174|3078|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1174||1174|3078||1 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|537|2201|lyfalmen|V0596|2201|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||537||537|2201||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2594|5032|lyfalmen|V0049|2916|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2594||2594|5032||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4265|7332|lyfalmen|V0054|3591|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||4265||4265|7332||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|54340|71923|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||54340||54340|71923||2 422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|42014|56334|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||42014|56334||3 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2624|5074|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2624||2624|5074||3 422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|9968|15182|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||9968||9968|15182||1 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|8446|13087|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||8446||8446|13087||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2852|5387|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2852|5387||2 423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|19376|28131|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||19376||19376|28131||2 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|5196|8614|lyfalmen|V0373|4665|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5196||5196|8614||2 424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|1|0|0|0|SHI|0|0|0|100|DKK|10342|15697|lyfalmen|||1|30|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|lisdexamfetamine||10342||10342|15697||3 424811|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.03.2018||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|17256|25213|lyfsjukr|||2|2|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||17256||17256|25213||1 424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|0|G|0|TVA|0|0|0|100|DKK|13330|15620|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||10286||10286|15620||2 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|521|2179|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||521||521|2179||2 425282|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|130165|62895|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||47202||47202|62895||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1461|3473|lyfalmen|V0213|3317|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1461||1461|3473||1 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|DKK|13168|19586|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||13168||13168|19586||2 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|541|2207|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||541||541|2207||2 427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018||R|1|1|0|1|0|1|SHS|0|0|0|100|DKK|105216|137212|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||||105216|137212||1 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|7514|11804|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7514||7514|11804||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6353|10206|lyfalmen|||1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||6353||6353|10206||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3232||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2326||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011|31.12.2018|R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|34946|lyfalmen|||3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||25104||25104|34946||2 429093|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|glas|með skammtadælu|G03CA03|01.06.2016|30.11.2018|R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|1011|2854|lyfalmen|||2|64|0||Vistor hf|Takeda Oy|Estradíól||1011||1011|2854||1 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3015|5612|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3015||3015|5612||2 429358|R03BB0404|Braltus|innönddu|10|mcg|30|stk|1|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|0|G|0|TVA|0|0|0|100|DKK|4493|6206|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||3447||3447|6206||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|85371|111171|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||85371||85371|111171||1 429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017|30.11.2018|R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10719|5778|lyfalmen|||2|28|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3136||3136|5778||1 429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|3536|6329|lyfalmen|||2|200|0|66,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||3536||3536|6329||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|8670|13395|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||8670||8670|13395||3 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|5050|9751|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||5050||5050|9751||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|17555|5261|lyfalmen|V0184|4812|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2760||2760|5261||2 430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8900|7654|lyfalmen|V0831|7636|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4499||4499|7654||2 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|DKK|5152|8553|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5152||5152|8553||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|19528|28340|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||19528|28340||2 430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013|31.10.2018|R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|797|2134|lyfalmen|||2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||488||488|2134||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1048|2904|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1048||1048|2904||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8665|13388|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||8665||8665|13388||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1250|3182|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1250|3182||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|3245|5928|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3245||3245|5928||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17560|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17560||2 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|0|1|TPA|0|1|0|100|DKK|327854|414111|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||327854||327854|414111||1 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1833|3985|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1833||1833|3985||1 432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|3389|lyfalmen|V0693|3389|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1400||1400|3389||2 432482|N03AX1211|Gabapentin PCD|hylki|400|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|2200|2604|lyfalmen|V0251|2604|2|120|0|26,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||830||830|2604||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|DKK|32947|44866|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||32947|44866||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2490|4265|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||2170||2170|4265||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||2141||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10530|15955|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10530||10530|15955||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2219|4516|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2219||2219|4516||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|4875|8172|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||4875||4875|8172||1 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|412227|519047|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||412227||412227|519047||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|153203|196894|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||153203||153203|196894||2 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TAB|0|0|0|100|XEU|5001|2610|lyfalmen|V0490|2610|2|98|0|98,0000|Alvogen|Teva Pharma B.V.|Montelúkast||834||834|2610||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|66606|101933|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||63234||63234|101933||1 434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||15098||15098|28814||2 434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|13081|19467|lyfalmen|||1|0,36|0||Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||13081||13081|19467||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|7150|11303|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||7150||7150|11303||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3272|3939|lyfalmen|V0010|3871|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3939||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|685|2405|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||685||685|2405||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|0|G|0|MEA|0|0|1|100|DKK|5145|8544|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||5145||5145|8544||2 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|0|G|0|MEA|0|0|1|100|DKK|5916|9605|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||5916||5916|9605||2 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|9102|13990|lyfalmen|V0315|5758|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9102||9102|13990||2 434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|0|1|0|1|AMI|0|0|0|100|DKK|2220406|2767916|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeuticks UK Ltd.|Migalastat||2220406||2220406|2767916||1 435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|12786|19061|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||12786||12786|19061||1 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2701|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3811||1 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|1|AST|0|1|0|100|DKK|192563|245847|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||192563||192563|245847||2 436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|232|1781|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||232||232|1781||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|121533|157506|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||121533||121533|157506||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|39852|53599|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||39852||39852|53599||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|988|2822|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||988||988|2822||1 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|CFS|0|0|0|100|XEU|64964|85361|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||64964||64964|85361||3 436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|1944|lyfalmen|V0555|1944|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||350||350|1944||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|691|2413|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||691||691|2413||1 437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|0|1|FIN|0|1|0|100|DKK|567762|712489|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||567762||567762|712489||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|19374|28128|lyfalmen|V0712|28128|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||19374||19374|28128||1 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|1044|2899|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1044||1044|2899||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|1|AST|0|1|0|100|DKK|55361|73215|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||55361||55361|73215||2 438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|0|HRA|1|0|0|100|XEU|21041|40089|vetalmen|||0|1|0||Vistor hf|Dechra Limited|Clodronic acid||21041||21041|40089||1 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1929|4117|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1929||1929|4117||1 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1943|4136|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||1943||1943|4136||1 438428|N02AE0101|Bupremyl|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|IKR|1062|2701|lyfalmen|V0943|2701|2|4|0|2,8000|Icepharma hf|Mylan AB|Búprenorfín||900||900|2701||2 438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1594|3656|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1594||1594|3656||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|5899|2831|lyfalmen|V0605|2781|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||995||995|2831||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRG|0|1|0|100|DKK|213778|272232|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafeníb||213778||213778|272232||2 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|145463|187268|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||145463||145463|187268||1 438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4757|8009|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||4757||4757|8009||1 439548|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|146907|189064|lyfsjukr|||2|120|0||Icepharma hf|Mylan AB|Imatiníb||146907||146907|189064||2 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|18905|27483|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||18905||18905|27483||1 439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|50592|14737|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||9645||9645|14737||2 439680|A10BJ0101|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|13050|19424|lyfalmen|||1|60|0|40,0000|Vistor hf|AstraZeneca AB|Exenatide||13050||13050|19424||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2133|4398|lyfalmen|||1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2133||2133|4398||1 439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017|30.11.2018|R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|15007|19278|lyfalmen|||2|28|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||12944||12944|19278||1 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1242|2902|lyfalmen|V0163|2507|1|70|0|3,7333|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1046||1046|2902||1 440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|153876|197731|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||153876||153876|197731||1 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5749|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5749||2 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1245|3176|lyfsjukr|||2|10|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1245||1245|3176||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1964|4165|lyfsjukr|||2|10|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1964||1964|4165||1 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|963|2787|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||963||963|2787||1 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|929|2741|lyfalmen|V0046|2324|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||929||929|2741||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GEI|0|0|0|100|DKK|106896|139301|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||106896||106896|139301||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|927|2738|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||927||927|2738||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2361|3101|lyfalmen|V0283|3101|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1191||1191|3101||2 442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1741|1901|lyfalmen|||2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||319||319|1901|30.11.2018|2 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|70480|92337|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||70480||70480|92337||3 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10093|15354|lyfalmen|V0460|13075|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10093|15354||1 443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1277|3220|lyfalmen|V0560|3187|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1277||1277|3220||2 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2966|5544|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2966||2966|5544||1 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|23542|32970|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||23542||23542|32970||1 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|21729|30677|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||21729||21729|30677||1 443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|22451|31590|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||22451||22451|31590||3 443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|897|2519|lyfalmen|V0038|2104|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||768||768|2519||2 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1663|3327|lyfalmen|V0039|2976|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1355||1355|3327||2 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|2475|4339|lyfalmen|V0116|3269|2|14|0|14,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||2090||2090|4339||2 444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2725|5213|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2725||2725|5213||2 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|824|2596|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||824||824|2596||2 444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|0|1|0|1|NEP|0|0|0|100|DKK|1406415|1755539|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1406415||1406415|1755539||1 444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|XEU|1908|3799|lyfalmen|V0337|3799|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1698||1698|3799||1 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|2762|5264|lyfalmen|V0061|3337|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2762||2762|5264||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|19459|28245|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||19459||19459|28245||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1905|4084|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1905||1905|4084||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|2018|4240|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||2018||2018|4240||2 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|4878|8176|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4878||4878|8176||1 444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|149472|192254|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||149472||149472|192254||2 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|17399|25410|lyfalmen|V0705|25410|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||17399||17399|25410||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4445|7580|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4445||4445|7580||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1815|3960|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1815||1815|3960||1 445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|7019|3238|lyfalmen|V0684|2825|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1290||1290|3238||2 445580|H05BX0105|Cinacalcet Accord|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|AEE|0|0|0|100|XEU|47671|21008|lyfalmen|V0722|19355|2|28|0|42,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||14201||14201|21008||1 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|5695|9301|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5695||5695|9301||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|4502|7659|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer AB|Nífedipín||||4502|7659||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|14748|21761|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||14748||14748|21761||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|9820|5866|lyfalmen|V0694|5809|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3200||3200|5866||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|10651|16122|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10651||10651|16122||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|6109|9870|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6109||6109|9870||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|7502|11788|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7502||7502|11788||1 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9273|14225|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9273||9273|14225||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2887|3997|lyfalmen|V0948|3939|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1842||1842|3997||2 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1840|3995|lyfalmen|V0202|3451|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1840||1840|3995||1 448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6031|4600|lyfalmen|V0214|4600|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4600||2 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|56343|74457|lyfalmen|V0727|74457|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||56343||56343|74457||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1015|2859|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1015||1015|2859||2 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|3888|2694|lyfalmen|V0686|2129|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||895||895|2694||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|879|2672|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||879||879|2672||2 449647|N05AH0414|Quetiapin Hexal|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|4237|6533|lyfalmen|||2|100|0|12,5000|Artasan ehf|Hexal A/S|Quetíapín||3684||3684|6533|31.12.2018|1 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|4657|7872|lyfsjukr|||2|10|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||4657||4657|7872||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|3058|5671|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3058||3058|5671||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4299|8327|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4299||4299|8327||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1087|2958|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1087||1087|2958||2 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|119249|154665|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||119249||119249|154665||1 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|377498|475854|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||377498||377498|475854||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|2225|3750|lyfalmen|V0313|2761|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1662||1662|3750||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|7776|13403|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7776||7776|13403||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|0|0|1|LIN|0|0|0|100|XEU|18936|27525|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||18936|27525||5 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|43083|57686|lyfalmen|||1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||43083||43083|57686||1 451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|662|2373|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Prednisólón||662||662|2373||1 451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|8054|12547|lyfalmen|V0610|12547|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||8054||8054|12547||1 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|40258|54113|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||40258||40258|54113||2 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|Trimb Healthcare AB|Ketókónazól|||||||1 452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|7274|11474|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||7274||7274|11474||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5777||2 452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRG|0|1|0|100|DKK|856656|1071793|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||856656|1071793||2 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2838|lyfalmen|V0010|2212|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2838||2 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|8498|13159|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||8498||8498|13159||2 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|7301|11511|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||7301||7301|11511||2 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1227|3151|lyfalmen|V0597|2618|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1227||1227|3151||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3683|6531|lyfalmen|V0598|5043|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3683||3683|6531||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2345|4690|lyfalmen|V0584|3393|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2345||2345|4690||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1306|2251|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1306||1306|2251||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7069|11192|lyfalmen|V0585|7314|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7069||7069|11192||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3947|6895|lyfalmen|V0586|5134|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3947||3947|6895||2 453515|N03AX1211|Gabapentin PCD|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|1800|2563|lyfalmen|V0250|2563|2|120|0|20,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||800||800|2563||2 453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1917|2026|lyfalmen|V0685|1626|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||410||410|2026||1 453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|98700|128030|lyfalmen|V0920|128030|1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||98700|128030||2 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|13185|19610|lyfalmen|V0587|12918|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||13185||13185|19610||2 453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6279|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6279||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2434|4812|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2434||2434|4812||1 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|4694|9076|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4694||4694|9076||2 454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|7217|11395|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7217||7217|11395||1 454659|N05AH0414|Quetiapin Hexal|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|6465|9380|lyfalmen|V0910|8069|2|100|0|37,5000|Artasan ehf|Hexal A/S|Quetíapín||5753||5753|9380||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|10002|15229|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||10002||10002|15229||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|34097|39624|lyfalmen|V0342|8991|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||28803||28803|39624||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|0|0|1|OPH|0|0|0|100|DKK|49604|65933|lyfsjukr|||1|1|0||Artasan ehf|Novartis Europharm Ltd|Tópótecan||49604||49604|65933||1 454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|355344|448301|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||355344||355344|448301||2 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1015|1995|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1015||1015|1995||1 454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|800|2563|lyfalmen|V0174|2563|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2563||2 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4286|7361|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4286||4286|7361||1 455223|J05AR0303|Emtricitabine/Tenofovir disoproxil Krka|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.08.2017||R|0|1|0|1|0|1|KNM|0|1|0|100|IKR|50000|66434|lyfsjukr|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Tenófóvír dísóproxíl og emtrícítabín||||50000|66434||2 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6878|10929|lyfalmen|V0713|9596|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6878||6878|10929||1 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1217904|1521084|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1217904||1217904|1521084||2 455492|G04BE0310|Sildenafil LYFIS|filmhtfl|50|mg|24|stk|1|þpakki||G04BE03|01.09.2016|31.12.2018|R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|8916|8344|lyfalmen|||2|24|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||5000||5000|8344||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|744|2486|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||744||744|2486||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|815|2584|lyfalmen|||2|15|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||815||815|2584||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1627|3701|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||1627||1627|3701||1 456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2740|5233|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2740||2740|5233||2 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5264|4903|lyfalmen|V0277|4903|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||2500||2500|4903||2 457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017|30.11.2018|R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10735|5711|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3087||3087|5711||1 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|45542|49960|lyfalmen|V0451|49960|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||36975||36975|49960||2 457232|A07DA0601|Truberzi|filmhtfl|75|mg|56|stk|1|þpakki||A07DA06|01.08.2017||R|1|0|0|1|0|0|AIP|0|0|0|100|XEU|15669|23029|lyfalmen|||2|56|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Eluksadólín||||15669|23029||1 457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MLT|0|0|1|100|XEU|1401|3390|lyfalmen|V0561|3390|2|100|0||BGP Products AsP|Mylan Ireland Limited|Lídókaín||1401||1401|3390||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|PEU|0|0|0|100|DKK|6144|9919|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6144||6144|9919||1 457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2662|5126|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2662||2662|5126||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|2410|2277|lyfalmen|V0003|2208|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||592||592|2277||1 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9886|17040|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||9886||9886|17040||2 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1012|2855|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1012||1012|2855||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|FIN|0|1|0|100|DKK|358428|452137|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||358428||358428|452137||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1166|3067|lyfalmen|V0577|2670|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1166||1166|3067||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1208|3125|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1208||1208|3125||2 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|107825|140457|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||107825|140457||3 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|9303|13124|lyfalmen|V0653|12895|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||8473||8473|13124||1 458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|0|1|BNB|0|1|0|100|XEU|10939871|13612485|lyfsjukr|||1|5|0||Icepharma hf|Biogen Netherlands B.V.|Nusinersen||10939868||10939868|13612485||2 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|864968|1082131|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||864968||864968|1082131||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|84940|110626|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||84940||84940|110626||2 459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|19490|28288|lyfsjukr|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||19490|28288||2 459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|15914|lyfalmen|V0964|15914|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10500||10500|15914||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|757|2504|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||757||757|2504||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1388|3372|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1388||1388|3372||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|18760|35762|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||18760||18760|35762||2 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|2267|2230|lyfalmen|V0284|2230|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||558||558|2230||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|1430|3430|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1430||1430|3430||2 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|0|1|AEE|0|1|0|100|XEU|126467|163642|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||126467||126467|163642||1 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|HSS|0|0|0|100|DKK|8371|12984|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||8371||8371|12984||1 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|216866|276073|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||216866||216866|276073||2 460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|6677|4414|lyfalmen|V0144|4146|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2145||2145|4414||1 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|4422|8560|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||4422||4422|8560||2 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|4354|7314|lyfalmen|V0585|7314|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||4252||4252|7314||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|494204|621004|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||494204||494204|621004||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1880|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1880||2 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1255564|1567923|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1255564||1255564|1567923||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|298120|377130|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||298120||298120|377130||1 461731|N02AJ0601|Parkodin|töflur|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.01.1989|31.10.2018|R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|232|1781|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||232||232|1781||1 461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|16841|24642|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||16841||16841|24642||1 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|IND|0|0|0|100|DKK|3854|6767|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||3854||3854|6767||1 462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|4100|7105|lyfalmen|V0966|6823|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4100||4100|7105||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4748|2838|lyfalmen|V0605|2838|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1000||1000|2838||2 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|46251|61693|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||46251|61693||1 463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4109|7118|lyfalmen|V0126|7118|1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4109|7118||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1928|4116|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1928||1928|4116||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2 463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|3109|5359|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||3109||3109|5359||1 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2478|3499|lyfalmen|V0947|3389|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1480||1480|3499||2 464326|L01XX1905|Onivyde|irþ|5|mg/ml|10|ml|1|hgl||L01XX19|01.04.2017||R|0|0|0|0|0|1|ALT|0|0|0|100|DKK|94195|122332|lyfsjukr|||1|10|0||Lyfjaver ehf|Baxalta Innovations GmbH|Írinótekan||94195||94195|122332||3 464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|14915|21991|lyfalmen|V0718|21991|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||14915||14915|21991||1 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|8460|13106|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||8460||8460|13106||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|1713|3554|lyfalmen|V0967|2838|2|14|0|7,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||1520||1520|3554||2 464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|||2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón|||||2863|31.12.2018|1 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|1613|3682|lyfalmen|V0376|3682|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1613||1613|3682||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1050|2064|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||||1050|2064||1 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|1715|3822|lyfalmen|||1|98|0|49,0000|Icepharma hf|BGP Products ApS|Verapamíl||1715||1715|3822||2 465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2949|5521|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2949||2949|5521||2 465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|0|1|AEB|0|1|0|100|DKK|69436|91017|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||69436||69436|91017||1 465848|A07DA0303|Immex|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.05.2018||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|812|2329|lyfalmen|V0447|2329|2|100|0|20,0000|Alvogen|Alvogen|Lóperamíð||630||630|2329||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2763|2976|lyfalmen|V0039|2976|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Flúoxetín||1100||1100|2976||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|553|2223|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||553||553|2223||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1724|3835|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1724||1724|3835||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1142|3034|lyfalmen|V0545|2142|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1142|3034||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1307|3261|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1307||1307|3261||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|4529|7696|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4529||4529|7696||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|250150|317469|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||250150||250150|317469||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|16768|24541|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||16768||16768|24541||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2430|4807|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2430||2430|4807||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6610|10560|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6610||6610|10560||1 466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3998|6965|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||3998||3998|6965||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|18781|27312|lyfalmen|V0728|24819|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||18781||18781|27312||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|2929|5493|lyfalmen|V0063|4752|1|100|0|50,0000|Icepharma hf|Meda AB|Móklóbemíð||2929||2929|5493||2 466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|325|1909|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||325||325|1909||2 467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|6252|5923|lyfalmen|V0622|5916|2|30|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3241||3241|5923||1 467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5303|9140|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||5303||5303|9140||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5490|9018|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5490||5490|9018||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|12826|19116|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||12826||12826|19116||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5494|9024|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||5494||5494|9024||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|24407|34064|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||24407||24407|34064||1 467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|9229|14165|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||9229||9229|14165||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|PIP|0|0|0|100|DKK|71330|93412|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||71330||71330|93412||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|369|1970|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||369||369|1970||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5459|6509|lyfalmen|V0317|2838|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3667||3667|6509||1 468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|13615|8911|lyfalmen|V0720|8082|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||5412||5412|8911||2 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6646|6484|lyfalmen|V0318|3527|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3649||3649|6484||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2082|3589|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2082||2082|3589||2 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5522|10647|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5522||5522|10647||2 468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6472|10370|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6472||6472|10370||1 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|3058|5671|lyfalmen|V0467|3107|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3058||3058|5671||1 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6589|10531|lyfalmen|V0712|9376|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6589||6589|10531||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2876|5420|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2876||2876|5420||1 469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|AEP|0|0|0|100|DKK|2208|4501|lyfalmen|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2208||2208|4501||2 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6843|10881|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6843||6843|10881||1 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|2227|2300|lyfalmen|V0037|2288|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||609||609|2300||1 469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|BCP|0|0|0|100|IKR|14998|22105|lyfalmen|V0968|22105|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ltd.|midodrine||14998||14998|22105||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|6203|5916|lyfalmen|V0622|5916|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3236||3236|5916||1 470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|0|G|0|TAB|0|0|0|100|XEU|13935|16606|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||11003||11003|16606||2 470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|0|1|0|1|IPC|0|0|0|100|DKK|45159|52695|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||39137||39137|52695||2 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3653|6490|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3653||3653|6490||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|24028|33585|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||24028||24028|33585||1 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|5487|9014|lyfalmen|||1|5|0|10,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||5487||5487|9014||2 471550|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.10.2017||R|1|0|0|0|G|0|MEA|0|0|1|100|SEK|746|2489|lyfalmen|||1|30|0|15,0000|Icepharma hf|Meda AB|Fenýlprópanólamín||746||746|2489||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4210|8158|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4210||4210|8158||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1599|3663|lyfalmen|V0048|2310|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1599||1599|3663||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3574|6381|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3574||3574|6381||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|0|1|TEA|0|0|0|100|SEK|8252|12820|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8252||8252|12820||1 472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|4689|7115|lyfalmen|V0811|7098|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||4107||4107|7115||2 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2593|5031|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2593||2593|5031||1 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ATN|0|0|1|100|DKK|1282|3227|lyfalmen|||1|5|0|5,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Ketórólak||1282||1282|3227||2 473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAQ|0|1|0|100|XEU|119934|155517|lyfsjukr|||2|4|0|28,5800|Biogen Idec Ltd.|Samsung Bioepis NL B.V.|Etanercept||119934||119934|155517||2 473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4407|7528|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4407||4407|7528||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MEA|0|0|0|100|DKK|9833|14996|lyfsjukr|||1|400|0||Icepharma hf|Meda AB|Dextran||9833||9833|14996||2 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|6744|10744|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||6744||6744|10744||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7432|3030|lyfalmen|V0687|3030|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1139||1139|3030||1 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|26882|51171|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||26882||26882|51171||2 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010|31.12.2018|R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|698|2423|lyfalmen|||3|30|0|1,5000|LYFIS ehf|LYFIS ehf|Pramipexól||698||698|2423||2 474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|925|2735|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||925||925|2735||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|1100|2976|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2976||1 475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2904|3664|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1600||1600|3664||2 475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2 476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5695||5695|10975||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|58527|77219|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||58527|77219||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1119|3002|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||1119||1119|3002||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3965|6919|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||3965|6919||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MBV|0|0|0|100|DKK|15577|22902|lyfalmen|V0954|11265|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||15577||15577|22902||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|4028|7006|lyfalmen|V0934|5178|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4028||4028|7006||1 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CBV|0|1|0|100|XEU|52451|69534|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe B.V.|Apremilast||52451||52451|69534||2 477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAQ|0|1|0|100|XEU|119934|155517|lyfsjukr|||2|4|0|28,5800|Biogen Idec Ltd.|Samsung Bioepis NL B.V.|Etanercept||119934||119934|155517||2 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|28055|9445|lyfalmen|V0272|9445|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9445||2 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3364||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|650|2357|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||650||650|2357||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3364||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|446|1960|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||362||362|1960|30.11.2018|1 478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|14435|21330|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14435||14435|21330||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|6724|12927|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||6724||6724|12927||2 478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|1954|2834|lyfalmen|V0825|2834|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||997||997|2834||2 479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|0|MVX|0|0|0|100|IKR|4900|8069|lyfalmen|V0115|8042|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4800||4800|8069||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|22963|32238|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||22963||22963|32238||2 479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|891|2688|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||891||891|2688||1 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|108204|140928|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||108204||108204|140928||1 479991|L01XX5001|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|747110|935548|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||747110||747110|935548||1 480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2914|5699|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2914||2914|5699||2 480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|4256|5774|lyfalmen|V0080|5774|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3133||3133|5774||2 480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|28940|39798|lyfalmen|V0975|39798|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||28940||28940|39798||2 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|11593|17419|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||11593||11593|17419||1 481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|632|2332|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||632||632|2332||1 481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|25104|34946|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|34946||2 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4186|7224|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||4186||4186|7224||1 481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|6465|7035|lyfalmen|V0681|7032|2|30|0|27,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||4049||4049|7035||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|230|1779|lyfalmen|V0055|1779|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||230||230|1779||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|14404|21288|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||14404||14404|21288||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MEA|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2 482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|0|0|1|AEB|0|1|0|100|DKK|60765|80050|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||60765||60765|80050||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|29338|40301|lyfalmen|V0977|40301|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||29338|40301||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5843|9504|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5843||5843|9504||2 483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|49659|66003|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||49659||49659|66003||2 483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|4520|7683|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4520||4520|7683||2 483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|2221|4519|lyfalmen|V0368|4519|2|15|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Brímónidín||2221||2221|4519||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|6006|9729|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6006||6006|9729||1 483711|S01ED5114|Latanoprost/Timolol Alvogen|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1757|3880|lyfalmen|V0374|3880|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1757||1757|3880||2 483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2486|4884|lyfalmen|V0902|4655|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4884||2 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|898|2698|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||898||898|2698||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|258|1817|lyfalmen|V0055|1779|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||258||258|1817||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|4870|8165|lyfalmen|V0961|5860|1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||4870||4870|8165||1 484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|364610|459825|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||364610||364610|459825||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|119344|154783|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||119344||119344|154783||1 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|1106|2984|lyfalmen|||1|300|0|50,0000|Icepharma hf|Meda AB|Benzýdamín||1106||1106|2984||2 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|9173|14088|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||9173||9173|14088||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|45018|60133|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||45018||45018|60133||1 484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|8835|13622|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||8835||8835|13622||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1269|3209|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1269||1269|3209||2 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9291|14250|lyfalmen|V0714|14250|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9291||9291|14250||2 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|362075|456672|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||362075||362075|456672||1 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|12897|19213|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||12897||12897|19213||1 485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|0|KNM|0|0|1|100|IKR|4800|4903|lyfalmen|V0116|4903|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2500||2500|4903||2 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIC|0|0|0|100|DKK|72506|94900|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||72506||72506|94900||1 485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5253|8692|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||5253||5253|8692||1 486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|486|2131|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||486||486|2131||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|535|2198|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||535||535|2198||1 487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|739689|926319|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||739689||739689|926319||1 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|2359|4709|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||2359||2359|4709||1 487650|N04BD0204|Rasagiline Mylan|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.11.2016|30.11.2018|R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|20882|13065|lyfalmen|||2|112|0|112,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||8430||8430|13065||2 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|29214|40144|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||29214||29214|40144||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MBV|0|0|0|100|DKK|49028|65205|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Interferón alfa-2b||49028||49028|65205||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|26231|33527|lyfalmen|V0453|33527|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||23982||23982|33527||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|IKR|1033|2288|lyfalmen|V0469|2288|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||600||600|2288||2 487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8110|15557|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||8110||8110|15557||1 488152|G04BE0807|Tadalafil Mylan|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|3273|3733|lyfalmen|V0924|3240|2|4|0|4,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||1650||1650|3733||2 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|248504|315422|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||248504||248504|315422||1 488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|6194|9987|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6194||6194|9987||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|9911|15103|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||9911||9911|15103||1 488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 489085|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|100|stk|1|glas||N06BA04|01.08.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|15835|20825|lyfalmen|||2|100|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||14068||14068|20825||1 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|5660|9252|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||5660||5660|9252||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|79855|104195|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||79855|104195||1 489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|0|SGB|0|0|0|100|XEU|18473|26888|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||18473||18473|26888||1 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1799|3938|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1799||1799|3938||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1666|3755|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1666||1666|3755||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4324|7414|lyfalmen|V0133|7414|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4324||4324|7414||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3713|6573|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3713||3713|6573||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|9572|10003|lyfalmen|V0112|2770|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6205||6205|10003||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11686|13351|lyfalmen|V0113|2770|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||8638||8638|13351||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13721|16466|lyfalmen|V0114|2770|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10901||10901|16466||1 491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|2295952|2861871|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||2295950||2295950|2861871||2 491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|327948|414228|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||327948||327948|414228||1 491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18363|26737|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||18363||18363|26737||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|PEU|0|1|0|100|DKK|119746|155283|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||||119746|155283||1 491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|0|1|AEB|0|0|0|100|DKK|40273|54132|lyfsjukr|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||40273||40273|54132||1 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|2072|3423|lyfalmen|V0693|3163|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1425||1425|3423||2 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|skpokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3322|6034|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||||3322|6034||1 492114|J07BB0205|Influvac|stl|||0,5|ml|1|áfspr|með nál|J07BB02|01.08.2017||R|0|0|0|0|0|0|PGB|0|0|0|100|DKK|771|2523|lyfalmen|||1|0,5|0||Icepharma hf|BGP Products ApS|Inflúensa, hreinsaðir mótefnavakar||771||771|2523||2 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|486916|611940|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||486916||486916|611940||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2674|5142|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2674||2674|5142||2 492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|0|G|0|TEA|0|0|1|100|SEK|1413|3407|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1413||1413|3407||1 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5914|9602|lyfalmen|V0002|5894|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||5914||5914|9602||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|15425|22693|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||15425||15425|22693||1 492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2 493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017|30.11.2018|R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10727|5778|lyfalmen|||2|28|0|6,3000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3136||3136|5778||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|24696|34430|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24696||24696|34430||1 493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|83378|108651|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||83378||83378|108651||1 493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|62089|81724|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||62089||62089|81724||1 493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|3251|lyfalmen|V0213|3251|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1300||1300|3251||2 493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|1960|2743|lyfalmen|V0113|2715|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2743||2 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1061|2922|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1061||1061|2922||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3046|5654|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3046||3046|5654||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|65600|86165|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||65600||65600|86165||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|164001|210324|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||164001||164001|210324||2 494474|J02AC0106|Fungyn|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1250|2081|lyfalmen|V0551|2081|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||450||450|2081||2 494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|IKR|7287|5866|lyfalmen|V0145|5159|2|8|0|16,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||3200||3200|5866||2 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|2001|4216|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2001||2001|4216||1 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1997|4211|lyfalmen|V0128|2436|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1997||1997|4211||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2902|5456|lyfalmen|V0410|4568|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2902||2902|5456||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2429|4774|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||2429||2429|4774||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|2570|4999|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2570||2570|4999||1 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|CFS|0|0|0|100|XEU|812054|1016320|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||812054||812054|1016320||3 495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|390846|492456|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||390846||390846|492456||2 495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3000|3871|lyfalmen|V0010|3871|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1750||1750|3871||2 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|19425|7054|lyfalmen|V0384|5015|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||4063||4063|7054||1 495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|0|1|ACC|0|0|0|100|XEU|79942|104305|lyfsjukr|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||79942||79942|104305||1 495692|N05AX1211|Aripiprazole Mylan Pharma|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|IKR|7772|2825|lyfalmen|V0683|2825|2|56|0|37,3300|Icepharma hf|Pharmathen S.A.|Aripiprazól||990||990|2825||2 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|5399|8893|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5399||5399|8893||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2358|4708|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||2358||2358|4708||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011|31.12.2018|R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|37989|lyfalmen|||3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||27510||27510|37989||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4046|7847|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4046||4046|7847||2 496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|0|SDF|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Klemastín|||||5082||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PLS|0|0|0|100|DKK|414|2032|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||414||414|2032||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|748|2492|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||748||748|2492||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|174709|109950|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||84405||84405|109950||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|219327|279134|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||219327||219327|279134||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2853|5389|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2853||2853|5389||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1305|2497|lyfalmen|V0056|2497|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||752||752|2497||1 497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|0|0|GRP|0|0|0|100|NOK|5782|4407|lyfalmen|||1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2140||2140|4407||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|549|2218|lyfalmen|V0448|2200|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||549||549|2218||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1095|2969|lyfalmen|V0449|2907|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||1095||1095|2969||1 497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|0|0|0|UNI|0|0|0|100|DKK|3763|6641|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||3763||3763|6641||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1361|3335|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1361||1361|3335||2 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4628|lyfalmen|V0472|4628|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4628||2 498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12534|3238|lyfalmen|V0683|2825|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1290||1290|3238||2 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|68329|99211|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||61545||61545|99211||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|17112|25015|lyfalmen|V0610|12547|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17112||17112|25015||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|22086|31129|lyfalmen|V0718|21991|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22086||22086|31129||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|8562|13247|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8562|13247||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|5545|9094|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||5545||5545|9094||2 499462|M05BA0606|Ibandronic acid WH|irþ|2|mg|2|ml|1|hgl|lausn|M05BA06|01.03.2018||R|0|1|0|0|0|1|WEH|0|0|0|100|IKR|7722|11417|lyfsjukr|||2|2|0|0,3333|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||7233||7233|11417||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|10080|15336|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||10080||10080|15336||1 500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|900|2136|lyfalmen|V0050|2136|2|100|0|15,8300|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||490||490|2136||2 500476|L01XE3901|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01XE39|01.04.2018||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|1788795|2231113|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1788795||1788795|2231113||1 500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|64964|85361|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||64964||64964|85361||2 501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|1|TVB|0|1|0|100|NOK|16753|24521|lyfsjukr|||1|2,5|0||Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||16753||16753|24521||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|4087|6823|lyfalmen|V0966|6823|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||3895||3895|6823||2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5245|8681|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5245||5245|8681||1 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|12891|19205|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||12891||12891|19205||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|24954|34756|lyfalmen|V0974|34756|1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||24954||24954|34756||2 501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2511|4918|lyfalmen|V0434|4502|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2511||2511|4918||2 502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3290|3656|lyfalmen|V0143|3527|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1594||1594|3656||2 502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1774|3904|lyfalmen|V0926|3904|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||1774||1774|3904||2 502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2 502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|3836|6742|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||3836||3836|6742||2 502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|5212|8636|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||5212||5212|8636||1 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|12259|18335|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||12259|18335||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|27545|38033|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||27545||27545|38033||1 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|18923|27508|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai GmbH|Perampanel||18923||18923|27508||1 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4465|7608|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4465||4465|7608||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011|31.12.2018|R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|9817|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||6070||6070|9817||2 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3808|6703|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3808||3808|6703||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1465|2746|lyfalmen|V0494|2240|2|90|0|180,0000|Actavis Group hf|Actavis hf|Glímepíríð||933||933|2746||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|6329|10173|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||6329||6329|10173||1 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|33544|45621|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Europe MA EEIG|Síldenafíl||33544||33544|45621||1 504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|536|2200|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||536||536|2200||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1026|2874|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1026||1026|2874||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|12377|23652|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||12377||12377|23652||1 505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2838|lyfalmen|V0335|2838|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2838||2 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3186|5847|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3186||3186|5847||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|7270|11468|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7270||7270|11468||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|18923|27508|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai GmbH|Perampanel||18923||18923|27508||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2172|4452|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2172||2172|4452||2 506276|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|1390|3375|lyfalmen|||2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1390||1390|3375|31.12.2018|2 506431|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|4420|5032|lyfalmen|V0145|2579|2|4|0|8,0000|Artasan ehf|Sandoz A/S|Tadalafíl||2594||2594|5032||1 506553|C01CA1703|Hypotron|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|0|0|0|BCP|0|0|0|100|IKR|7499|11784|lyfalmen|V0968|11053|2|50|0|4,1666|CampusPharma AB|Brancaster Pharma Ltd.|midodrine||7499||7499|11784||2 506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|12000|7792|lyfalmen|V0831|7792|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4599||4599|7792||2 506963|C01EB2101|Rapiscan|stl|400|mcg|5|ml|1|hgl||C01EB21|01.01.2018||R|0|0|0|0|0|1|RAS|0|0|0|100|NOK|7171|11332|lyfsjukr|||1|5|0||Icepharma hf|Rapidscan Pharma Solutions EU Ltd.|Regadenoson||7171||7171|11332||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2178|4460|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2178||2178|4460||1 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|3105|5736|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||3105||3105|5736||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1725|3836|lyfalmen|V0092|3836|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1725||1725|3836||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|SEK|795|2556|lyfalmen|||1|5|0||Abcur AB|Amdipharm Limited|Fúsidínsýra||795||795|2556||2 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|6409|3293|lyfalmen|V0687|3030|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1330||1330|3293||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|703|2229|lyfalmen|V0555|1944|2|2|0|1,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||557||557|2229||1 508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|0|MVA|0|0|0|100|DKK|18117|26398|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||18117||18117|26398||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4517|8740|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4517|8740||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4069|7890|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4069||4069|7890||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12056|23043|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12056||12056|23043||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|0|1|SGB|0|1|0|100|XEU|525075|659399|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||525075||525075|659399||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8438|13076|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8438||8438|13076||1 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|1945|4139|lyfalmen|V0134|3370|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||1945||1945|4139||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|39970|53748|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||39970||39970|53748||1 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|73064|95606|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||73064|95606||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|14708|21706|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche Registration GmbH|Epóetín||14708||14708|21706||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|22016|31040|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche Registration GmbH|Epóetín||22016||22016|31040||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|36113|48870|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche Registration GmbH|Epóetín||36113||36113|48870||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|RRG|0|0|0|100|DKK|55815|73789|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche Registration GmbH|Epóetín||55815||55815|73789||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|425|2047|lyfalmen|V0601|1944|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||425||425|2047||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|145863|187765|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||145863|187765||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3691|4556|lyfalmen|V0445|3832|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Fínasteríð||2248||2248|4556||1 511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|721|2454|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||721||721|2454||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2379|4736|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2379||2379|4736||1 511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|0|1|WIL|0|0|0|100|XEU|2342|4685|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2342|4685||2 511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|39244|52830|lyfalmen|||1|1,08|0||Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||39244||39244|52830||1 511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|14350|21213|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||14350||14350|21213||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4645|7855|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4645||4645|7855||1 512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|3400|3527|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3527||2 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2067|2497|lyfalmen|V0057|2497|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||752||752|2497||1 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|946|2275|lyfalmen|V0109|2275|2|100|0|66,6700|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||591||591|2275||1 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2 513312|A02BC0510|Eradizol|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.06.2017||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6600|Alvogen|Alvogen|Esómeprazól|||||||2 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2379|4676|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2379||2379|4676||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1877|3689|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||1877||1877|3689||2 514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|9764|7656|lyfalmen|V0111|6665|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||4500||4500|7656||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4215|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4215||2 514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|0|G|0|KRK|0|0|0|100|IKR|6000|8069|lyfalmen|V0910|8069|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4800||4800|8069||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1397|3385|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1397||1397|3385||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|16181|23733|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||16181|23733||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2131|2494|lyfalmen|V0692|2494|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2494||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3724|4928|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2518||2518|4928||1 515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|11391|17141|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||11391||11391|17141||3 516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|130662|168859|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||130662|168859||2 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4750|7093|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4091||4091|7093||2 516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|16855|24661|lyfalmen|||1|0,94|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||16855|24661||1 516803|L01XE0105|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|0|1|0|1|RTH|0|1|0|100|XEU|146081|72963|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatiníb||55162||55162|72963||2 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|8870|10030|lyfalmen|V0384|10030|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||6225||6225|10030||1 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|18600|7793|lyfalmen|V0273|7793|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||4600||4600|7793||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2611|5056|lyfalmen|V0462|3635|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2611||2611|5056||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIG|0|0|0|100|SEK|27903|38486|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||27903||27903|38486||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2843|5375|lyfalmen|V0471|3696|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2843||2843|5375||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3057|5670|lyfalmen|V0472|3471|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3057||3057|5670||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|27442|37903|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||27442||27442|37903||2 517914|QI09AL0001|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL|01.01.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|9095|15676|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||9095||9095|15676||2 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|16052|lyfalmen|V0711|15729|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||10600||10600|16052||2 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|988|2822|lyfalmen|||1|20|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||988||988|2822||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|4078|7075|lyfalmen|||1|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||4078||4078|7075||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1842|3997|lyfalmen|V0590|3187|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1842||1842|3997||1 518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1122|3006|lyfalmen|V0004|3006|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1122||1122|3006||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|17022|24891|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||17022||17022|24891||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|887|2683|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||887||887|2683||2 519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|2692|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8703||2 519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|792|2178|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||520||520|2178|31.12.2018|2 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AEP|0|0|1|100|DKK|1328|3290|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1328||1328|3290||2 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5063|4319|lyfalmen|V0515|3586|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2076||2076|4319||1 520104|C07BB0701|Bisbetol Plus|filmhtfl|17,5|mg|100|stk|1|þpakki|5+12,5 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2136|4402|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||2136||2136|4402||2 520160|J01XA0108|Vancomycin Actavis|st/irþ|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|796|2167|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||512||512|2167||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|19944|28913|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||19944|28913||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|15835|23257|lyfalmen|V0143|3527|1|12|0|12,0000|Icepharma hf|Pfizer Europe MA EEIG|Síldenafíl||15835||15835|23257||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|5153|8555|lyfalmen|V0144|1382|1|4|0|8,0000|Icepharma hf|Pfizer Europe MA EEIG|Síldenafíl||5153||5153|8555||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PEU|0|0|0|100|DKK|14257|21085|lyfalmen|V0144|4146|1|12|0|24,0000|Icepharma hf|Pfizer Europe MA EEIG|Síldenafíl||14257||14257|21085||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1408|2571|lyfalmen|V0056|2497|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||806||806|2571||1 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|IND|0|0|0|100|DKK|10859|16408|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||10859||10859|16408||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2486|2571|lyfalmen|V0057|2497|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||806||806|2571||1 520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9292|8344|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8344||2 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|SEK|276|1842|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||276||276|1842||2 520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|glas||B01AA03|01.01.2019||R|1|0|0|0|G|0|TVB|0|0|0|100|XEU|1478|3496|lyfalmen|||2|100|0|40,0000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Warfarín||1478||1478|3496||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8552|16395|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||8552||8552|16395||1 522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8146|5075|lyfalmen|V0688|5075|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2625||2625|5075||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|108529|141332|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||108529||108529|141332||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|154114|198027|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||154114||154114|198027||1 522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4510|3865|lyfalmen|V0285|3527|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1746||1746|3865||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1880||1 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|168762|216245|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||168762||168762|216245||1 523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1512|2709|lyfalmen|V0144|1382|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||906||906|2709||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|290321|367431|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||290321||290321|367431||1 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1382|3364|lyfalmen|V0903|2976|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1382||1382|3364||1 523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10498|12198|lyfalmen|V0954|11495|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||7800||7800|12198||2 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1403|3393|lyfalmen|V0584|3393|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1403||1403|3393||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|315|1896|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||315||315|1896||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1858|4019|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1858||1858|4019||1 524257|L02BB0401|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB04|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|432754|544577|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||432754||432754|544577||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7643|6465|lyfalmen|V0010|3871|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6465||1 524351|L01XX2401|Oncaspar|stl/irl|750|ein/ml|5|ml|1|hgl||L01XX24|01.10.2016||R|0|0|0|0|0|1|ALT|0|0|0|100|SEK|200396|255589|lyfsjukr|||1|5|0||Lyfjaver ehf|Baxalta Innovations GmbH|Pegaspargase||200396||200396|255589||3 524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|2975|lyfalmen|V0039|2916|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1099||1099|2975||2 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|6729|10724|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6729||6729|10724||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|620|2315|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||620||620|2315||2 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|12451|23793|vetalmen|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||12451||12451|23793||2 525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4200|7243|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4200||4200|7243||2 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|30331|41557|lyfalmen|V0977|41123|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30331|41557||2 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|4801|8070|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||4801||4801|8070||2 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|4371|7478|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||4371||4371|7478||2 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2280|4600|lyfsjukr|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2280|4600||2 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4827||2 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4889||2 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3599|6416|lyfalmen|V0435|6416|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3599||3599|6416||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|5506|9040|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5506||5506|9040||1 526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|9168|5316|lyfalmen|V0516|5316|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2800||2800|5316||2 526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|14125|lyfalmen|V0423|14125|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||9200||9200|14125||2 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|13565|7020|lyfalmen|V0111|6665|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||4038||4038|7020||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3489|6264|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3489||3489|6264||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||2018||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|11130|16781|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||11130||11130|16781||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|13791|6272|lyfalmen|V0516|5316|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3495||3495|6272||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1306|3260|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1306||1306|3260||1 527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4779|8040|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4779||4779|8040||1 527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3000|2906|lyfalmen|V0825|2834|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1049||1049|2906||2 527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|224962|286142|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||224962||224962|286142||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1615|3174|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1615||1615|3174||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|886|2324|lyfalmen|V0046|2324|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||626||626|2324||1 528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3884|6279|lyfalmen|V0961|6279|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3500||3500|6279||2 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13596|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13596||2 528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2969||1 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9202|6162|lyfalmen|V0011|4862|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3415||3415|6162||1 528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|590|2011|lyfalmen|V0562|2011|2|100|0|33,3300|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||399||399|2011||2 528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1816|3962|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1816||1816|3962||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|5399|8893|lyfalmen|V0971|8831|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5399||5399|8893||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6072|9819|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6072||6072|9819||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|4140|6003|lyfalmen|V0621|6003|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||3299||3299|6003||2 529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|11088|15914|lyfalmen|V0963|15914|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10500||10500|15914||2 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|60568|79801|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||60568||60568|79801||1 529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|0|0|1|MBV|0|1|0|100|DKK|250803|318281|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||250803||250803|318281||1 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10409|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10409||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530172|J05AP0901|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AP09|01.10.2015||R|1|0|0|1|0|1|ABD|0|1|0|100|DKK|151443|194705|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Dasabuvir||151443||151443|194705||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|5835|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6688||1 530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2488|3045|lyfalmen|V0824|3045|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3045||2 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1443|2836|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1443||1443|2836||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2522|4933|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2522||2522|4933||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5616|9192|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5616||5616|9192||1 531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18383|26764|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||18383||18383|26764||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|3955|6906|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3955||3955|6906||3 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|571|2248|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||571||571|2248||1 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|41025|14044|lyfalmen|V0711|14044|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||9141||9141|14044||2 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|0|0|1|WEH|0|1|0|100|XEU|104252|136013|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||104252||104252|136013||2 532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|23491|40489|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||23491||23491|40489||2 532881|C07BB0701|Bisbetol Plus|filmhtfl|35|mg|100|stk|1|þpakki|10+25 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|3843|6751|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||3843||3843|6751||2 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1757|3880|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1757||1757|3880||2 532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1198|3111|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1198||1198|3111||1 533048|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|17911|15873|lyfalmen|||2|100|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||10470||10470|15873||1 533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|224209|285206|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||224209||224209|285206||2 533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|0|1|RRG|0|0|0|100|DKK|714795|895357|lyfsjukr|||1|10|0||Icepharma hf|Roche Registration GmbH|Ocrelizumab||||714795|895357||2 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2473|2193|lyfalmen|V0006|2116|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||531||531|2193||1 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|19979|28961|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||19979||19979|28961||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|51843|68765|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||51843||51843|68765||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|2658|5213|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||2658||2658|5213||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7576|5316|lyfalmen|V0117|5316|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2800||2800|5316||2 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4711|7946|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||4711||4711|7946||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1984|4193|lyfalmen|V0092|3836|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1984||1984|4193||1 535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2221|3828|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2221||2221|3828||1 535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3200|2906|lyfalmen|V0826|2834|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1049||1049|2906||2 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1502|2439|lyfalmen|V0692|2328|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||710||710|2439||1 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|354|1949|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||354||354|1949||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|369|1970|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||369||369|1970||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MBV|0|0|0|100|DKK|26361|36536|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme B.V.|Interferón alfa-2b||26361||26361|36536||1 536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|1960|2743|lyfalmen|V0112|2715|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2743||2 536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|82400|107414|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||82400||82400|107414||1 536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|11785|lyfalmen|V0419|11785|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||7500||7500|11785||2 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2356|4705|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2356||2356|4705||2 536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|7824|12231|lyfalmen|||2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7824||7824|12231||1 536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|16671|24408|lyfalmen|||1|1,41|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||16671|24408||1 537029|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|15190|12867|lyfalmen|V0959|11956|2|90|0|108,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||8286||8286|12867||1 537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GSE|0|0|0|100|DKK|64964|85361|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||64964||64964|85361||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5471|8992|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5471||5471|8992||1 537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1500|3527|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3527||2 537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|14000|13437|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13437||2 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2311||1 537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyfalmen|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||1 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|6170|9954|lyfalmen|||2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6170||6170|9954||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MRP|0|0|0|100|SEK|94200|122338|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||94200||94200|122338||2 538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2640|5096|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2640||2640|5096||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2682|4065|lyfalmen|V0678|4065|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan||1891||1891|4065||2 538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4571|7753|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||4571||4571|7753||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNP|0|0|0|100|XEU|8234|12795|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||8234||8234|12795||1 539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4530|7697|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4530||4530|7697||1 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|76820|100356|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||76820||76820|100356||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|693|2416|lyfalmen|||2|25|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||693||693|2416||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|726|2461|lyfalmen|||2|100|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||726||726|2461||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539793|L01XE4201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|416025|523771|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||416025||416025|523771||1 539906|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|9453|5542|lyfalmen|V0816|5525|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2964||2964|5542||2 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1586|3645|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1586||1586|3645||1 539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|DKK|8654|11265|lyfalmen|V0954|11265|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||7122||7122|11265||2 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19368|28120|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||19368||19368|28120||1 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|40537|11729|lyfalmen|V0721|11124|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7459||7459|11729||2 540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|0|1|TEA|0|0|0|100|SEK|20118|28639|lyfsjukr|||1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||20118||20118|28639||1 540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|8252|3264|lyfalmen|V0684|2825|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||1309||1309|3264||1 540709|N04BD0204|Rasagiline Mylan|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.11.2016|30.11.2018|R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|5476|6888|lyfalmen|||2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||3942||3942|6888||2 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CPV|0|1|0|100|XEU|646159|809993|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||||646159|809993||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|179742|229901|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||179742||179742|229901||1 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|5200|8619|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5200||5200|8619||2 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|0|G|0|WEH|0|0|0|100|XEU|4905|3209|lyfalmen|V0682|2825|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1269||1269|3209||2 542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|með skammtadælu|G03CA03|01.03.2017|30.11.2018|R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|1011|2854|lyfalmen|||2|64|0||Vistor hf|Takeda Oy|Estradíól||1011||1011|2854||1 542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|6840|4405|lyfalmen|V0683|2825|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||2138||2138|4405||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6435|10319|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6435|10319||2 542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|0|RTH|0|0|0|100|XEU|16298|8082|lyfalmen|V0720|8082|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||4810||4810|8082||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|841|2620|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||841||841|2620||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|14013|20749|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||14013|20749||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3364|3092|lyfalmen|V0203|3089|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1184||1184|3092||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|996|2833|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||996||996|2833||2 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|71924|94164|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||71924||71924|94164||2 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|250|0|21,7857|Icepharma hf|Meda AB|Semen psyllii (ispaghula)|||||||2 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3192|3778|lyfalmen|V0143|3527|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||1683||1683|3778||2 544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|501809|630462|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||501809||501809|630462||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|262279|332554|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||262279||262279|332554||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|11509|17303|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||11509||11509|17303||1 544571|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|7716|9599|lyfalmen|V0145|5159|2|8|0|16,0000|Artasan ehf|Sandoz A/S|Tadalafíl||5912||5912|9599||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37503|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37503||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|0|1|RRG|0|1|0|100|DKK|233005|296145|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||233005||233005|296145||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RTH|0|0|0|100|XEU|1495|3370|lyfalmen|V0134|3370|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1386||1386|3370||2 545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|814|2582|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||814||814|2582||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|773|2526|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||773||773|2526||1 545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|0|G|0|VBA|0|0|1|100|XEU|1173|2976|lyfalmen|V0903|2976|2|100|0|100,0000|Actavis Group PTC ehf|Actavis BV|Prómetazín||1100||1100|2976||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1886|4058|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1886||1886|4058||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26701|36966|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||26701||26701|36966||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21528|30423|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||21528||21528|30423||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26858|37164|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||26858||26858|37164||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22817|32053|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||22817||22817|32053||1 546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|3836|4208|lyfalmen|V0010|3950|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1995||1995|4208||1 546947|N05AX1211|Aripiprazole Mylan Pharma|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|IKR|7772|2825|lyfalmen|V0682|2825|2|56|0|18,6600|Icepharma hf|Pharmathen S.A.|Aripiprazól||990||990|2825||2 547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|14082|20844|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14082||14082|20844||1 547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|3096|5723|lyfsjukr|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||3096||3096|5723||2 547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|0|0|0|JUB|0|0|0|100|IKR|4100|7036|lyfalmen|V0581|7036|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||4050||4050|7036||2 547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2918|3076|lyfalmen|V0251|2170|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||1173||1173|3076||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5298||1 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|0|1|RGO|0|0|0|100|DKK|8535|13210|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||8535||8535|13210||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|0|1|RGO|0|0|0|100|DKK|2744|5239|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||2744||2744|5239||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8950|13781|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||8950|13781||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|FIN|0|0|0|100|DKK|94284|122445|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||94284||94284|122445||2 548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1370|3348|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||1370||1370|3348||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|489|2135|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||489||489|2135||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|HES|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||2080||1 548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|G|0|GGE|0|0|0|100|SEK|7465|7904|lyfalmen|V0694|5693|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||4680||4680|7904||2 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|134983|174234|lyfsjukr|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||134983||134983|174234||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|6858|10901|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6858||6858|10901||1 549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5316|lyfalmen|V0117|5316|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2800||2800|5316||2 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|29338|40301|lyfalmen|V0976|40301|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||29338|40301||2 550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|0|G|0|SAO|0|0|1|100|XEU|463|1736|lyfalmen|V0936|1736|2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||199||199|1736||2 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1437|2123|lyfalmen|V0551|2081|2|7|0|1,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||480||480|2123||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4928|lyfalmen|V0471|4928|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4928||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1524|3560|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1524||1524|3560||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6913|10977|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||6913||6913|10977||2 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|1467|3481|lyfalmen|||1|1|0|2,6667|Icepharma hf|Meda AB|Tríamcínólón||1467||1467|3481||2 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2349|4695|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||2349||2349|4695||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1812|2240|lyfalmen|V0466|2240|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2240||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2691|3930|lyfalmen|V0467|1740|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3930||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1355|1491|lyfalmen|V0003|1104|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1491||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2821|2240|lyfalmen|V0003|2208|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2240||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|5587|3930|lyfalmen|V0010|2212|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3930||1 551969|S01EE0106|Latanoprost Mylan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.04.2017|30.11.2018|R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1371|2796|lyfalmen|||2|7,5|0|75,0000|Icepharma hf|Mylan AB|Latanóprost||969||969|2796||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1482|3502|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1482||1482|3502||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552481|R06AE0501|Postafen|töflur|25|mg|20|stk|1|þpakki||R06AE05|01.05.2018||R|1|0|0|0|G|0|GOP|0|0|1|100|DKK|162|1685|lyfalmen|||1|20|0|10,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||162||162|1685||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|14506|23384|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||14506||14506|23384||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2842|5374|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2842||2842|5374||1 552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2 553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|165528|212223|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||165528||165528|212223||2 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|9532|14582|lyfalmen|V0237|14582|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||9532|14582||1 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3065|5681|lyfalmen|V0237|4861|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3065||3065|5681||1 553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|0|G|0|EVO|0|0|1|100|IKR|5000|8344|lyfalmen|||2|100|0|66,6666|LYFIS ehf|Evolan Pharma AB|Alímemazín||5000||5000|8344||2 553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2288|lyfalmen|V0169|2288|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||600||600|2288||2 553684|N06BA0904|Atomoxetine Sandoz|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|10231|5525|lyfalmen|V0812|5525|2|28|0|3,5000|Artasan ehf|Sandoz A/S|Atomoxetín||2952||2952|5525||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|494204|621004|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||494204||494204|621004||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|36763|49692|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||36763|49692||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|8521|16337|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||8521||8521|16337||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5880|6325|lyfalmen|V0029|6047|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3533||3533|6325||1 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1236804|1544590|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1236804||1236804|1544590||2 554721|J01XA0108|Vancomycin Actavis|st/irþ|1000|mg/hgl|1|hgl|1|pakki||J01XA01|01.07.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|1382|2699|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||899||899|2699||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|144497|186066|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||144497||144497|186066||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1579|3635|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1579||1579|3635||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|2198|4487|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2198||2198|4487||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1124|3009|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1124||1124|3009||1 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014|31.12.2018|R|0|1|0|0|0|1|THO|0|0|0|100|USD|434977|547342|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||434977||434977|547342||1 556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2 556694|C10AX1401|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|64979|85380|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||64979||64979|85380||1 556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|0|VAL|0|0|0|100|DKK|10458|12353|lyfalmen|V0954|11495|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||7913||7913|12353||2 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|17358|25354|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||17358||17358|25354||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4307|7390|lyfalmen|V0972|6172|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4307||4307|7390||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8397|13020|lyfalmen|V0973|11277|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8397||8397|13020||1 557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|9453|5542|lyfalmen|V0814|5492|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||2964||2964|5542||2 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2541|4720|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2367||2367|4720||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|216783|275970|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||216783|275970||1 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 558954|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.01.2017||R|0|0|0|0|0|1|BBV|0|0|0|100|SEK|44294|59217|lyfsjukr|||1|5|0|0,4000|Vistor hf|Janssen-Biologics B.V.|Abciximab||44294||44294|59217||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4125|7140|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4125||4125|7140||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1857||1 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|0|1|CBV|0|1|0|100|XEU|43272|57925|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe B.V.|Paklítaxel||43272||43272|57925||2 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1266|3204|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1266||1266|3204||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|4761|8015|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4761||4761|8015||1 560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|0|1|COR|0|0|0|100|DKK|97514|126530|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||97514||97514|126530||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|398889|502459|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||398889||398889|502459||1 560682|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|238239|108882|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||83561||83561|108882||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013|31.10.2018|R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|117830|57238|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||42729||42729|57238||1 561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995|30.11.2018|R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1357|3330|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1357||1357|3330||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|179742|229901|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||179742||179742|229901||1 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1472|2946|lyfalmen|V0098|2876|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1078||1078|2946||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|43989|58832|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||43989||43989|58832||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3790|6679|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||3790||3790|6679||1 562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|1|FEC|0|0|0|100|XEU|844257|1056372|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||844257||844257|1056372||2 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BXG|0|1|0|100|SEK|226882|288530|lyfsjukr|||1|300|0||Shire Sweden AB |BaxterAG*|Immúnóglóbúlín, normal, manna, gefin í æð||226882||226882|288530||3 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|1|RGP|0|1|0|100|DKK|76039|99368|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||76039||76039|99368||1 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5746|9371|lyfalmen|V0705|8470|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||5746||5746|9371||1 563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33106|45067|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||33106||33106|45067||2 563213|D07AC1702|Flutivate|krem|0,05|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2002|4218|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2002||2002|4218||1 563285|N06BA0904|Atomoxetine Sandoz|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|10231|5525|lyfalmen|V0813|5525|2|28|0|6,3000|Artasan ehf|Sandoz A/S|Atomoxetín||2952||2952|5525||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1220|3141|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1220||1220|3141||1 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|22141|9367|lyfalmen|V0720|8082|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||5743||5743|9367||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3168|5822|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3168||3168|5822||2 563653|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1501|2240|lyfalmen|V0494|2240|2|90|0|180,0000|Vistor hf|Bluefish Pharmaceuticals AB|Glímepíríð||565||565|2240||1 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1398|2748||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|410012|516293|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||410012||410012|516293||1 563799|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1614|3683|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1614||1614|3683||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2 563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|593|2278|lyfalmen|V0596|2201|2|28|0|1,8600|Alvogen|ratiopharm GmbH|Oxýcódon||593||593|2278||2 564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3200|4628|lyfalmen|V0348|4573|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||2300||2300|4628||2 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|18969|27571|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||18969||18969|27571||3 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|911|2716|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||911||911|2716||1 564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|0|MER|0|0|0|100|XEU|2118|3651|vetorma|||0|3|0||Vistor hf|Merial|Milbemycin oxime í blöndum||2118||2118|3651||1 564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2332|4672|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2332||2332|4672||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||30.11.2018|1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|7600|6380|lyfalmen|V0286|6380|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3573||3573|6380||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9291|14250|lyfalmen|V0714|14250|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9291||9291|14250||1 565625|M01AE0102|Ibufen|mixtúra|20|mg/ml|100|ml|1|glas||M01AE01|01.08.2016||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|100|0|1,6700|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|7647|14678|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||7647|14678||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|21674|30608|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||21674||21674|30608||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1459|3470|lyfalmen|V0444|2789|1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1459||1459|3470||1 566853|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.10.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1812|3956|lyfalmen|||1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1812||1812|3956||1 566873|N05BB0102|Allerzine|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.09.2017||R|1|0|0|0|0|0|IPC|0|0|1|100|SEK|939|2008|lyfalmen|V0907|2008|2|100|0|33,3333|Alvogen|Alvogen IPco S.á.r.l.|Hýdroxýzín||397||397|2008||2 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13081|19467|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13081||13081|19467||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|165877|212657|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||165877||165877|212657||1 567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3587|2770|lyfalmen|V0114|2770|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2770||2 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|15308|22532|lyfalmen|V0651|22532|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15308||15308|22532||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3100||2 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|5127|8519|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5127|8519||1 567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1905|4084|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1905||1905|4084||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2321|4657|lyfalmen|V0291|2425|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2321||2321|4657||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|2434|4812|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||2434||2434|4812||2 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4496|7650|lyfalmen|V0292|3114|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||4496||4496|7650||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRG|0|0|0|100|DKK|336566|424946|lyfalmen|V0919|424945|1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||336566|424946||2 567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 567837|G04BE0808|Tadalafil Sandoz|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|8676|13404|lyfalmen|||2|28|0|14,0000|Artasan ehf|Sandoz A/S|Tadalafíl||8676||8676|13404|30.11.2018|1 567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 568054|N02CX0701|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CX07|01.12.2018||R|0|0|0|1|0|0|NEL|0|0|0|100|DKK|61195|80594|lyfalmen|||1|1|0||Vistor hf|Novartis Europharm Ltd|Erenumab||61195||61195|80594||1 568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2191|2834|lyfalmen|V0826|2834|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||997||997|2834||2 568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2838|lyfalmen|V0334|2838|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2838||2 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|909|2713|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||909||909|2713||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|4731|7974|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai GmbH|Perampanel||4731||4731|7974||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2569|3032|lyfalmen|V0058|2687|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1141||1141|3032||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3464|3867|lyfalmen|V0059|3114|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1747||1747|3867||1 569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|850|1942|lyfalmen|V0827|1942|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||349||349|1942||2 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VIH|0|0|0|100|DKK|118024|153141|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||118024||118024|153141||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9451|14470|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||9451||9451|14470||2 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|4800|2838|lyfalmen|V0001|2838|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2838||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|13591|20169|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13591||13591|20169||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|15630|22975|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||15630||15630|22975||1 569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|7243|lyfalmen|V0811|7243|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4200||4200|7243||2 570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BFP|0|0|0|100|XEU|5895|8767|lyfalmen|V0657|8757|2|30|0|10,0000|Vistor hf|Bluefish Pharmaceuticals AB|Modafinil||5307||5307|8767||1 570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1780|2710|lyfalmen|V0110|2563|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||907||907|2710||2 570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2530|4944|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2530||2530|4944||2 570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1836|3989|lyfalmen|V0938|3989|1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1836||1836|3989||1 570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|0|G|0|DIC|0|0|1|100|IKR|3584|4765|lyfalmen|V0196|4765|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||2400||2400|4765||2 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|2996|5855|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||2996||2996|5855||1 571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|650|2013|lyfalmen|V0908|2013|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2013||2 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|XEU|3136|5778|lyfalmen|V0384|5015|2|15|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||3136||3136|5778||2 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|1|CHI|0|0|0|100|DKK|73126|95684|lyfsjukr|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||73126||73126|95684||1 571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|262384|332685|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||262384||262384|332685||1 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|481962|605778|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||481962||481962|605778||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||30.11.2018|1 571526|J05AB1402|Valganciclovir Teva|filmhtfl|450|mg|60|stk|1|þpakki||J05AB14|01.12.2018||R|1|0|0|0|0|1|TAB|0|0|0|100|DKK|53348|70669|lyfsjukr|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Valgancíklóvír||53348||53348|70669||2 572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|0|1|0|1|ACC|0|1|0|100|XEU|36794|49731|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare Limited|Temozolomid||36794||36794|49731||1 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|70749|92678|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||70749||70749|92678||1 572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1641|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2659||2 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||30.11.2018|1 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|5827|3926|lyfalmen|V0245|3860|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||1790||1790|3926||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3308|6015|lyfalmen|||1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||3308||3308|6015||1 573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|0|1|0|1|GSE|0|0|0|100|DKK|2227472|2776704|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||2227472|2776704||2 573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|76990|100571|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||76990||76990|100571||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|13477|20012|lyfsjukr|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||13477||13477|20012||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|22096|31141|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||22096||22096|31141||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4660|4296|lyfalmen|V0144|4146|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2059||2059|4296||2 574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|0|1|RRG|0|1|0|100|DKK|369174|465502|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||369174||369174|465502||2 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|9126|14023|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||9126||9126|14023||1 574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|6808|6754|lyfalmen|V0322|2916|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3845||3845|6754||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4030|2460|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||725||725|2460||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|12269|6754|lyfalmen|V0323|4400|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3845||3845|6754||1 575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|0|SGB|0|0|0|100|XEU|22127|31180|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||22127||22127|31180||1 575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|1|WIL|0|1|0|100|XEU|35374|47935|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||35374||35374|47935||2 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|761296|953192|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||761296||761296|953192||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1089|2135|lyfalmen|V0159|2135|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||489||489|2135||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|SEK|1308|2443|lyfalmen|V0160|2443|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||713||713|2443||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1392|2494|lyfalmen|V0158|2494|2|20|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||750||750|2494||2 575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|0|1|G|0|FEP|0|0|0|100|DKK|78487|102465|lyfalmen|||1|2,16|0||Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||78487||78487|102465||1 575919|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|9646|14739|lyfalmen|V0900|14739|2|100|0|33,3300|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9646||9646|14739||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|1086|2160|lyfalmen|V0243|1922|2|42|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||507||507|2160||1 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CPV|0|1|0|100|XEU|1199089|1497683|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1199089||1199089|1497683||2 576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5680||5680|10947||2 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|8972|13811|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||8972||8972|13811||2 576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|13500|10684|lyfalmen|V0680|10684|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||6700||6700|10684||2 577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|422|2043|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||422||422|2043||1 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|18781|27312|lyfalmen|V0727|24819|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||18781||18781|27312||1 577682|N06BA0904|Atomoxetine Sandoz|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|14113|6559|lyfalmen|V0817|6559|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Atomoxetín||3703||3703|6559||1 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|10178|15471|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10178||10178|15471||2 577921|C10AX0902|Ezetimib Actavis|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|0|GPA|0|0|0|100|DKK|10565|12788|lyfalmen|V0954|11495|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Ezetimíb||8229||8229|12788||1 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|4094|7097|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4094||4094|7097||1 578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|331056|418093|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||331056||331056|418093||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|6204|10693|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||6204||6204|10693||2 578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|607|2297|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||607||607|2297||1 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|IKR|14658|14400|lyfalmen|V0423|14125|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14400||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|951|2771|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||951||951|2771||1 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|2260|4573|lyfalmen|||1|98|0|98,0000|Icepharma hf|BGP Products ApS|Verapamíl||2260||2260|4573||2 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|191659|244723|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||191659||191659|244723||1 579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1572|3626|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1572||1572|3626||1 579864|C07AB0214|Bloxazoc|forðatfl|100|mg|30|stk|1|þpakki||C07AB02|01.05.2017|31.12.2018|R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|800|2563|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||800||800|2563||2 579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|9090|13973|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9090||9090|13973||1 579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|3446|2508|lyfalmen|V0107|2508|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2508||2 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|XEU|13062|9251|lyfalmen|V0111|6665|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||5659||5659|9251||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|659|2369|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||659||659|2369||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7568|11879|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||7568||7568|11879||1 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|0|1|FKD|0|0|0|100|DKK|6674|10648|lyfsjukr|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||6674||6674|10648||2 580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3564|6367|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3564||3564|6367||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1402|3392|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1402||1402|3392||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2881|5427|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2881||2881|5427||2 581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|3158|5259|lyfalmen|V0620|5259|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2759||2759|5259||2 581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|15226|lyfalmen|V0421|15226|2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||10000||10000|15226||2 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|12738|24337|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||12738||12738|24337||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2133|4398|lyfalmen|V0669|4056|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2133||2133|4398||1 582004|L01XE2901|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|0|1|0|1|EUL|0|0|0|100|SEK|216005|275002|lyfsjukr|||1|30|0||Eisai AB|Eisai Europe Ltd.|Lenvatinib||216005||216005|275002||1 582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2 582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|0|G|0|JUB|0|0|0|100|DKK|3763|6172|lyfalmen|V0972|6172|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||3422||3422|6172||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|15504|22802|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||15504||15504|22802||3 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21936|30939|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||21936||21936|30939||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25163|35020|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||25163||25163|35020||2 582611|A10BJ0601|Ozempic|stl|1|mg/ml|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|0|NON|0|0|0|100|DKK|18354|26724|lyfalmen|||1|3|0||Vistor hf|Novo-Nordisk|Semaglutide||18354||18354|26724||1 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|57137|75461|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||57137||57137|75461||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22306|31407|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||22306||22306|31407||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|29468|40465|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||29468||29468|40465||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1803|3944|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1803||1803|3944||1 583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|45568|60829|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||45568||45568|60829||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|839|2617|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||839||839|2617||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|76954|100526|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||76954||76954|100526||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24380|34030|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||24380||24380|34030||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|39008|52532|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||39008||39008|52532||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|73140|95702|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||73140||73140|95702||2 583806|G04BE0310|Sildenafil LYFIS|filmhtfl|100|mg|24|stk|1|þpakki||G04BE03|01.09.2016|31.12.2018|R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|10000|9720|lyfalmen|||2|24|0|48,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6000||6000|9720||2 583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1642|3722|lyfsjukr|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1642||1642|3722||2 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MBV|0|0|0|100|DKK|16344|23958|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme B.V.|Interferón alfa-2b||16344||16344|23958||1 585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|0|1|MBV|0|1|0|100|DKK|469497|590275|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||469497||469497|590275||1 585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak|||||||1 585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|19885|28832|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19885||19885|28832||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5334|8804|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5334||5334|8804||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3931|6873|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3931||3931|6873||1 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|2116|lyfalmen|V0006|2116|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||475||475|2116||2 585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|10918|16489|lyfalmen|||1|4|0|20,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||10918||10918|16489||2 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3684|6533|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3684||3684|6533||1 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|27180|37572|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||27180||27180|37572||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|12510|18681|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||12510||12510|18681||2 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|0|1|NEL|0|1|0|100|DKK|333695|421376|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||333695||333695|421376||1 586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|61744|81288|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||61744||61744|81288||1 586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017|30.11.2018|R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10735|5711|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||3087||3087|5711||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|26021|36106|lyfalmen|V0652|36106|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||26021|36106||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|3956|4815|lyfalmen|V0196|4765|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||2436||2436|4815||1 587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|140400|180971|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||140400||140400|180971||1 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4094|7097|lyfalmen|V0095|7097|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||4094||4094|7097||1 587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|0|WEH|0|0|0|100|IKR|11132|12498|lyfalmen|V0957|12498|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||8018||8018|12498||2 587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|4013|5774|lyfalmen|V0081|5774|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3133||3133|5774||2 588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|0|1|0|1|OEL|0|1|0|100|DKK|150353|193350|lyfsjukr|||1|3|0||Vistor hf|LEO Pharma A/S|Brodalumab||150353||150353|193350||1 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|0|G|0|WEH|0|0|0|100|XEU|18282|3209|lyfalmen|V0683|2825|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1269||1269|3209||2 588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PEU|0|0|0|100|DKK|645465|809130|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||645465||645465|809130||1 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1714|3821|lyfalmen|||1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1714||1714|3821||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|6979|11068|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||6979||6979|11068||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EIG|0|0|0|100|SEK|18923|27508|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai GmbH|Perampanel||18923||18923|27508||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|8275|6032|lyfalmen|V0282|5909|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3320||3320|6032||1 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|576645|723537|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||576645||576645|723537||1 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9971|15186|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||9971||9971|15186||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013|31.10.2018|R|0|1|0|1|0|1|ABD|0|1|0|100|DKK|116189|150859|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||116189||116189|150859||1 590135|C10AA0107|Simvastatin LYFIS|filmhtfl|10|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|1693|2288|lyfalmen|V0108|2128|2|100|0|33,3400|LYFIS ehf|LYFIS ehf|Simvastatín||600||600|2288||2 590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|1|0|1|ACC|0|0|0|100|XEU|36858|49812|lyfsjukr|||2|90|0|36,0000|Artasan ehf|Accord Healthcare Limited|Síldenafíl||36858||36858|49812||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2710|3288|lyfalmen|V0041|3231|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1327||1327|3288||1 590825|L01XX5001|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|747110|935548|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||747110||747110|935548||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|148677|191265|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||148677||148677|191265||1 590947|H05BX0105|Cinacalcet Accord|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|AEE|0|0|0|100|XEU|32086|12097|lyfalmen|V0721|11124|2|28|0|28,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||7727||7727|12097||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|11423|17185|lyfalmen|V0347|17185|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||11423||11423|17185||3 591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|0|1|0|0|PEU|0|1|0|100|DKK|107608|140187|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||107608||107608|140187||2 591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1825|3974|lyfalmen|V0561|3390|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1825||1825|3974||2 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1343|3310|lyfalmen|V0168|2609|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1343||1343|3310||1 592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|1|LNA|0|0|0|100|SEK|2294|4619|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2294||2294|4619||2 592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2308|3045|lyfalmen|V0825|3036|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3045||2 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3352|6530|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3352||3352|6530||1 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|654572|800463|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||638496||638496|800463||1 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|802|2566|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||802||802|2566||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1175|3079|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1175||1175|3079||2 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|6835|5774|lyfalmen|V0694|5693|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||3133||3133|5774||2 594099|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|942|2167|lyfalmen|||2|90|0|135,0000|Vistor hf|Bluefish Pharmaceuticals AB|Glímepíríð||512||512|2167|31.10.2018|1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|16549|24240|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||16549||16549|24240||2 594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|1|0|G|0|RTH|0|0|0|100|IKR|3504|5316|lyfalmen|V0945|5316|2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||2800||2800|5316||2 594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|0|0|0|EVO|0|0|0|100|IKR|10293|14125|lyfalmen|V0969|13460|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||9200||9200|14125||2 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|15308|22532|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15308||15308|22532||1 595653|J01CR0205|Spectracillin|filmhtfl|1000|mg|10|stk|1|þpakki|875+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|752|2035|lyfalmen|||2|10|0|5,8333|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||416||416|2035||2 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PEU|0|1|0|100|DKK|20571|29212|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||20571||20571|29212||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|48772|64881|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||48772|64881||1 596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2 596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1169|2015|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Febantel, Pyrantelembonat,Prazikvantel||1169||1169|2015||2 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|1|ORC|0|0|0|100|DKK|15018|22133|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||15018||15018|22133||1 597041|R06AX2702|Aerius (Lyf og heilsa)|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.06.2016||R|1|0|0|0|G|0|HOL|0|0|1|100|NOK|2979|5562|lyfalmen|V0458|2431|3|90|0|90,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||2979||2979|5562||2 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1569|3622|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1569||1569|3622||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|1|BMS|0|1|0|100|DKK|568095|712904|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||568095||568095|712904||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BNB|0|0|0|100|XEU|108529|141332|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||108529||108529|141332||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 597814|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.01.2018|31.10.2018|R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2001|2577|lyfalmen|||2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||810||810|2577||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2130|4394|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||2130||2130|4394||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNP|0|0|1|100|XEU|330|1916|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||330||330|1916||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2 598843|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|tfílát||A07EC03|01.04.2018||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4390|7504|lyfalmen|V0953|7504|1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4390||4390|7504||2 598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||2139||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PEU|0|1|0|100|DKK|543976|682906|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||543976||543976|682906||1 599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|0|1|GRP|0|0|0|100|XEU|5181|8593|lyfsjukr|||2|20|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Oxalíplatín||5181||5181|8593||1 599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3191|6224|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3191||3191|6224||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|3999|7757|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||3999||3999|7757||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2417||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|25856|35897|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||25856|35897||1 599531|H05BX0105|Cinacalcet Accord|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|AEE|0|0|0|100|XEU|17357|9133|lyfalmen|V0720|8082|2|28|0|14,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||5573||5573|9133||1 599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|glas||B01AA03|01.01.2019||R|1|0|0|0|G|0|TVB|0|0|0|100|XEU|1170|3072|lyfalmen|||2|100|0|13,3333|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Warfarín||1170||1170|3072||1 599737|N05AX1211|Aripiprazole Mylan Pharma|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|IKR|7772|2825|lyfalmen|V0684|2825|2|56|0|56,0000|Icepharma hf|Pharmathen S.A.|Aripiprazól||990||990|2825||2 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3236|3488|lyfalmen|V0334|2838|2|100|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1472||1472|3488||1 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|0|1|GEL|0|0|0|100|NOK|110006|143169|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||110006||110006|143169||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22273|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22273||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2996|5054|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|5054||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1598|3661|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1598||1598|3661||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27435|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27435||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|11188|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|11188||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5493|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5493||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6486|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6486||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6951|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6951||2 970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23477|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23477||2 970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1995|4208|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||||1995|4208||2 974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6107|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6107||2 974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33003|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33003||2 974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6915|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6915||2 977225|G04BE0314|Sildenafil suspension - forskriftarlyf|mixtduft|2|mg/ml|300|ml|1|glas||G04BE03|01.12.2018||R|0|0|0|0|0|0|ARB|0|0|0|100|IKR|7630|11964|lyfalmen|||1|300|0|12,0000|Árbæjarapótek|Árbæjarapótek - forskriftarlyf|Síldenafíl||7630||7630|11964||0 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|8337|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|8337||2 980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|16998|24858|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24858||2